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Abstract 
Sensory gating is a mechanism by which irrelevant sensory information is 
filtered in the brain, enabling efficient information processing. The auditory 
conditioning-test paradigm, an index of sensory gating, measures the reduction 
in the auditory-evoked response (AER) produced by a test stimulus following an 
initial conditioning stimulus. Schizophrenic patients demonstrate a lack of 
attenuation of the test response measured in the P50 component of the cortical 
auditory-evoked potential. The N2/N40 auditory-evoked potential recorded from 
rat hippocampus is considered homologous to the human P50 wave. Altered 
glutamatergic neurotransmission and the endocannabinoid system have been 
implicated in the pathogenesis of schizophrenia with structural and functional 
abnormalities in the hippocampus and the medial prefrontal cortex (mPFC). 
The current study examined sensory gating using auditory conditioning-test 
paradigm in the dentate gyrus (DG) and the CA3 region of the hippocampus 
and in the medial prefrontal cortex (mPFC) before and after administration of N-
Methyl-D-Aspartate (NMDA) receptor antagonist phencyclidine (PCP; 1 mg/kg, 
Lp) or the cannabinoid agonist WIN55,212-2 (1.2mg/kg, Lp). 
Electrophysiological recordings were conducted in Lister hooded rats, under 
isoflurane anaesthesia, during the presentation of paired auditory stimuli. 
Extracellular action potential spikes and local field potentials (LFPs) were 
recorded simultaneously using multi-electrode arrays and the effects of acute 
administration of PCP (1 mg/kg, i.p) or WIN55,212-2 (1.2mg/kg, i.p) was 
determined. Gating of the N2 wave was assessed by measuring the ratio of the 
Test to Conditioning response amplitude (TIC ratio); TIC ratio ~ ~ 50% was 
indicative of gating. 
Robust auditory-evoked potentials were recorded from the hippocampal CA3 
and DG regions and the mPFC; some rats demonstrated auditory gating while 
others failed to. In rats that demonstrated gating of N2, mPFC showed higher 
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TIC ratios and shorter conditioning response latencies compared to DG and 
CA3. 
PCP disrupted auditory gating in all three areas with a significant increase in 
test response amplitudes in the gating rats. PCP had no effect on TIC ratios in 
the non-gating rats. The atypical antipsychotic clozapine (5mg/kg, Lp) prevented 
PCP induced disruption of gating in the CA3, DG and mPFC. WIN55,212-2 
disrupted auditory gating with a significant increase in test response amplitudes 
in the gating rats. WIN55,212-2 had no effect on TIC ratios in the non-gating 
rats. The cannabinoid receptor (CB1) antagonist SR141716A (1mg/kg, Lp) 
prevented WIN55,212-2 induced disruption of gating. Neither clozapine nor 
SR141716A had any effects on the non-gating rats. Both PCP and WIN55,212-
2 disrupted gating of the single-unit responses in the CA3, DG and mPFC, 
effects which were prevented by the pre-administration of clozapine or 
SR141716A. 
The non-gating rats may model some inhibitory deficits observed in 
schizophrenic patients. Administration of PCP disrupted auditory gating which 
was prevented by clozapine; similar deficits are observed in schizophrenic 
patients. Furthermore, cannabinoid receptor activation disrupted auditory gating 
which was prevented by CB1 receptor antagonism, suggesting the 
endocannabinoid system as a potential target for future clinical research in the 
treatment in schizophrenia. 
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Chapter One 
General Introduction 
1. General Introduction 
This PhD study focuses on sensory gating, a process by which the central 
nervous system filters incoming sensory stimuli and prevents 'flooding' of the 
brain with irrelevant or repetitive information. Filtering of unnecessary 
information is crucial for efficient information processing. Sensory gating can be 
measured reliably by examining the stimuli-evoked brain responses using 
electrophysiology. Studies on sensory gating have attracted both psychiatrists 
and neuroscientists as this process is altered in several psychiatric disorders, 
the most well known of which is schizophrenia. Studying sensory gating may 
lead to a better understanding of the mechanisms by which the brain filters, 
prioritises and processes relentless information received via all the senses. 
Moreover, it is possible that sensory gating may eventually be used as a 
diagnostic tool by psychiatrists and assist in new discoveries relating to the 
pathogenesis and treatment of schizophrenia. To examine the mechanisms of 
sensory g a t i n ~ ~ and to test possible treatment regimens, it would be desirable to 
reproduce the phenomenon in laboratory animal models which will assist in 
examining neural substrates of these mechanisms even at cellular level. In this 
study we sought to reproduce the sensory gating phenomenon in the rat by 
examining this process at the level of both local field potentials and single-units 
in two brain areas (i.e. hippocampus and prefrontal cortex) implicated in the 
pathogenesis of schizophrenia. We also sought to determine if sensory gating 
could be disrupted via pharmacological interventions in order to model the 
general deficits in information processing and the specific deficits in sensory 
gating observed in schizophrenia. 
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1.1 Sensory gating 
Sensory gating has been conceptualized as a continuously active process, 
contributing to an individual's ability to modulate a continuous stream of sensory 
and cognitive information (Adler et al., 1982; Light & Braff, 2003). This process 
allows the central nervous system to selectively attend to important stimuli while 
ignoring redundant, repetitive and trivial stimuli. Sensory gating allows for the 
identification of the occurrence of a stimulus, the assessment of its importance 
and the elicitation of a response. Response generation occurs to novel or 
changing stimuli ("gating-in") whereas suppression of responding ("gating-out") 
occurs when a stimulus is redundant or repetitive (Boutros et aI., 1999; 
Cromwell et al., 2005). Sensory gating has been observed with different 
sensory modalities, including olfactory (Best et aI., 2005; Murakami et aI., 
2005), somatosensory (Thoma et al., 2007), Visual (Bless et aI., 2007) and 
auditory (Adler et aI., 1982; Freedman et aI., 1996; Boutros et aI., 1999; 
Cadenhead et aI., 2000,2005). The gating process is most commonly assessed 
in both humans and animals by examining the brain responses to auditory 
stimuli using the auditory conditioning-test paradigm. The experiments 
discussed in this thesis utilized the auditory-conditioning-test paradigm to 
assess sensory (i.e. auditory) gating in the rat brain. 
1.1.1 Auditory conditioning-test paradigm 
A widely used quantitative measure of a subject's ability to filter sensory 
information is the amplitude ratio of the auditory-evoked responses, recorded 
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electrophysiologically, to two click stimuli presented 500 ms apart (Fig. 1.1). 
Sensory gating is operationally defined as the ratio of the amplitudes of the 
responses to the second (Test: T) stimulus to the first (conditioning: C) stimulus 
(TIC x 100%). A ratio <100% indicates suppression of the second response and 
a ratio of >100% indicates enhancement of the second response. Normal 
subjects have a smaller response to the second, or test click, than to the first, or 
conditioning click. Lower ratios reflect stronger attenuation of irrelevant input 
and thus better sensory gating. 
~ ~ ) g g ~ ) g g cs = Conditioning stimulus TS = Test stimulus 
-v 
C = Conditioning response 
-1t- T = Test response TIC ratio = Test response 
T amplitude/conditioning 
C TIC ratio = 40% response amplitude x 100 
Fig 1.1 Illustration of the auditory conditioning-test paradigm demonstrating the reduction of the 
response to the test stimulus (T) compared to the response to the identical conditioning stimulus 
(C) resulting in a TIC ratio <100% 
Auditory-evoked responses in the brain 
The auditory-evoked potential responses (AER) are recorded in humans using 
an electroencephalogram (EEG), the recording of electrical activity in the brain 
obtained from electrodes placed on the scalp. AERs consist of a series of peaks 
and troughs in the EEG, reflecting the response to an auditory stimulus such as 
a tone or a click (Fig'1.2). Most evoked potentia Is are generally of low amplitude 
relative to background brain activity and are not clearly evident in the EEG 
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record. One strategy employed to overcome this problem is to present the 
subject with a series of identical stimuli and use the average evoked activity. 
This method removes random background activity, resulting in the clear 
visualization of evoked potentials (de Sruin et al., 2003). AERs can be used to 
examine successive stages of information processing in the presence of an 
external stimulus. AERs occurring within 200 ms after the onset of stimulus are 
called exogenous or stimulus-driven responses, as they represent early stages 
of information processing and are mainly driven by the physical characteristics 
of the stimulus. Responses' occurring after 200 ms are called endogenous or 
concept-driven, as the latter part of the process is based on the cognitive and 
emotional importance of the stimulus (Soutros et al., 2004; Neuchterlein & 
Dawson, 2005). AERs are divided into three components depending on the 
latency i.e. duration of time from the stimulus to the response: (1) a putative 
brain stem response (responses within the first 10 milliseconds), (2) mid-latency 
components (from 10-200 ms) and (3) long latency components (responses 
after 200 ms; Soutres et al., 2004; Neuchterlein & Dawson, 2005). Two 
particular mid-latency AERs have been studied in a number of studies 
assessing sensory gating. These two components are the P50 (P1) wave, a 
positive component seen approximately 50 ms after auditory stimulation, and 
the N100 (N1), a negative component seen apprOXimately 100 ms after the 
stimulation (Freedman et al., 1983; Nagamoto et al., 1989; Soutros et al., 1999; 
Rosberg et al., 2000; Rentzch et al., 2008a, 2008b). Two positive waves have 
also been described in the long latency phase, P200 (P2) and P300 (P3), 
occurring after 200 ms and 300 ms, respectively (Soutros et aI., 2004; Rentzch 
b-
et al., 2008a, 2008 ). 
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Fig 1.2 Recording of auditory-evoked responses using scalp electrodes. The amplified EEG is 
averaged to examine AERs, a series of positive and negative waves; P1 (P50), the second 
positive wave in the mid-latency range is preceded by the Pa and Nb waves and followed by 
N1, P2, N2 and P3 waves (modified from de Bruin et aI., 2003). 
The auditory-evoked responses can be better studied by recording from 
intracranial electrodes, a method more feasible in animals than in humans. 
Intracranial electrodes not only allow recording from targeted areas in the brain 
and facilitate examination of the local field potentials (LFPs) but also useful in 
recording of single-unit activity extracellularly (Bullock, 1997). Local field 
potentials are vector sums of the intercellular (Le. synaptic) currents of the 
nerve cells in the vicinity of the recording electrode tip and single-unit activity 
represents the discharge of action potentia Is from post synaptic neurons 
(Bullock, 1997). A negative auditory-evoked LFP response occurring around 30-
80 ms recorded from the skull electrodes and also from the CA3 region of the 
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hippocampus in rats demonstrate properties similar to the human P50 wave 
(Adler et., 1986; Bickford et al., 1990). Adler and colleagues named this wave 
as N50 and later was commonly identified as N40 or N2 by the same research 
group and other researchers (Adler et., 1986; Bickford et al., 1990; Stevens et 
al., 1997; Van LUijtelaar et al., 1998,2001; de Bruin et al., 2001 a). 
1.1.2 Basic properties of auditory gating 
Gating of the scalp recorded AERs in both the mid-latency (P50, N100) and 
long-latency range (P200, P300) has been observed in healthy adult humans 
with the TIC ratio for the P50 (P1) wave observed to be less than 40% (Adler et 
al., 1982; Kisley et al., 2001, 2004). The P50 wave is the most commonly used 
AER in clinical and pre-clinical research since gating of the P50 is unaffected by 
the level of attention (Adler et al., 1982) and less altered by the behavioural 
states such as N-REM sleep or passive wakefulness compared to the other 
AERs (Kisley ~ t t al., 2001). Moreover, P50 gating is affected by psychological 
status such as stress (Jonson and Adler., 1993; Ermutlu et al., 2005), 
neoropsychiatric diseases (see section 1.1.4) and by some psychoactive drugs 
(see below) which has led P50 auditory gating to become a reliable and a 
consistent measure of the intact sensory filtering process. The N40 (N50/N2) 
wave has also been shown to demonstrate gating in both freely moving and 
anaesthetized rats (Adler et., 1986; Bickford et al., 1990, 1993; Boutros et al., 
1997; Van Luijtelaar et al., 2001). The N40 gating is not altered during N-REM 
sleep or passive wakefulness (van Luijtelaar et al., 1998) and is sensitive to 
pharmacological manipulations (Adler et., 1986; Bickford et al., 1990; Miller et 
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al., 1992; de Bruin et al., 2001; Krause et al., 2003) similar to the finding of the 
human P50 wave, making it an ideal animal model to examine the auditory 
gating process. 
The effect of age and gender on sensory gating has been the focus of some 
studies on auditory gating. The gating of the P50 wave has been shown to 
mature with age with higher TIC ratios in the early childhood and improved 
gating with age (Freedman et aI., 1991; Marshall et aI., 2004; Brinkman and 
Stauder, 2007). The findings of the above studies were correlated to the 
immaturity of the pre-frontal cortex in early childhood which was proposed to be 
an important area mediating auditory gating (Freedman et aI., 1991; Marshall et 
al., 2004). Marshall et al (2004) reported a negative correlation between age 
and the test response amplitude in children between 7 -13yrs and adult level 
gating by 11-13 yrs of age. Kisley et al (2003) studied auditory gating in infants 
of 1-4 months during REM sleep and found intact gating with improved TIC 
ratios with age even in infancy. Brinkman and Stauder (2007) demonstrated that 
sensory gating improves with increases in the response to the conditioning 
stimulus with age and reaches the adult level at the age of 8yrs. Hetrick et al 
(1996) reported that women have higher response amplitudes and less sensory 
gating compared to men. However, later studies found no significant differences 
in amplitudes or TIC ratios between men and women (Rasco et al., 2000; 
Brinkman and Stauder, 2007). 
Parametric studies examining the effects of stimulus properties on auditory 
gating are considered useful to establish the consistency, specificity and 
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stability of this measure. The changes in the intensity of the sound or the 
duration of the click do not seem to affect gating of the P50 wave in the 
conditioning-test paradigm (Griffith et al., 1995; Yee and White, 2001; Patterson 
et aI., 2008). Furthermore, studies have shown that the frequency or the type 
(mixed or pure tone) of the click do not affect the P50 properties and gating 
(Boutros and Belger., 1998; Ninomiya et al., 2000). Meta analysis of the P50 
gating studies by de Wilde et al (2007) and Patterson et al (2008) show that 
between studies differences in the P50 parameters and associated gating are 
dependent on the intensity of the auditory stimuli. Based on their findings, Wide 
et al (2007) suggested the use of stimuli between 85 - 90dB intensity to obtain 
maximum gating in normal individuals. However, between-groups gating 
differences were also attributed to other methodological factors such as 
response filtering parameters (Wilde et al., 2007; Patterson et al., 2008). The 
N40 auditory evoked responses with changes in the loudness, duration and 
frequency of the auditory stimuli have been studied in freely moving rats 
(Boutros et al., 1997; Zhou et al., 2008) and the gating ability has been shown 
to be persistent irrespective of the differences in the characteristics of the 
stimuli as long as the second stimulus did not carry any new information 
(Boutros et al., 1997; Zhou et al., 2008). Studies assessing the reproducibility of 
the P50 (Boutros et al., 1991; Fuerst et al., 2007; Rentzsch et al., 2008) and 
N40 waves (Boutros and Kwan, 1998) have indicated the usefulness of studying 
P50 and N40 gating as measures of intact information processing in the brain. 
Several studies over the past two decades have demonstrated that the gating 
ability of the P50 in humans and N40 (N50/N2) in rats vary with inter-stimulus 
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interval (lSI). In healthy human subjects, who exhibit normal gating at ISls of 
500-2000ms with maximal gating at 500ms (Adler et aI., 1982), show a 
complete absence of gating with IS Is of 6s (Adler et al., 1982) or 8s (Zouridakis 
et al., 1997).The N40 response in rats varies with ISI with maximum gating at 
ISI = 500 ms, correlating with the findings of human studies (Adler et al., 1986; 
Sickford et al., 1993; Krause et al., 2003). These results indicate that gating 
occurs only when two identical stimuli are presented within a short time interval. 
1.1.3 Neurobiology of auditory gating 
The exact neurophysiological mechanism responsible for auditory sensory 
gating is not fully understood but was initially proposed to be closely linked to 
habituation, a process involved in synaptic plastiCity (Adler et al., 1982; Soutros 
and Selger, 1999b; Rosberg et al., 2000). Habituation is a form of non-
associative learning which occurs when a stimulus is repeatedly presented, 
resulting in a gradual reduction of the response to the stimulus. If habituation is 
the mechanism behind sensory gating, the process would depend on the 
development of refractory periods. Furthermore, the amplitude of the test 
response would depend on the recovery status of the neuronal pool stimulated 
by the conditioning stimulus. However, refractoriness of sensory neurons is 
unlikely to be the sole mechanism behind gating of stimuli presented at an inter-
stimuli interval of up to 1-2s, since most neurons have refractory periods of only 
a few milliseconds (Soutros and Selger, 1999b). 
Recent studies implicate that gating of auditory stimuli involves multiple 
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neurotransmitter systems and recurrent inhibitory and excitatory circuits with 
endogenous and exogenous inputs to the brain areas mediating auditory gating 
(Miller and Freedman 1993, 1995; Flach et al., 1996; Moxon et al., 1999, 
2003a,b). These studies suggest that the conditioning stimulus activate both 
inhibitory and excitatory circuits and the inhibitory activity act as comparators to 
diminish the excitatory response to the identical test stimulus presented while 
the inhibitory circuits are still active (Miller and Freedman., 1995; Boutros and 
Belger, 1999). Several neurotransmitter systems have been implicated to play a 
part in the auditory gating process. Both dopamine and glutamate mechanisms 
are postulated to produce the excitatory responses to the conditioning stimuli 
while GABAergic and cholinergic mechanisms modulate the reduction in the 
excitatory response to the test stimulus (Flach et al., 1996; Moxon et al., 2003). 
Pharmacological studies suggest further involvement of serotonin (Adler et al., 
2005; Mann et al., 2008), noradrenaline (Miller et al., 1992; Stevens et al., 1991, 
1993; Adler et al., 1994), adenosine (Ghisolfi et al., 2002), corticosterone 
(Stevens et al., 2001) and endo-cannabinoids (see 1.5.2) in the auditory gating 
process highlighting the complexity of the interactions between multiple 
neurotransmitters and neuro-modulaters in this fundamental sensory 
processing. 
1.1.3 Neural substrates of auditory gating 
The exact anatomical sites involved in mediating sensory gating in humans 
have not yet been established due to the limitations in performing studies using 
intra-cerebral electrodes. Grunwald et al. (2003), in a study using intracranial 
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electrodes in epilepsy patients undergoing invasive pre-surgical evaluation, 
showed that the hippocampus, prefrontal cortex and tempo-parietal cortex 
contribute to sensory gating. They further suggested that the early phase in 
sensory gating is subserved by the temporo-parietal and prefrontal cortices, 
whereas the later phase is mediated by the hippocampus. In another recent 
study the same group demonstrated gating of auditory responses in the cortical 
areas responsible for initiating movements (supplementary sensory motor area) 
and top-down control of sensory input (lateral PFC) and also emphasized that 
the late responses from hippocampus might represent later components of the 
multistage sensory gating process (Kurthen et al., 2007). Functional imaging 
studies have suggested involvement of the hippocampus, thalamus, prefrontal 
cortex and the enterohinal cortex in the auditory gating process (Tregellas et al., 
2007). Higher response amplitudes and abnormal auditory gating were detected 
in patients who sustained prefrontal lesions (Knight et al., 1989) indicating the 
importance of the area in the gating process. 
Studies on sensory gating in both anaesthetized and freely moving rats have 
provided more insight to the areas involved in the gating of auditory responses. 
An early study by Bickford et al (1990), using intra-cerebral electrodes in rats 
under chloral hydrate anaesthesia, demonstrated that the CA3 region of the 
hippocampus had the maximal amplitude of N40 wave with an identical latency 
recorded from the scalp electrodes. Based on findings of the study, they 
proposed the CA3 region of the hippocampus as the generator of the N40 wave 
(Bickford et al., 1990). This was confirmed by recording from multiple brain sites 
including the frontaf cortex, auditory cortex, medial geniculate body, medial 
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septum and brain stem (Bickford et al., 1990). All these areas demonstrated 
auditory evoked responses: N20 and P30 waves were seen in the auditory 
cortex and medial geniculate body, a large N20 wave was recorded from the 
pontine reticular formation and small N40 waves were recorded from the medial 
septum and the frontal cortex. The largest amplitude N40 wave accompanied by 
a significant reduction in the test amplitude was recorded only from the CA3 
region, emphasizing the dominant role played by the hippocampus in sensory 
gating. Miller and Freedman (1993) examined the single unit activity in the 
medial septum in response to the auditory conditioning- test paradigm and 
demonstrated gating of single-unit responses in the medial septum. They also 
suggested that the medial septum exerts a direct cholinergic modulatory effect 
on the auditory gating in the CA3 region of the hippocampus. 
Another study by Bickford and colleagues demonstrated sensory gating in the 
brain stem pontine region, which also exerted a modulatory effect on 
hippocampal processing (Bickford et al., 1993). However, they failed to detect 
sensory gating in the inferior colliculus or the thalamus (Bickford et al., 1993). 
This suggested the presence of a separate auditory pathway (non-Ieminiscal) of 
sensory gating as opposed to the direct (Ieminiscal) auditory pathway (Fig 1.3). 
Moxon et al (1999) studied auditory gating from the brain stem, medial septum, 
CA3 and the auditory cortex, brain areas in the leminiscal and non-Ieminiscal 
pathways, in freely moving rats and demonstrated that gating ability was 
confined to the non-Ieminiscal auditory pathway. It has been proposed that CA3 
region integrates the gated information received via the non-Ieminiscal pathway 
and the non-gated information received via the leminiscal pathway to mediate 
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ultimate gated responses (Miller and Freedman, 1993; Moxon et aI., 2003) 
BRAINSTEM 
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Non- '------; COCHLEAR NUCLEUS f--------' Lemniscal 
Lemniscal Path 
Path Auditory nerve 
Sound 
Fig 1.3 Leminiscal and non-Ieminiscal auditory pathways (modified from Moxon et al., 
1999) 
Recent studies have found the involvement of other brain areas such as the 
reticular thalamus (Krause et al., 2003), amygdala (Cromwell et al., 2005), 
medial prefrontal cortex (Mears et al., 2006), striatum (Cromwell et al., 2007) 
and midbrain (Anstrom et al., 2007), expanding the auditory sensory gating 
circuits beyond the conventional non-Ieminiscal pathway. 
The current study examined auditory gating at both LFP and single-unit level in 
the CA3 and dentate gyrus of hippocampus and the medial prefrontal cortex in 
the rat brain. 
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1.2 Hippocampus 
The hippocampus is both downstream and upstream of essentially all the 
cortical association regions and is considered as an essential part of multi-
modal sensory integrating system in the CNS (Sweatt, 2004). Both human and 
rat studies have confirmed the important role played by the hippocampus in 
mediating the sensory gating process. 
The hippocampus is located deep within the temporal lobe of humans and other 
primates. In rats it is a rostro-caudal structure occupying a large area of the 
brain providing easy access to electrophysiological recordings. 
In both humans and rats, hippocampus is composed of two inter-connected 
parts known as the dentate gyrus and Ammon's horn. Ammon's horn has four 
sub-divisions in humans: CA 1, CA2, CA3 and CA4 (CA: Cornu Ammonis; 
Hammond, 2001; Sweatt, 2004). Only two of these sub divisions, CA1 and CA3, 
are prominent in rats (Fig 1.4A). Both dentate gyrus and Ammons' horn contain 
two types of neurons which are principle cells and interneurones. Principle cells 
in Ammons' horn and dentate gyrus are known as pyramidal and granular cells, 
respectively. Pyramidal cells are located in discrete layers of Ammons' horn and 
the dentate gyrus and comprise around 90% of the neurons in the CA regions of 
the hippocampus (Sweatt, 2004). The pyramidal cells in Ammon's horn are 
located in stratum pyramidale, a discrete layer extending from CA 1 to CA3, 
while interneurons are found in abundance in all layers of the hippocampus 
(Miller and Freedman, 1995). 
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The main internal circuit in the hippocampus is the tri-neuronal circuit, involving 
granular cells in the dentate gyrus and pyramidal cells in CA3 and CA 1. The 
circuit originates from granular cells which send axon collaterals called mossy 
fibers to synapse with pyramidal cells in CA3 which, in turn, send collaterals 
called schaffer fibers to CA 1 pyramidal cells (Fig 1.4 A). In addition, principle 
cells in all three regions form local recurrent excitatory circuits between each 
other and also form connections with interneurons to form recurrent inhibitory 
circuits (Fig 1.4 B). The hippocampal hemispheres are interconnected via the 
commissural pathway. Internal circuits connect the CA1 and CA3 with the 
dentate gyrus and other laminae in the hippocampus to modulate outgoing 
information according to the incoming signals (Hammond, 2001). 
Principle cells are the main projection cells of the hippocampus which form both 
internal and external communicating channels. Dentate gyrus and CA3 receive 
efferents from the entorhinal cortex, medial septum and thalamus (Hammond, 
2001; Moxon et al., 1999). The CA3 also projects to the medial septum. The 
CA 1 is the main output area sending afferents to the sub cortical areas and 
prefrontal cortex (Sweatt, 2004; Tierney et al., 2004). 
The extrinsic inputs to the hippocampus include projection fibers that are 
serotonergic, dopaminergic, cholinergic and noradrenergic (Flach et al., 1996; 
Moxon et al., 20038 ; Gilbert and Burdette, 1995; Sweatt, 2004).The intrinsic 
connections between the pyramidal neurons in the hippocampal network are 
glutamatergic and the inhibitory interneurons are predominantly GABAergic 
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(Hammond, 2001; Gilbert and Burdette, 1995; Sweatt, 2004). Neuromodulatory 
peptides such as somatostatin, vasopressin, cholecystokinen, neuropeptide Y, 
BDNF and NGF are also found within the hippocampus sometimes co-localized 
with GABA (Gilbert and Burdette, 1995; Sweatt, 2004). The hippocampal 
interneurons have also been shown to contain a high density of cannabinoid 
receptors (Wilson and Nicoll, 2002; Iversen, 2003; Howlett et al., 2004; Straiker 
and Mackie, 2006). Functional significance of some of the neurotransmitters 
and neuromodulaters in relation to sensory gating in the hippocampus will be 
discussed later in the thesis; however, it is worth noting that all these 
neurochemicals are mandatory for hippocampal integrity and attendant 
cognitive processing. 
(B) 
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Fig. 1.4 (A) Schematic diagram of a coronal section of the rat hippocampus demonstrating the 
tri-neuronal circuit (1 = granular cells of DG, 2 = pyramidal cells of CA3, 3 = pyramidal cells of 
CA 1) (8) illustration of feed-forward and feed-back inhibitory circuits between principle cells and 
interneurons (modified from Hammond, 2001). 
17 
1.3 Prefrontal cortex 
The prefrontal cortex (PFC) is the most anterior area of the frontal lobes and is 
responsible for mediating executive functions, mainly the orchestration of 
thoughts and actions in accordance with internal goals. The human PFC 
consists of cytoarchitecturally and functionally distinct areas out of which the 
dorsolateral prefrontal cortex is suggested to be involved in the cognitive 
processes such as attentional tasks and working memory (Postle, 2005; Lewis 
et al., 2004; Hashimoto et al., 2008). Increased heamodynamic responses in 
response to the auditory conditioning-test paradigm have been reported in the 
human dorsolateral PFC indicating the involvement of the area in the auditory 
gating process (Tregellas et al., 2007). 
The rat PFC is classically defined as the part of the frontal lobe with the 
strongest reciprocal connections with the mediodorsal nucleus of the thalamus 
(Thierry et al., 2000). According to the findings of some lesion studies, the rat 
medial prefrontal cortex (mPFC) demonstrates functional similarities to the 
human dorsolateral prefrontal cortex (Granon et al., 1994; Delatour and 
Gisquet-Verrier, 2000). These studies have reported deficiencies in cognitive 
processes involving attention and working memory in the mPFC-lesioned rats 
(Granon et al., 1994; Delatour and Gisquet-Verrier, 2000; Ostlund and Balleine., 
2005). The mPFC of the rat is delineated into sUb-regions; anterior cingulate 
area, pre-Iimbic area, inferior limbic area and medial orbital areas, (Fig.1.5) 
based on the architechtonic criteria and the anatomical relationship with distinct 
cortical and sub-cortical structures (Thierry et al., 2000; Gabbott et al., 2005). 
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The major neuronal population in the mPFC is the glutamatergic pyramidal cells 
comprising 70-80% of the neurons and the rest are GABAergic interneurons 
(Gabbott et al., 2005). Pyramidal cells are the main projection neurons from the 
mPFC and form main input and out put circuits with other cortical areas and the 
limbic system (Gabbott et al., 2005). 
Fig. 1.6 A diagram of the coronal section of the rat brain demonstrating the sub-regions 
of the mPFC (Ac = anterior cingulate area, Prl = pre limbic area, 11 = inferior limbic 
area, Mo = medial orbital area) (modified from Paxinos and Watson, 1997) 
The anatomical and functional inter-connections between the hippocampus and 
the prefrontal cortex are considered to be crucial for higher order cognitive 
processes such as working memory and organization of behaviors (Floresco et 
al., 1997; Tiemey et al., 2004). The hippocampo-prefrontal pathway in rats 
originates from the CA 1 and subbiculum of the hippocampus and innervates the 
pre-limbic and medial-orbital areas of the medial pre-frontal cortex (Jay et al., 
1989; Thierry et al., 2000). The hippocampal pyramidal cells have been shown 
to have direct excitatory effects on both pyramidal cells and interneurons in the 
medial pre-frontal cortex thus faCilitating cortical feedback and feed forward 
inhibitory and excitatory processes (Thierry et al., 2000; Tiemey et al., 2004, 
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Lewis et al., 2004). Despite of the direct and very important inputs from 
hippocampus to mPFC, no direct communications from mPFC to hippocampus 
have been found (Thierry et al., 2000; Vertes et al., 2007). However, reciprocal 
connections between the two areas are suggested, with some studies reporting 
enterohnial cortex, thalamus or the neucleus accumbens as the mediator of 
information from rat mPFC to the hippocampus (Grace, 2000; Vertes et al., 
2007) 
Both prelimbic area in the mPFC and the hippocampus have demonstrated 
auditory gating (see 1.1.3), thus the reciprocal connections between the two 
areas could be important in filtering out irrelevant information. 
1.4 Auditory gating and neuropsychiatric dysfunctions 
As mentioned above, normal subjects have a smaller response to the second 
(test) click cor:npared to the first (conditioning) click, reflecting sensory gating. 
The test response of normal subjects is often <40% of their conditioning 
response, whereas the test response of schizophrenic patients is often >85% of 
their conditioning response (Kisley et al., 2001, 2004). P50 gating defects are 
also seen in patients with other neuropsychiatric illnesses such as bipolar 
disorder (Franks et aI., 1983; Baker et aI., 1987), post traumatic stress disorder 
(Ghisolfi et al., 2004; Neylan et al., 1999), panic disorder (Ghisolfi et al., 2006) 
and Alzheimer's disease (Jessen et al., 2001; Cancelli et al., 2006), indicating 
that a common feature of these disorders is a deficit in information processing. 
A dysfunction or imbalance in dopaminergic and cholinergic mechanisms is also 
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suggested as a common defect shared by the diseases with abnormal auditory 
gating. A sensory gating defect is considered a biological marker for 
schizophrenia, as studies have shown that P50 sensory gating abnormalities 
are present not only in patients but also in their first degree relatives (Waldo et 
al., 1988, 1994) and in people with schizotypal personality (Cadenhead et al., 
2000). 
1.5 Schizophrenia 
Schizophrenia is a chronically disabling neuropsychiatric disorder that affects 
multiple aspects of cognition and behaviour, including attention, perception, 
thought process, emotion and volition (Harrison, 1997, 1999; Gainetdinov et al., 
2001; Lewis and Levitt, 2002). This disease affects 1 % of the world population 
without ethnic, educational or socioeconomic prejudice (Tamminga, 1997, 
2003). The disease typically emerges in late adolescence or early adulthood 
and leads to lifetime disability in the majority of affected individuals (Harrison, 
1997, 1999). Schizophrenia is characterized by positive symptoms, negative 
symptoms and neurocognitive deficits. Positive symptoms are features 
additional to normal experience and behaviour, such as delusions, 
hallucinations, disorganized speech and behaviour. Negative symptoms denote 
a lack or decline in normal experience and behaviour, such as emotional 
withdrawals, poor rapport and lack of drive. Neurocognitive deficits refer to 
cognitive and emotional dysfunction (i.e. memory impairment, attention deficits, 
impairment in executive functions) and are considered the core abnormalities of 
the disease which pave the way for the positive and negative symptoms, which, 
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in turn, are highly likely to reinstate the existing neurocognitive deficits, creating 
a vicious cycle of disease maintenance (Waiters, 2005). The symptoms of the 
disease are attributed to imbalances or deficits in neurotransmitters such as 
dopamine, glutamate, serotonin and GABA (see 1.7) 
In any disease, diagnosis based on symptoms should ideally be confirmed by 
using more specific objective means. This is not feasible in many psychiatric 
diseases, including schizophrenia, for which a globally acceptable standardized 
tool has yet to be implemented. However, potential tools including evoked 
potential recording are being used in research and show promise (Waiters, 
2005; Table1.1). 
Table 1.1 Objective diagnostic tools useful for diagnosis of schizophrenia 
Type of measurement 
Psychometric 
measurements 
Evoked potentials 
Brain Imaging - measures 
changes in the structure 
and function of the brain 
Tool used 
Thought disorder index in response to questions (TDI) 
Dysfunction in smooth pursuit eye movement (eye 
tracker) 
Failure to inhibit auditory evoked responses to repeated 
stimuli (measured by electroencephalography (EEG) 
and magnetoencephalagraphy (MEG) 
Loss of prepulse inhibition (PPI) to startle reflex (PPI is 
a measure of inhibitory function, where a weak stimulus 
inhibits the startle response caused by a sudden intense 
stimulus) - measured by electromyogram (EMG) which 
measures the eye blink (muscle activity) component of 
the startle response 
Changes in regional blood flow by functional magnetic 
resonance imaging (fMRI), changes in binding or 
localization of emitting tracer by positron emission 
tomography (PET), Changes in structure by computer 
axial tomography (CT) 
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Antipsychotic drug treatment accompanied with psychosocial management is 
the mainstay of effective treatment of schizophrenia. Treatments with anti-
psychotics aim to correct the imbalances or defects in the neurotransmitters 
hypothesized to be involved in the symptomatology of the disease and mainly 
target to antagonize central dopamine receptors (01, 02, 03, 04 and 05; see 
1.7.2). Typical antipsychotics such as chlorpromazine, fJuphanazine, 
haloperidol, trifJuroperazine and thioridazine antagonise dopamine 02 receptors 
(Tamminga, 1997). These drugs are effective in treating positive but not 
negative symptoms or neurocognitive deficits and also cause unwanted 
extrapyramidal side effects by blockade of dopamine receptors in the basal 
ganglia. Atypical antipsychotics, a group of drugs discovered more recently, are 
more effective in treating both positive and negative symptoms, are often 
effective in patients resistant to typical antipsychotics, and cause less 
extrapyramidal side effects (Tamminga 1997, 2003). Some examples of atypical 
antipsychotics are clozapine, resperidone, olanzapine, quetiapine and 
ziprasidone. In this PhO study the effects of clozapine on phencyclidine induced 
changes in auditory gating in the rat hippocampus and mPFC were examined. 
1.5.1 Clozapine 
Clozapine is the first of the atypical antipsychotics to be developed and so far is 
one of the most effective pharmacological treatments for schizophrenia 
(Tamminga, 1997). However, it is not used as a first line treatment due to the 
undesirable side-effects such as agranulocytosis, myocarditis, seizures, and 
cardio-respiratory effects. 
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Clozapine is a dibenzodiazepine derivative (Fig. 1.6; Tamminga, 1997). It is 
completely absorbed when used orally, but has a bioavailability of around 47% 
due to high first pass metabolism (Schaber et al., 1998). The effects of the drug 
can be observed from around 2 hrs, but takes about 7-10 days to reach a 
steady state plasma concentration following oral administration (Guitton et al., 
1998). Clozapine is extensively metabolised in the liver and has an elimination 
half life of around 14hrs (Schaber et al., 1998; Guitton et al., 1998). When 
clozapine was administered systemically in animal studies, effects on the 
studied parameters were observed 10-15 min following administration (Bakshi 
et al., 1994; Swerdlow et al., 1998; Joy et al., 2004) 
Fig. 1.6 Chemical structure of clozapine- 8-chloro-11-(4-methyl-1-piperazinyl)-5H-
dibenzo(b,e)(1,4)diazepine 
A systemic review by Wahlbeck et al (1999) comparing the effects of clozapine 
with typical antipsychotic treatments confirms that clozapine is convincingly 
more effective than typical antipsychotic drugs in reducing symptoms of 
schizophrenia, producing clinically meaningful improvements and postponing 
relapse. Another systemic review by Aqid et al (2008) emphasizes that 
clozapine is superior even to other atypical antipsychotics in treating refractory 
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schizophrenia. However, Meltzer and McGurk (1999) reviewing 12 clinical 
studies, reported that clozapine improves some cognitive functions such as 
attention and verbal fluency, but the effect on some executive functions such as 
working memory remains inconclusive. 
Clozapine has been shown to improve auditory gating deficits in schizophrenic 
patients with superior efficacy compared to other atypical antipsychotics (Adler 
et aI., 2004; Nagamoto et aI., 1996; Light et aI., 2000). Typical antipsychotics 
such as haloperidol do not improve gating deficits in schizophrenic patients 
(Nagamoto et al., 1996; Becker et al., 2004). 
In animal studies clozapine reversed pharmacologically induced (e.g. 
phencyclidine) behavioural abnormalities resembling schizophrenic symptoms 
such as PPI abnormalities and deficits in tasks involving working memory 
(Bakshi et aI., 1994; Linn et aI., 2003; Grayson et aI., 2007; Oidrikson et aI., 
2007). However, the effects of clozapine on pharmacologically-induced deficits 
in sensory gating has not been examined except for one study in which acute 
and chronic administration of clozapine failed to prevent amphetamine induced 
auditory gating deficits in rats (Joy et al., 2004). 
Clozapine has a very rich pharmacology with antagonistic effects on dopamine 
receptors (transient binding to 02 and higher affinity for 04; Seeman et ai, 
1997; Seeman, 2004), serotonin receptors (e.g. 5-HT2A, 5-HT2C, 5HT1A), 
noadrenergic receptors (61, 62) and cholinergic receptors (nicotinic and 
muscarinic) extending throughout cortical and subcortical structures 
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(Tamminga, 1997; Seeman, 2004). Clozapine is also suggested to have a 
partial agonist effect on glutamate (NMDA) receptors (Tsai et al., 1999; Gray et 
al., 2008) and potentiate cortical GABA activity (Bragina et al., 2007; Daskalakis 
et al., 2008). The actions on D2 and 5-HT2A receptors have received a great 
deal of attention since some studies suggested the improved cognitive 
symptoms following clozapine treatment are associated with its greater 5-HT2A 
binding vs. D2 binding (Meltzer et al., 1996; Remington, 2003). Some authors 
have attempted to explain the actions of clozapine based only on its selectivity 
and affinity for dopamine receptors. These reports suggest that transient 
binding to D2 receptors followed by rapid dissociation to allow normal DA 
transmission and equal binding to striatal D1 and D2 receptors with possible 
partial agonist effects on D1 receptors, explain improved cognitive symptoms 
and lack of extrapyramidal side effects following clozapine (Kapur and Seeman, 
2001; Tauscher et al., 2004). Recent studies have suggested the importance of 
the agonist effects of clozapine on glutamate and GABA receptors in relation to 
its antipsychotic efficacy (Tsai et al., 1999; Gray et al., 2008; Shim et al., 2008; 
Bragina et al., 2007; Daskalakis et al., 2008). Based on the findings of the 
above studies, it is evident that no unitary pharmacological mechanism can 
account for the wide range of actions of clozapine. 
1.6 Auditory gating and schizophrenia 
The auditory gating deficit in schizophrenia (Fig. 1.7) is suggested to have a 
genetic association and considered a potential endophenotype of the disease 
(Siegel et aI., 1984; Clementz et aI., 1998; Waldo et aI., 2000) 
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Fig. 1.7 P50 responses to auditory conditioning-test paradigm demonstrating sensory 
gating in healthy subjects and disruption of gating in schizophrenics. Arrows indicate 
the stimulus and the waves marked by vertical ticks are P50 responses (modified from 
Flach et al., 1996). 
Research on human P50 recording has failed to establish an exact clinical 
correlation to the sensory gating defects seen in schizophrenia, with some 
studies showing no correlation to negative symptoms (Adler et al., 1990) and 
others showing some correlation to both positive and negative symptoms 
(Cadenhead et al., 2000; Thoma et al., 2005). However, more recent studies 
have indicated a significant correlation between neurocognitive deficits and 
sensory gating defects measured by the auditory conditioning-test paradigm 
(Potter et al., 2006). 
Apart from the gating deficits some studies on schizophrenia show that 
unmedicated patients exhibit smaller P50 amplitude and shorter P50 latency 
responses to conditioning stimuli, compared to controls (Adler et al., 1982; 
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Boutros et al., 2004).The decrease in the conditioning amplitude and latency 
seen in schizophrenia is hypothesized to result from a synaptic mechanism 
called occlusion, the decrease in the expected response due to presynaptic 
fibers sharing post-synaptic neurons. The hypothesis postulates that when a 
neuronal population is hyperactive, the constant background discharge makes it 
less likely that the majority of neurons will respond synchronously to the 
stimulus being studied, leading to smaller amplitudes in response to 
conditioning stimuli (Adler et al., 1982; de Bruin et al., 2003). This hyperactivity 
is proposed to be due to the lack of functioning inhibitory inputs in the 
schizophrenic brain. While treatment with typical antipsychotics (e.g. 
haloperidol) restores the conditioning amplitude and latency, it does not restore 
the TIC ratio (Nagamoto et al., 1996; Boutros et al., 1999b; Light & Braff, 2003). 
Some encouraging results from studies on treatment strategies have shown that 
the gating deficit can be corrected by some pharmacological and behavioural 
interventions. Nicotine administration either by smoking or via a nicotine patch 
has been shown to briefly improve gating in schizophrenic patients (Adler et al., 
1993; Griffith et aI., 1998; De Luca et al., 2004). Brief improvement in gating 
deficits has also been detected following a period of N-REM sleep (Griffith et al., 
1993). It has also been shown that atypical antipsychotics, especially clozapine, 
can improve P50 gating in schizophrenic patients (Nagamoto et al., 1996; Adler 
et al., 2004). 
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1.7 Auditory gating and animal models of schizophrenia 
Although the specific causative factors that give rise to schizophrenia are not 
fully understood, there are several hypotheses actively being investigated which 
collectively suggest that schizophrenia is a multi-factorial disorder with genetic 
and neurodevelopmental components. Detailed study of the aetiology and 
treatment of schizophrenia necessitated the development of animal models of 
the disease. Lesion models based on neurodevelopmental hypotheses and 
pharmacological models, largely based on the theories on neurochemical 
abnormalities, have been extensively used to study the pathophysiology of 
schizophrenia. Since auditory gating deficit is considered a biological marker in 
schizophrenia (see 1.6), presence of gating deficits significantly enhances the 
validity of an animal model of the disease. 
1.7.1 The Neurodevelopmental model 
The neurodevelopmental hypothesis of schizophrenia posits that the illness 
results from either an early (during or after birth) static brain lesion with a longer 
latency until the appearance of clinical signs and symptoms, or a late 
(adolescence) brain disturbance of limited duration and short latency (Lewis and 
Levitt, 2002). This hypothesis is supported by some studies which have found 
abnormalities in the brain structure and function in the patients with 
schizophrenia. The enlargement of the ventricles accompanied by increased 
CSF volume (Lew}s and Levitt, 2002; Smythies, 1998) and decreased cortical 
thickness of certain brain regions such as temporal lobe and prefrontal cortex 
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(Weinberger, 1987; Smythies, 1998) and disturbed cortical and sub-cortical 
cytoarchitecture such as maldistribution of cortical neurons, dysplasias of 
enterohinal cortex and disarray of hippocampal pyramidal neurons (Harrison, 
1997,1999) are some of the findings from the postmortem and imaging studies 
of the schizophrenic brain. Volumetric MRI studies also reported reduction in 
cortical and hippocampal size in the patients with schizophrenia compared to 
controls (Nelson et al., 1998; Harrison, 1999). Functional abnormalities such as 
decreased regional blood flow and metabolic activity in the frontal and temporal 
lobes have also been detected in schizophrenics (Weinberger, 1987; Lewis and 
Levitt, 2002). The above studies suggest the involvement of specific brain areas 
such as the prefrontal cortex, ventral tegmental area, striatum, neucleus 
accumbens, amygdala, and hippocampus in the pathogenesis of schizophrenia. 
Prefrontal cortex, which mediates cognitive and executive functioning, has long 
been implicated as a main dysfunctional site in the causation of the disease. 
Many studies have confirmed the involvement of prefrontal cortex in the 
pathogenesis of schizophrenia (Weinberger et al., 1987; Yu et al., 2004). 
Humans with prefrontal lesions demonstrate abnormal P50 responses and 
gating deficits similar to those observed in schizophrenic patients (Knight et al., 
1989). Animals with PFC lesions have been shown to exhibit impairments in 
working memory tasks and learning resembling cognitive deficits in 
schizophrenia (Granon et al., 1994; Delatour and Gisquet-Verrier, 2000; 
Ostlund and Balleine., 2005; Kinoshita et al., 2008) 
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As discussed above some human studies have shown functional and 
anatomical defects in the hippocampus in schizophrenic patients. Lesion 
studies in animals have demonstrated behavioural abnormalities and 
abnormalities in working memory and attention, similar to the deficits seen in 
schizophrenic patients (Lipska et aI., 2002; Adams et aI., 2008). Abnormal 
auditory gating, resistant to typical antipsychotic treatment, was observed in rats 
with hippocampal lesions induced by kainic acid and the deficits were correlated 
to the neuronal loss in the CA3 and hilar regions of the hippocampus (Stevens 
et aI., 1998). 
Examining the sensory processing in the hippocampus and prefrontal cortex is 
thus validated not only due to their potential importance in the auditory gating 
process but also due to the involvement in the pathogenesis of schizophrenia. 
1.7.2 The pharmacological model 
Neurotransmitters have long been thought to be involved in the development of 
schizophrenia. It is likely, although not yet certain, that the disorder is 
associated with some imbalance of the complex, interrelated transmitter 
systems of the brain involving one or more of dopamine, glutamate, serotonin, 
acetylcholine and gamma-aminobutyric acid (GABA). Though, all these 
neurotransmitter systems could equally be important in the pathogenesis of the 
disease, the dopamine hypothesis and the glutamate hypothesis have received 
a great deal of attention specially in developing animal models of the disease. 
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The dopamine hypothesis 
The dopamine hypothesis of schizophrenia postulates a dysregulation of 
dopaminergic neurotransmission in the CNS. The main dopaminergic pathways 
described in the mammalian brain are the nigrostriatal system which projects 
from the substantia nigra of the mid brain to the basal ganglia (striatum), the 
mesolimbic system which projects from the midbrain ventral tengmental area to 
the nucleus accumbens, the mesocortical system projects from the midbrain 
ventral tegmental area to the prefrontal cortex and the tubero-infundibular 
system projects from hypothalamus to the anterior pituitary (Oargham et al., 
2003). 
According to the dopamine hypothesis, subcortical mesolimbic dopamine 
projections are hyperactive, resulting in hyperstimulation of O2 receptors and 
giving rise to positive symptoms, whereas mesocortical dopamine projections to 
the prefrontal cortex are hypoactive, resulting in hypostimulation of 0 1 receptors 
and giving rise to negative symptoms and cognitive impairment (Oavis et 
aI., 1991; Oargham et aI., 2003). 
As mentioned above, neuroleptic blockade of central 02 receptors improves 
symptoms of schizophrenia, whereas psychomimetics (e.g. apomorphine, 
amphetamine) which potentiate dopamine effects in the CNS, produce positive 
symptoms and attention deficits similar to those seen in schizophrenia in 
otherwise healthy individuals (Mcketin et aI., 1999; Marcotte et aI., 2001; Moxon 
et al., 2003). However, the ability of dopamine agonists to mimic schizophrenic 
like behaviour in experimental animals is a subject of debate. Apomorphine 
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disrupts PPI in animals and the disruption can be reversed by haloperidol 
(Swerdlow et al., 1998; Linn et al., 2003). Amphetamine has also been shown to 
produce auditory gating deficits in both freely moving and anesthetized rats 
(Adler et aI., 1986; Bickford et al., 1990; Krause et al., 2003). However, the 
abnormal T/C ratio following amphetamine was due to the reduction in the 
conditioning response amplitude only and was considered not to represent 
gating abnormalities of the test response in schizophrenic patients (Adler et al., 
1986). Auditory gating studies on rat genotypes with abnormal dopaminergic 
properties demonstrated that gating deficits were found only in one of the 
genotypes (WAG/Rij) which demonstrated high dopamine activity in both the 
nigrostraital system and the mesolimbic system (de Bruin et al., 2001), while 
another study found that this genotype also exhibited deficits in cortical 
GABAergic inhibitory process correlated with the sensory processing deficits 
(Luhmann et al., 1995) shedding doubts on the correlation between dopamine 
imbalance and sensory gating deficits in schizophrenia. 
Although the dopamine hypothesiS is one of the most influential theories, it does 
not explain all aspects of schizophrenia as either dopamine agonists or 
antagonists have failed to mimic or restore, respectively, the negative 
symptoms and cognitive deficits seen in the disease. 
The glutamate hypothesis 
Glutamate is the major excitatory neurotransmitter in the mammalian brain. It 
serves as the neurotransmitter of pyramidal cells which are the sources of. 
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efferent interconnecting pathways of the cerebral cortex and the limbic system. 
Glutamate is also indirectly involved in release and uptake of other 
neurotransmitters such as dopamine, acetylcholine, serotonin and GABA (Goff 
and Coyle, 2001; van Berckel, 2003; Coyle, 2006). 
The effect of glutamate is mediated by two major classes of receptors: 
ionotropic (ion channels) and metabotropic (G protein coupled receptors). The 
ionotropic receptors are ligand gated channels and are divided in to three 
classes each named for the congeners of glutamate to which they respond in 
maximum fashion: kainate, AMPA (amino-3-hydroxy-5-methyl-isoxazole-4-
proprionic acid) and NMDA (N-methyl D-aspartate). Kainate and AMPA 
receptors are found in neurons and glia, the supportive cells of CNS, whereas 
NMDA receptors are found exclusively in neurons. There is a high expression of 
NMDA receptors in the hippocampus (Goff and Coyle, 2001; van Berckel, 
2003). Kainate and AMPA receptors are simple ion channels which permit Na+ 
influx and K+ efflux in the activated state. The NMDA receptor is also a cation 
channel but is unique in several ways compared to other ion channels (Fig 1.8). 
The NMDA receptor permits the passage of Ca2+. It also needs an amino acid, 
glycine to be bound to a site on the receptor surface for its normal function. 
When glutamate binds the receptor opens but at the resting membrane potential 
the channel is blocked by Mg2+. This block is removed only when the membrane 
is partially depolarized by AMPA or other ion channels (Goff and Coyle, 2001; 
van Berckel, 2003). 
The glutamate hypothesis posits that NMDA receptor hypofunction is 
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responsible for the emergence of schizophrenia. The hypothesis is based on 
the findings that NMDA receptor blockers like phencyclidine (PCP) and 
ketamine produce clinical features including negative symptoms and cognitive 
deficits identical to those seen in schizophrenia (Krystal et al., 1994; Malhotra et 
al., 1996; van Berckel., 1998; Oranje et al., 2002). 
ExlraceIl ular 
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Fig 1.8 Schematic diagram of NMDA receptor showing sites of modulation 
It has been suggested that NMDA receptor hypofunction causes excessive 
release of other central neurotransmitters such as dopamine, giving rise to the 
positive symptoms of schizophrenia (Jentsch and Roth, 1999; Olney et al. , 
1999; Svensson, 2000; Tsai and Coyle, 2002). The NMDA antagonists such as 
PCP and MK-801 have been shown to increase mesocortical dopamine levels 
and distort the firing patterns of PFC-projecting dopamine neurons, thus 
impairing information processing between cortical and subcortical structures 
especially between PFC and VTA (Murase et al. , 1993; Moghaddam et al. , 
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1997; Balla et al., 2001). Some studies have demonstrated that NMDA receptor 
blockade increases cortical glutamate release (Takahata and Mogaddam, 1998; 
Olney et al., 1999). This excessively accumulated glutamate leads to excitotoxic 
cell death by binding to the receptors in the neuronal cell body and increasing 
intracellular calcium (Olney et al., 1999; van Berckel, 2003). This neurotoxic 
process is hypothesized to cause more chronic negative symptoms and 
neurocognitive deficits. Aghajanian and Marek, (2000) suggest that cortical 
glutamate increase by NMDA antagonists is mediated indirectly by the 
activation of cortical 5-HT2A receptors or via a similar pathway, linking the 
glutamate hypothesis with serotonin hypothesis of schizophrenia. NMDA 
blockade is also suggested to inhibit GABAergic activity in cortical and sub-
cortical structures, thus releasing inhibitory effects on the excitatory circuits and 
causing neuronal hyper-activity giving rise to the positive symptoms and 
cognitive deficits (Olney et al., 1999; Goff and Coyle, 2001; Jodo et al., 2005). 
1.7.2.1 The phencyclidine model of schizophrenia 
Phencyclidine (PCP) belongs to the class of non-dissociative anaesthetics, but 
is no longer used medically due to its disturbing neuropsychiatric side effects 
during postoperative emergence. However, it has continued to be used illicitly 
as a recreational drug (e.g. "Angel dust", "crystal"). PCP is an 
arylcyclohexylamine derivative (Fig. 1.9) and has more than 30 structural 
analogues used in research and on the street. 
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Fig. 1.9 Chemical structure of phencyclidine- 1-(1-phenylcyclohexyl)piperidine 
pep is well absorbed and readily penetrates the central nervous system and its 
rapidity of action varies with the route of administration. Intravenous (Lv.) and 
inhalation administration allows for activity within a few minutes whereas 
intranasal and oral administration takes longer (20-40 minutes; Gorelick & 
Balster, 2005). The time for the peak effects to occur also varies with the route 
of administration: 10 min with intravenous, 5-30 min with inhalation and 90 min 
with oral administration (Gorelick & Balster, 2005). pep is metabolized in the 
liver and elimination half life of pep varies from 7-46hrs and the effects of 
intoxication last for 4-8hr after recreational doses (Gorelick & Balster, 2005). 
Although pep acts mainly as a non-competitive antagonist at the NMDA 
glutamate receptor (Fig.1.8), it has effects on a number of other 
neurotransmitter systems. It has indirect agonist effects on the dopamine and 
noradrenalin systems by blocking their reuptake. pep also has a non-
competitive inhibitory effect on both nicotinic and muscarinic receptors, in 
"addition to exerting inhibitory effects on voltage-dependent sodium and 
potassium channels (Morris et al., 2005; Murray, et al., 2002). 
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As mentioned before, the idea of using PCP to model schizophrenia has 
recently received a great deal of attention since both PCP and the structurally 
related drug ketamine produce symptoms that extend beyond psychosis per se 
to include other symptoms associated with schizophrenia. 
Jentsch and Roth (1999) reviewed reports on acute and long term PCP! 
ketamine exposure in humans and found that both regimens can induce 
psychosis, thought disorder, delusions, flattened affect and withdrawal, with the 
effects of chronic exposure being more persistent. Chronic or sub-acute 
administration of PCP in experimental animals produce not only behavioural 
and cognitive deficits but also structural abnormalities in the brain resembling 
the changes observed in schizophrenic patients (Goff and Coyle, 2001; 
Pietraszek, 2003; Pratt et al., 2008). A recent study by Pratt et al (2008) 
demonstrated that chronic and sub-chronic PCP administration to rats 
decreased glucose utilization in the PFC accompanied by a reduction in 
GABAergic interneuron markers and deficits in attentional set-shifting test (a 
test to assess executive functions) resembling the changes found in 
schizophrenic patients. 
PCP models using a single dose systemic administration show disrupted 
performance in attention assessed by PPI, Morris water maze, and working 
memory tasks (Geyer et al., 1984; Verma and Moghaddam, 1996; Sams-Dodd, 
1995; Martinez et al., 1999; Marcotte et al., 2001). Altered social interactions 
and behavioural disturbances, such as hyperactivity and stereotyped 
movements, resembling schizophrenia have also been observed following 
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single dose administration (Sams-Dodd, 1996, 1999; Marcotte et al., 2001; 
Suzuki et al., 2002). Atypical anti-psychotics have been shown to reverse or 
prevent acute PCP induced stereotyped movements, social isolation and PPI 
deficits (Sams-Dodd, 1997; Bruins et al., 2005). PCP disrupts auditory gating in 
rats under chloral hydrate anaesthesia in a dose dependent manner with peak 
disruptions observed around 45 min-1hr following Lp. administration (Miller et 
al., 1992). Findings of these studies validate the acute PCP model to study the 
neurobiology and pharmacology of schizophrenia. 
1.8 Cannabinoids and schizophrenia 
Cannabinoids, the active compounds of the plant Cannabis Sativa (marijuana, 
hashish, etc.), have been used medicinally and recreationally for centuries. 
Cannabis produces alterations in mood, memory and perception and is 
suggested to be associated with psychotic illnesses. A recent meta-analysis by 
Moore et al (2007), combining results of 35 population-based longitudinal 
observational studies of the relationship between the use of cannabis and 
psychiatric disorders in later life, found an overall increased risk of 41 % in the 
development of any psychosis among individuals who had used marijuana in 
the past. Some case-control studies of psychotomimteic drug - use among 
schizophrenic patients, have revealed that schizophrenic patients have a higher 
incidence of consumption of cannabis, amphetamine, cocaine and other 
psychoactive drugs compared to the normal controls and patients with other 
psychiatric illnesses (Hambrecht and Hafner, 1996; Bersani et al., 2002). 
Prospective and longitudinal studies have suggested that cannabis use 
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precipitates schizophrenia in vulnerable individuals and exacerbates symptoms 
in patients already diagnosed with the disease (Hambrecht and Hafner, 2000; 
Bersani et al., 2002). However, there are studies arguing that cannabis use is 
not causative, but merely a result of the negative or pro-dromal symptoms of the 
disease. These studies based on patient communications suggest that cannabis 
is used for its euphoric effects to relieve negative symptoms of schizophrenia 
(Hambrecht and Hafner, 2000; Constain, 2008). 
The identification of the primary psychoactive compound in cannabis, 119 -
tetrahydrocannnabinol (119-THC), led to the synthesis of high affinity 
cannabinoid ligands, which also led to the discovery of endogenous 
cannabinoid receptors in the brain and peripheral tissues (i.e. CB1 and CB2). 
The CB1 receptor is the most abundant and best characterized receptor found 
in the brain and is highly expressed in the hippocampus, basal ganglia, 
cerebellum and cortex (Wilson and Nicoll, 2002; Iversen, 2003; Howlett et al., 
2004; Straiker and Mackie, 2006). 
CB1 receptors are G-protein coupled receptors and their activation leads to 
inhibition of adenyl cyclase, inhibition of certain voltage sensitive calcium 
channels (predominately those found presynaptically), activation of inwardly 
rectifying potassium channels, and activation of the mitogen-activated protein 
kinase (Howlett et al., 2004; Biosogno, 2005; Straiker and Mackie, 2006). The 
identification of CB receptors led to the identification of their endogenous lipid 
ligands, endocannabnoids (e.g. anandamide, 2-archidonylglycerol). These 
endocannabinoids are not stored like neurotransmitters, but rapidly synthesized 
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post synaptically in response to depolarization and act on pre-synaptic CB 
receptors as a retrograde messenger to mainly inhibit neurotransmitter release 
(Wilson and Nicoll, 2002; Bisogno, 2005; Di Marzo, 2006). The CB1 receptor 
mediated inhibition of GABA release from the pre-synaptic terminal is denoted 
as depolarization- induced suppression of inhibition (DSI) and the same effect 
on excitatory terminal inhibiting release of glutamate is designated DSE 
(depolarization- induced suppression of excitation; Howlett et al., 2004; Straiker 
and Mackie, 2006). The DSE and DSI are transitory effects terminated with 
rapid degradation of the endocannabinoids by the hydrolyzing enzymes (e.g. 
fatty acid amide hydrolase, monoacylglycerol). The endocannabinoid system, 
consisting the CB receptors, endocannabinoids, transporters and the enzymes 
responsible for production and degradation, is thus functioning as a regulatory 
apparatus which is activated on demand to re-establish transient perturbations 
of the homeostasis of the neurotransmitters, which may in turn control the 
endocannabinoid system in the brain. 
Dysregulation of the endocannabinoid system is suggested to be involved in 
the pathogenesis of schizophrenia. Administration of 6 9-THC to normal 
volunteers induced psychotic symptoms and cognitive impairments similar to 
those observed in schizophrenic patients (Emrich et al., 1997). Postmortem 
studies have detected increase density of CB1 receptors in the in the prefrontal 
cortex of the schizophrenic patients compared to controls (Dean et al., 2001; 
Zavitsanou et al., 2004). Leweke et al (1999) found increased levels of 
endocannabnoids in the schizophrenic patients CSF. Chronic as well as acute 
administrations of cannabis have produced P50 gating abnormalities in 
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otherwise healthy individuals (Patrick et al., 1999,2000; Rentzsch et al., 2007). 
The results of these studies suggest a strong link between a dysregulated 
endocannabnoid system and schizophrenia. Ujike and Morita (2004), reviewing 
the human studies on cannabis and schizophrenia proposed that the 
hyperactivity of the endocannabinoid system is involved in the pathogenesis of 
schizophrenia or the neural mechanisms of the negative symptoms of the 
disease. 
Synthetic agonists (e.g. WIN55,212-2, HU210, C55,940) and antagonists of 
CB1 receptors (e.g. SR141716A, AM251) are used to examine the 
neuropsychiatric effects of cannabis in animal studies. Cannabinoid agonists 
have demonstrated neuroprotective effects probably due to the inhibitory 
actions on Glutamatergic excitatory transmission and modulation of immune 
responses along with its anti-oxidant properties, thus considered as important 
potential therapeutic agents in neurodegenerative diseases such as 
Huntington's, Alzheimer's and multiple sclerosis (patcher et al., 2006). 
However, as mentioned above, cannabis and synthetic CB1 agonists have 
produced neurocognitive deficits following acute as well as chronic 
administration in humans as well as in animals with deficits resembling to those 
observed in schizophrenia (Solowij and Michie, 2007). These deficits are 
attributed to the inhibition of GABAergic activity and resultant increase in 
dopamine activity in the meso-cortical areas (hyperdopaminergic state) and also 
the hypoglutamatergic state produced by the effects of cannabinoids on 
excitatory neurons (Brodkin and Moerschbaecher, 1997; Pistis et al., 2001; 
Solowij and Michie, 2007). The current study used WIN55,212-2 (Fig. 1.10) a 
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non-selective cannabinoid receptor agonist and the CB1 receptor antagonist 
SR141716A (Fig. 1.11) to study the effects of cannabinoids on auditory gating. 
Fig. 1. 10 Chemical structure ofWIN55,212-2 
(RH + )-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1 ,2, 3-de )-1 ,4-benzoxazin-6-yl]-1-
napthalenylmethanone 
WIN55,212-2 is an aminoalkylindole derivative with both CB1 and CB2 receptor 
agonist properties (Howlett et al., 2004; Pertwee, 2006) . It is metabolised in the 
liver and produce analgesic, behavioural and cognitive effects lasting for several 
hrs following single systemic administration (Howlett et al., 2004; Drews et al., 
2005). WIN55,212-2, though structurally different, produces CNS effects similar 
to ~ 9 - T H C C through its CB1 full agonist effects and is preferred in cannabinoid 
research due to its better solubility and higher potency compared to the highly 
lipophilic ~ 9 - T H C . . Acute, sub-acute and chronic administration of WIN55,212-2 
animals produces behavioural and other CNS effects such as increased 
locomotor activity at low doses and hypolocomotion at high doses (Schneider 
and Koch, 2003; Drews et al., 2005), impairment of some tasks involving 
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memory, attention and sensory processing such as object recognition, 
progressive ratio test, continuous performance tasks and PPI (Schneider and 
Koch, 2002, 2003; Drews et al., 2005; Solowij and Michie, 2007). Most of these 
effects are reversed or prevented by the CB1 antagonist SR141716A (patcher 
et al., 2006). 
Fig. 1.11 Chemical structure of SR141716A - 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-
methyl-N-(piperidin-1-yl)-1 H-pyrazole-3-carboxamide 
SR141716A (rimonabant) exhibits a significant CB1 selectivity and potency and 
prevents or reverses CB1 mediated effects both in vivo and in vitro (Brodkin and 
Moerschbaecher, 1997; Martin et al., 2003; Hajos et al., 2008). Some in vitro 
studies have suggested that SR141716A acts as an inverse agonist at CB1 
receptors (Sim-Selly et al., 2001). However, apparent inverse agonist effects 
are proposed to be due to the inhibitory or antagonist effects on tonically active 
endocannabinoid system (Crompton et al., 1996; Pattij et al., 2007). 
In animal studies SR141716A prevented the deficits in locomotor activity 
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(Crompton et aI., 1996), memory (Mallet and Beninger, 1998), learning (Brodkin 
and Moerschbaecher, 1997), attention (Arguello and Jentsch, 2004) and 
sensory processing (Martin et aI., 2003) induced by CB agonists (Le. THC, 
WIN55,212-2, C55,940) indicating the disruptions were mediated via the CB1 
receptors. However, SR141716A did not produce any effects on locomotor 
activity, learning, memory or attention when administered alone (Brodkin and 
Moerschbaecher, 1997; Arguello and Jentsch, 2004; Martin et aI., 2003) 
suggesting the tonically active endocannabinoid system was not mandatory in 
the tested behavioural and cognitive processes. 
An interesting study examining the effects of SR141761A on chronic marihuana 
uses reported that a single dose of SR141761A (administered 2 hrs prior to 
THC) prevented acute psychological and physiological effects of smoked 
marijuana (Heustis et aI., 2001). They also noted that SR141716A alone did not 
produce any psychological or physiological effects (Heustis et aI., 2001). A 
placebo-controlled study evaluating the effect of SR141716A on patients with 
schizophrenia and schizo-affective disorders observed no outcome difference 
compared to the placebo group (Meltzer et aI., 2004). However, limitations of 
the study such as inadequacy of the dose precluded a definitive conclusion and 
further studies on SR141716A efficacy in treating schizophrenia were 
encouraged (Meltzer et aI., 2004). 
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1.9 Aims and Objectives 
We had three main objectives in this study of sensory gating in the rat brain. 
The first and foremost was to study and characterise auditory-evoked LFP 
responses (AERs) and auditory gating in the CA3 region of the hippocampus 
under isoflurane anaesthesia. If sensory gating was detected in CA3, we hoped 
to examine sensory gating in the dentate gyrus, an area involved in the tri-
neuronal circuit of the hippocampus. Examining auditory responses in these 
areas was expected to provide a better understanding of the feed-forward and 
feedback circuitry which modulates sensory gating mechanism in the 
hippocampus. 
The second objective was to examine AERs and sensory gating in the mPFC 
while simultaneously recording from hippocampus. We expected that 
simultaneous recording of LFPs and single-unit responses from both these 
regions, using auditory conditioning- test paradigm would provide experimental 
e v i d e n ~ e e to the role played by the prefrontal cortex and hippocampo-prefrontal 
pathway in the sensory gating process. 
The third objective was to examine auditory gating in hippocampus and mPFC 
using pharmacological rat models of schizophrenia. It was hypothesised that 
gating would be disrupted in the hippocampus and mPFC following 
psychomimetic pharmacological (phencyclidine or WIN55,212-2) manipulations. 
Disrupted gating following pharmacological manipulations, in the isoflurane 
anesthetised rat, would provide a model of information processing dysfunctions, 
which would allow for further electrophysiological and pharmacological studies 
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to investigate the pathogenesis and treatment of schizophrenia. 
Chapter 3 
The main objective of this chapter was to examine AERs and characterize the 
basic properties of sensory gating in the CA3 region of the hippocampus by 
analyzing LFP responses to the auditory conditioning-test paradigm. To achieve 
this objective it was essential to demonstrate AERs and sensory gating in CA3 
which would then allow characterisation of auditory- evoked LFPs. Following the 
detection of AERs and gating we aimed to study the stability/variability of 
auditory gating in response to different sound pressure levels and at different 
inter-stimuli intervals. Another goal was to detect AERs and gating in the DG 
and compare with the findings from CA3. 
Chapter 4 
The objective of this chapter was to study auditory-evoked LFP responses in 
the medial prefrontal cortex to characterize the basic properties of sensory 
gating in this region. The first goal was to demonstrate AERs and sensory 
gating in mPFC which would then allow characterisation of auditory- evoked 
LFPs. The next step was to examine the findings from mPFC with 
simultaneously recorded CA3 and DG responses. 
Chapter 5 
In this chapter we aimed to examine and compare the effects of phencyclidine 
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(PCP) on auditory-evoked LFP response gating in the CA3 and DG of 
hippocampus and mPFC under isoflurane anaesthesia. It was hypothesised that 
PCP would produce disruption of auditory gating in rat CA3, DG and mPFC with 
similar changes reported from scalp electrodes in schizophrenic patients. A 
further goal was to study the effect of clozapine on PCP induced changes with 
the hypothesis that clozapine would prevent the PCP induced deficits in 
auditory gating in CA3, DG and mPFC. 
Chapter 6 
The objective of this chapter was to study and compare the effects of WIN55, 
212-2 on auditory-evoked LFP gating in the CA3 and DG of hippocampus and 
mPFC under isoflurane anaesthesia. We hypothesised that WIN55,212-2 would 
disrupt sensory gating in rat CA3, DG and mPFC with similar changes reported 
from scalp electrodes in schizophrenic patients. The next step was to examine 
the effect of the CB1 antagonist, SR141716 on WIN55,212-2 induced changes 
with the intention to prevent the WIN55,212-2 induced deficits in auditory gating 
in CA3, DG and mPFC. 
Chapter 7 
The aim of this chapter was to evaluate the single-unit responses to the auditory 
conditioning-test paradigm in the CA3, DG and mPFC and to compare with the 
simultaneously recorded LFP responses before and after pharmacological 
interventions, providing important observations and opening pathways for future 
research. 
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Chaflter Two 
Methods 
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2. Methods 
2.1 Animals 
Experiments were performed on male Lister hooded rats (n = 42) from the 
University of Nottingham Biomedical Sciences Services Unit in-house colony, 
weighing 250-400g at the time of surgery. Animals were group housed in 
standard plastic cages (3 to 6 animals per cage), 12h:12h light: dark cycle 
(lights on at 7:00 AM), light intensity 100-2001ux at cage bottom, room ambient 
temp 22±1 DC; food and water were available ad libitum. Experimental 
procedures were carried out in accordance to the UK Home Office regulations 
under project licence 40/2715. 
2.2 Surgical procedure 
Anaesthesia was induced with 3.5% isoflurane (IVAX Pharmaceuticals, UK) in a 
50%:50% N20:02 mixture (BOC Gases, UK). The isoflurane level was reduced 
progressively and maintained at 1.5-2% throughout surgery to ensure a state of 
complete areflexia of the hind paw withdrawal reflex. Rats were mounted in a 
modified stereotaxic frame (Kopf model 1730) using hollow ear bars adapted 
with Sony Walkman® stereo-earphones to present auditory stimuli. Core 
temperature was monitored and maintained at 37-38 QC using a homeothermic 
heating pad and controller (Harvard Instruments, UK). A scalp incision was 
made and 5 ~ m m diameter craniotomies were performed separately above the 
right hippocampus and right mPFC. The dura was reflected and excised from 
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the cortex and the exposed cortex kept moist with 0.9% (w/v) sodium chloride. 
Scalp & skin wound edges were treated with lignocaine (2% w/v; Arnolds 
Veterinary Products, UK). Anaesthetic gases were scavenged using a passive 
system to Fluosorbers or actively to the external atmosphere. 
2.3 Recording procedure 
An eight or sixteen channel micro-wire electrode bundle or array (2x4 or 2x8 
pattern -0.25 x 0.7mm; Teflon-coated stainless steel, 50 )lm diameter per wire; 
NB Labs, Texas USA) with a stainless steel ground electrode connected to a 
unity-gain headstage (Plexon Inc, Tx USA) was used to record local field 
potentia Is (LFPs) and simultaneous spike activity from a number of single 
neurones (Fig 2.1). The impedance of the electrodes was -100-300 kn 
measured at 1 kHz (Robinson, 1968). 
The electrode array / head stage assembly was clamped to a Kopf-type 
manipulator and the electrodes were stereotactically placed in the CA3 and DG 
(3.6mm-3.9 mm posterior, 3mm to 3.2 mm lateral and to 3.8 mm ventral from 
bregma) and mPFC (3.2 mm anterior, 0.5mm to 0.8 mm lateral and 2.5mm 
ventral from bregma) according to the atlas of Paxinos and Watson (1997). The 
electrode array and bundle were lowered slowly & progressively through the 
right cortical hemisphere and positioned in the hippocampus and mPFC via fine 
micromanipulator control until the areas were identified from the co-ordinates of 
the rat atlas ~ n d d the LFP wave form patterns. Unit activity was recorded from 
all the electrodes and LFPs were recorded from two electrodes in each region: 
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The headstage was connected to a multichannel PBX preamplifier (Plexon Inc., 
TX, USA), to amplify and filter extracellular action potential spikes (gain x 1000, 
band pass filtered for spikes at 250 HZ-9 kHz) and LFPs (gain x 1000, 0.7-
170Hz). The preamplifier was then connected to Multichannel Acquisition 
Processor (MAP) system for further amplification, filtering, ND conversion and 
digital signal proceSSing of spikes. 
2.4 MAP System 
2.4.1 Single- unit activity (spikes) 
Analogue output from the pre-amplifier was fed to 32 channel MAP system, 
which provided computer-contrOlled amplification (x1,000-32,000; typically the 
gain was set at x1-2,000 for the experiments), band-pass filtering (100Hz-8kHz; 
with 50Hz notch if required), ND conversion (signals were digitised at 40kHz, 
providing 25IJs precision, on each channel at 12-bit resolution), then routed to 
digital signal processors (DSPs, Motorola 56002), boards running at 40MHz. 
The MAP system timing board allowed distribution of digital timing and 
synchronisation outputs to external devices, while the DSP boards provided 
inputs for sampling digital or analogue (e.g. auditory stimuli) signals. The MAP 
box was linked to a PC via an MXI Bus board (National Instruments, UK) within 
the host PC (Dell 1.5GHz with 1GB RAM and 160GB hard drive) running C++ 
host software under Windows XP. Recorded files were distributed to a lab-
based computer server ("Ramon", a dual Pentium processor PC) and data then 
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archived to an external 500GB hard drive and CDs. 
Commercially available software (RASPUTIN, Plexon Inc, TX) allowed on-line 
isolation and discrimination using dual voltage-time widows or principal 
component analysis (Fig. 2.1C; Abeles & Goldstein, 1972) of neuronal spikes 
from background noise. Firing rate was also monitored aurally with the aid of a 
loudspeaker. Typically, one to four neurones were observed and discriminated 
per microware on-line and subsequently validated off-line (Off Line Sorter v2.86; 
Plexon Inc; see Nicolelis et ai, 2003). Activity was also displayed on a Hameg 
507 analogue-digital oscilloscope 
2.4.2 Local Field Potentials 
Local field potentials were recorded in parallel with spikes (Fig. 2.2) from two 
electrodes per region. Neural signals were split at the Plexon PBX preamplifier, 
a m p l i f i ~ d d x1000 and filtered (0.7-170Hz). LFP signals were then fed via a 
National Instruments data acquisition (NIDAQ) card (PCI-6071 E 1.25MS/sec, 
64 channels 12-bit resolution) in the host PC and digitised at 1 kHz. 
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2.5 Auditory sensory gating stimuli 
Auditory stimuli were generated using Cool Edit 96 (Syntrillium Software 
Corporation, Phoenix, USA) on the host PC. Paired auditory clicks (3kHz 70-
90dB (SPL) tones, 10ms duration, with an inter-pair interval 500ms repeated at 
10s intervals were supplied binaurally through custom-made (Medical School 
Workshop) stereotaxic ear bars integrally connected to a pair of Sony Walkman 
earphones to establish auditory gating (Bickford-Wimer et al 1990; Miller & 
Freedman, 1995). 
The auditory signals were calibrated to decibels sound pressure level, using a 
Bruel and Kjaer (4138 1/8 inch) condenser microphone and Bruel and Kjaer 
(2636) measuring amplifier. Calibration was conducted in a plastic coupler 
designed to generate a cavity approximately the size of the rat's meatus on the 
end of the hollow ear bar, with the 1/8 inch microphone replacing the tympanic 
membrane (MRC Institute of Hearing Research, Nottingham). 
Stimuli were averaged on-line over 128 stimulus presentations; the number of 
trials was measured using an online Matlab script (AD Perievent, Plexon Inc.) 
which also displayed averaged auditory responses (Fig 2.1 B). 
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Fig 2.1 Schematic diagram illustrating the recording procedure 
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(A) Schematic diagram of the recording system: anaesthetised rat was presented with 
auditory stimuli and auditory-evoked LFPs and single unit activity was recorded from 
electrodes placed in brain areas. The information from the headstage was passed to a 
preamplifier and LFPs and spikes were separated . Further digital processing of spikes 
was done using the MAP system and the results displayed on the host computer 
(8) Averaged auditory-evoked LFPs displayed on screen during a recording session: the 
figure generated using a Matlab programme allowing to keep a count of the number of 
events and to look at the averaged response simultaneously 
(C) Appearance of action potentials of a single neurone, sorted on-line , as displayed on 
the monitor during a recording session 
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Fig. 2.2 Single-unit rasters and LFPs recorded from the CA3, DG and mPFC 
in response to three successive pairs of auditory stimuli. 
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Representative samples of single-units (upper panel) and LFPs (lower panel) recorded from 
CA3, DG and mPFC in a male Lister hooded rat (four representative single units and one LFP 
recording from each region) demonstrating the appearance of raw data during a recording 
session (visualized off line using Nex). Vertical ticks indicate the time stamps of action potentials 
of the single-units (see a/so section 2.8.2). Changes in the single-unit activity in the CA3 and 
DG were not apparent in the raw data, but increased single-unit activity in the mPFC and 
increased LFP activity in the CA3, DG and mPFC regions were observed following auditory 
stimuli . 
I =Condi! ioning stimulus (Cs) I =Test stimulus (Ts) 
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2.6 Drug administration 
1-(1-Phenylcyclohexyl) piperidine (PCP) was obtained from Sigma Aldrich 
(Dorset, UK) and stored in an air-tight container at room temperature. PCP was 
made up freshly in 0.9 % (w/v) saline and used a single dose of 1 mg/kg 
intraperitoneally (Miller et al., 1992). 
8-chloro-11-( 4-methyl-1-piperazinyl)-5H-dibenzo(b,e)( 1,4) diazepine (clozapine) 
was obtained from Sigma Aldrich (Dorset, UK) and stored in an air-tight dark 
container at room temperature away from light. Clozapine was made up freshly 
(5mg in 51-11 of Glacial Acetic acid, 4501-11 of 0.9% (w/v) of sodium chloride and 
451-11 of sodium hydroxide) and used a single dose of 5mg/kg intra peritoneally 
(Joy et al., 2004). 
(R)-(+)-(2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1 ,2,3-de)-1 ,-4-
benzox9zin-6-yl)-1-naphthalenylmethanone mesylate (WI N55,212-2) was 
purchased from Tocris Cookson Ltd (Avonmouth, UK)and stored in a tightly 
sealed container in the refrigerator at 4 cC. WIN 55,212-2 was dissolved in a 
vehicle containing 5% of Propylene glycol, 2% Tween 80 and 9% (w/v) saline, 
for injection on the day of the experiment and used a single dose of 1.2mg/kg 
intraperitoneally (Schneider and Koch, 2002; 2003). 
N-piperidono-5-( 4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-
carboxamide (SR141716A) was supplied by the National Institute of Mental 
Health Chemical Synthesis and Drug Supply Program (contract N01-MH-
32005). SR141716A was dissolved in 100% ethanol (4.64mg 11ml) to make a 
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10IJM stock solution and stored at -20°C. At the time of the experiment 100IJI of 
stock was dissolved in 3641J1 of 0.9% saline (w/v) to make up a working 
concentration of 1 mg/ml (Brodkin and Moerschbaecher, 1997; Mallet and 
Beninger, 1998). 
Injection volume for all the drugs was 1 ml/kg. 
The effects of either phencyclidine (1 mg/kg; Lp) or WIN55,212-2 (1.2mg/kg; Lp) 
on auditory gating were studied by recording the auditory responses to 128 
trials of auditory stimuli, 15 and 45 minutes following drug administration. The 
effects of clozapine (5mg/kg; Lp) or SR141716A (1mg/kg; Lp) alone on auditory 
gating were examined by recording the responses to 128 trials of auditory 
stimuli 15minutes after drug administration. Phencyclidine (1 mg/kg; Lp) was 
administered to animals who received a prior injection of clozapine (5mg/kg; Lp) 
and the effect of clozapine on phencyclidine-induced gating deficits were 
assessed by recording auditory responses, 15 and 45 minutes after 
phencyclidine administration. Effects of SR141716A on WIN55, 212-2 induced 
gating deficits were assessed similarly by administering WIN55,212-2 
(1.2mg/kg; Lp) to animals who had already received an injection of SR141716A 
(1mg/kg; Lp) and recording the auditory responses, 15 and 45 minutes of WIN 
administration. 
Protocols of drug administration for each set of experiments will be explained in 
detail in the respective results chapters. 
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2.7 Histological verification of recording sites 
At the end of each experiment, 1 0 ~ ~ current was passed for 10 seconds 
(D.C.constant current lesion marker; Grass instruments, Quincy, MA) through 
one or more pairs of the stainless-steel microwire electrode to deposit ferric ions 
at the positive electrode. Rats were perfused transcardially with 0.9% (w/v) 
saline followed by 4% potassium ferrocyanide. Brains were removed and 
stored overnight in a 4% paraformaldehyde. Tissue blocks were sectioned 
transversely at 20 Ilm on a vibratome (Campden Instruments, UK). Iron 
deposits at the electrode tips were revealed by the Prussian Blue Reaction. 
Brain sections were examined under a Olympus stereomicroscope and digital 
images recorded with a Nikon CoolPix 4500 camera saved as *.jpg files. 
Images were visualised using Paint Shop Pro (v 5.03). Recording sites were 
identified with reference to the rat brain atlas of Paxinos & Watson (1997) (Fig. 
2.3). 
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Fig 2.3 Histological verification of the recording sites (representative sites from 
all the animals used for the study) in (A) mPFC and (8) hippocampus 
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(A) Histological verification of the recording sites in the medial prefrontal cortex in relation to 
the rat atlas showing electrode localization in the prelimbic area of the mPFC (1) and a 
photomicrograph showing electrode marking in the prelimbic cortex (2) . 
(8) Histological verification of recording sites in the hippocampus in relation to the rat atlas 
demonstrating electrodes being located in CA3 and DG of hippocampus (1) , 
photomicrographs showing electrode marking in CA3 and DG (2; an e n l a r g ~ d d
photomicrograph of the right hippocampus is inserted to demonstrate the positioning of 
electrodes) . 
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2.8 Data analysis & statistics 
Data was analysed off-line using Off-Line Sorter version 2.86 (Plexon Inc, 
USA), NeuroExp/orer (v3.257 or v4.0x; NeuroExplorer Inc USA), Prism (v4.03; 
GraphPad, USA) and with custom-designed Mat/ab scripts running V7.0 
(release R2006 or R2007; with associated Matlab Signal Processing, Neural 
Network, Statistics and Image Processing Toolboxes; The Mathworks). Data 
was analysed using t- test or ANOVA as appropriate. Data was expressed as 
mean ± SEM (standard error of mean), statistical significance was taken when 
P < 0.05. 
2.8.1 LFP analyses 
Auditory evoked potentials were analysed off-line using Neuroexp/orer and 
presented as peri-event averaged LFPs. Further analysis of averaged LFPs 
was done using Matlab scripts. 
2.8.1.1 Peri-event averaged LFPs 
Peri-event averaged LFPs graph the event-related responses as peaks and 
troughs, averaged over a required number of trials around a requested peri-
event period (Y axis-response amplitude). Averaging removes random 
background electrical activity allowing clear visualization of the electrical signals 
(Fig 2.4). We averaged aUditory-evoked responses (AERs) over 128 trials over 
a period of 0.5 second before and 1 second after the conditioning stimulus (bin 
time 1 ms). 
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2.8.1.1.1 Identification of the auditory-evoked responses 
The AERs were identified according to the polarity and the order of occurrence, 
using the averaged LFPs, i.e. N1, P1, N2, P2, N3 peaks (Fig. 2.4; Table 2.1) 
(Van Luijtelaar et al., 2001; Boutros et al., 2004). Amplitudes and latencies of 
the averaged AERs were measured by transferring the NEX developed graph to 
Matlab and using a Matlab script (Amplat) developed by Margarita Zachariau 
(School of Mathematical Sciences, University of Nottingham). Amplitudes were 
measured from the preceding positive peak I negative peak to the negative I 
positive peak of the response (Boutros et al., 1997; Moxon et aI., 1999) and the 
latencies were measured from the time of the stimulus to the peak of the 
positive or negative wave response (Boutros et al., 1997; Moxon et al., 1999). 
The ratio of the test amplitude to the conditioning amplitude (TIC ratio) was 
calculated for each averaged response and a ratio of s 50% indicated that 
gating was present (Miller et al., 1992; Joy et al., 2004). The latencies, 
amplitudes and TIC ratios of all the waveforms recorded from CA3, DG and 
mPFC were analysed in a group of animals that showed reduction in the test 
response amplitude on peri-event averaged LFPs (n = 10) to select a mid-
latency peak which was consistent and exhibited gating in all three areas (Table 
2.1). The mid-latency N2 wave which was consistent in CA3, DG and mPFC 
and demonstrated maximum gating in all three areas was selected for further 
analysis in the thesis. The N2 wave was identified as the second negative peak 
during 100 ms period following the stimulus onset. Identification of the AERs 
according to the order of occurrence in a specified latency range excluded the 
error of identifying N 1 as N2. 
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Fig 2.4 Peri-event averaged LFPs recorded from (A) CA3, (8) DG and (C) 
mPFC in response to 128 auditory stimuli trials. 
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Representative peri-event averaged LFPs of (A) CA3, (8) DG and (C) mPFC demonstrated 
positive and negative AER complexes (N1, P1, N2, P2 & N3) in response to the conditioning 
and test stimuli (timing of the stimuli are indicated by the triangles; Cs = conditioning stimulus, 
Is = test stimulus) . 
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Table 2.1 Conditioning response latencies (CLA T), conditioning response 
amplitudes (CAMP) and TIC ratio (T/C%; mean ± SEM) of the mid-latency 
auditory evoked responses, i.e. N1, P1, N2, P2, N3 recorded from CA3, DG and 
mPFC (n = 10). 
~ ~ N1 P1 N2 P2 N3 Area 
CA3 
CLAT (ms) 25 ± 1 42 ± 3 65±4 111 ± 5 154 ± 8 
CAMP ( ~ V ) ) 78± 5 159 ± 16 222 ± 28 173 ± 22 100 ± 29 
TIC % 52 ± 8 39 ± 5 31 ±4 36 ± 6 58 ± 10 
DG 
CLAT (ms) 23 ± 1 37 ± 1 63 ± 1 108 ±4 149 ± 6 
CAMP ( ~ V ) ) 40 ± 2 113 ± 8 158 ± 4 166 ± 12 94 ± 14 
TIC % 62 ± 9 38 ± 3 36 ± 3 42 ± 3 65 ± 9 
mPFC 
CLAT (ms) 22 ± 1 34 ± 2 58 ± 1 80 ± 2 120 ±11 
CAMP ( ~ V ) ) 17 ± 2 149 ± 52 95± 9 66 ± 9 43 ± 17 
TIC % 65 ± 7 59 ± 9 48± 5 78 ± 10 130 ± 9 
The CLAT of N1, P1, N2, P2 and N3 waves recorded from the CA3, DG and mPFC were within 
the midlatency range (20 -200 ms). In CA3 and DG only three waves (P1, N2 and P2) had 
mean TIC ratios S 50% and in mPFC only the N2 wave exhibited a mean TIC ratio S 50%. The 
N2 wave from all three areas exhibited the lowest mean TIC ratio compared to the other peaks. 
The N2 wave also demonstrated the highest mean CAMP in CA3 and DG compared to the 
other AERs. 
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2.8.2 Single-unit analyses 
Neuronal action potentials were validated and sorted off-line with Off-Line 
Sorter using a combination of manual and automatic techniques (including T-
Distribution E-M, valley-seeking, k-means clustering methods - see Lewicki, 
1998) according to the following criteria: voltage thresholds >2 s. Os. of 
amplitude distribution; signal: noise ratio >2.5:1 (verified on oscilloscope 
screen); <1 % interspike intervals <1.2ms; stereotypy of waveform shapes 
(using waveform algorithm and PCA). Plots of sorted spikes as PC1 v time 
stamps provided a visual indication of any temporal effects or auditory/drug-
evoked changes in spike sorting during the recording session (Fig 2.5). 
Within Neuroexplorer the discriminated single-unit data was initially visualised 
off-line as spike rasters which represented time-stamps of neuronal action 
potential spikes, viewed as vertical ticks, corresponding to the temporal (time 
stamped) occurrence of the spikes. Data was subsequently analysed as peri-
stimulus time histograms and epoch counts. 
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Fig. 2.5 Sorting single units using Offline sorter 
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(A) Appearance of an isolated single unit from mPFC as displayed on screen following 
offline sorting using manual and automatic sorting methods. The graph displays the 
templates (average waveforms) for the unit, separated from background noise and the 
action potentials of the other single units recorded from the same electrode. 
(8) The same isolated single unit from mPFC displayed as a cluster in the cluster display 
window of the offline sorter. Cluster display plots all waveforms (as small dots) that 
crossed a fixed voltage threshold in a X-Y space defined by two principal components 
(PC1 & PC2) . Upon removal of artifacts, well defined clusters are manually separated to 
contain isolated single units. 
(C) A 3D plot from Offline sorter displaying the distribution of spike activity (time stamps = 
time of occurrence of the action potentia Is) of the above neurone during the whole 
recording session (X axis= Time stamps Y &Z axis=PC1) . The graph indicates an 
increased spike activity following auditory stimuli (first arrow) and decreased activity 
following cannabinoid administration (second arrow). 
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2.8.2.1 Peri-stimulus time histograms 
In general, the peri-eventl peri-stimulus time histogram shows (PSTHs) the 
conditional probability of a spike in the spike train at a specific time, on the 
condition that there is a reference event at time zero. 
In our analysis the reference event was the conditioning stimulus and we looked 
at the changes of firing of the single neurons within a time frame of 0.5s pre and 
1s post conditioning stimulus period (Y-axis spike counts; bin size 10ms) (Fig 
2.6A). Response magnitudes (spikes S-1) were derived from PSTH epochs. 
2.8.2.2 Epoch counts 
Epoch counts analyse the spike activity for requested number of bins (epochs) 
of any requested size. Neuronal firing was studied during 0.5s of pre-
conditioning stimulus period, 0.5s post conditioning stimulus and 0.5s following 
the test stimulus to compare the spike activity before and after the conditioning 
and test stimuli (Fig 2.6 B).The numerical results were then analysed using 
Prism. 
The aim of this chapter was to present a general description of the 
methodologies used in this in-vivo electrophysiological study of auditory gating. 
Experimental protocols for each set of experiments will be described in-detail in 
subsequent re,sults chapters. 
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Fig 2.6 (A) Peri-stimulus time histogram (bin size = 10 ms) and (8) Epoch count 
analysis of a single unit recorded from the CA3 of hippocampus in response 128 
trials of auditory stimuli. 
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(A) An example of a peri- stimulus time histogram of a single unit recorded from the CA3 region 
of the hippocampus showing the unit firing rate during 500 ms pre-stimulus period and one 
second following conditioning stimulus period (the test stimulus presented at 500ms; 
horizontal dashed lines are the mean firing rate- lower line, 95% confidence limit = upper 
line). The histogram shows significantly increased single-unit activity (above 95% 
confidence limit) compared to pre-stimulus period following the conditioning stimulus and 
reduced activity following test stimulus compared to post conditioning stimulus period . 
(8) Epoch count analysis of the same single-unit recorded from CA3 demonstrating the spike 
activity 100ms before the conditioning stimulus (Epoch Number 1), 100 ms after the 
conditioning stimulus (Epoch Number 2) and 100 ms period following the test stimulus 
(Epoch Number 3) . Epoch analysis shows increased spike activity following the conditioning 
stimulus compared to pre-stimulus period and reduced spike activity following test stimulus 
compared to post conditioning stimulus period. 
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Chapter Three 
Characterization of sensory gating in the 
CA3 region and dentate gyrus of the rat 
hippocampus 
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3. Characterization of sensory gating in the CA3 
region and dentate gyrus of the rat hippocampus 
3.1 Introduction 
The hippocampus plays a major role in modulating the brain's sensitivity to 
external stimuli by participating in the process of sensory gating. Recent human 
studies using intracranial electrodes and imaging techniques, to delineate the 
brain areas responsible for gating of auditory evoked responses (AERs), have 
indicated the hippocampus as the modulator of sensory gating (Grunwald et al., 
2003; Boutros et al., 2005; Tregellas et al., 2007). Gating of the mid latency P50 
AER, recorded from the scalp, in response to an auditory conditioning- test 
paradigm is considered a reliable biological marker of schizophrenia. 
The hippocampus is a relatively accessible region in the rat brain for intracranial 
recordings compared to the human brain and the N40 wave, recorded from the 
skull as' well as from the CA3 region of the hippocampus in anaesthetised and 
freely moving rats, has similar properties to the human P50 AER (see section 
1.1.1; Adler et al., 1986; Bickford et al., 1990; Miller et al., 1992). 
The CA3 of the hippocampus receives auditory information via the lemniscal 
and non-Iemniscal pathways (see section 1.1.3). Rat studies have 
demonstrated auditory gating in areas involved in the non-Iemniscal pathway 
(e.g. brain stem and medial septum) but not in the lemniscal pathway (e.g. 
auditory cortex and medial geniculate) suggesting that auditory gating is 
exclusive to the non-Ieminiscal pathway (Bickford et al., 1990; 1993; Miller & 
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Freedman., 1993; Moxon et al., 1999). Sensory information from cortical 
sensory areas is funnelled down to CA3 via the dentate gyrus which receives 
outputs from perirhinal and entorhinal cortices, which are cortical areas involved 
in the leminiscal pathway. A recent human study, using intracerebral electrodes, 
detected auditory gating in the rhinal areas which suggests the possibility of 
gating in the leminiscal pathway (Boutros et al., 2005). It is important to 
examine the role played by the dentate gyrus in auditory gating since it is 
relaying auditory information to CA3 from the surrounding cortical areas. 
Previous studies on sensory gating have used either injectable anaesthetics 
(Bickford et al., 1990; 1993; Krause et al., 2003) or freely moving rats (Adler et 
al., 1986; Moxon et al., 1999). However no studies have assessed sensory 
gating under isoflurane anaesthesia. Isoflurane is an easily maintainable 
gaseous anaesthetic which prevents fluctuations in the level of anaesthesia and 
also avoids the drawbacks associated with repeated injections of anaesthetics. 
The maln objective of this chapter was to characterize the basic properties of 
auditory gating in the CA3 region and dentate gyrus (DG) of the hippocampus 
by analyzing LFP responses to an auditory conditioning-test paradigm in Lister-
hooded rats under isoflurane anaesthesia. We also studied the stability and 
variability of auditory gating in the CA3 and DG in response to different inter-
stimuli intervals (ISls). 
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3.2 Methods 
3.2.1 Animals 
Male Lister hooded rats (n = 42; weight 250g - 400g) were anaesthetised with 
isoflurane; N20:02 and all the electrophysiological procedures were carried out 
as described in chapter 2. Simultaneous recordings from CA3 and DG were 
carried out using an electrode array (2x8) and only the animals with electrodes 
placed in CA3 and DG, confirmed by histology, were used for analysis. 
3.2.2 Experimental protocol 
Basal activity of the two areas was recorded for 5 minutes prior to the auditory 
stimuli. Auditory stimuli (90dB intensity, 0.5s ISI, 10s inter-trial interval) were 
presented over 128 trials and auditory evoked LFP and unit responses were 
recorded simultaneously from the CA3 and DG. Following detection of AERs in 
the CA3 and DG, responses to five different inter-stimuli intervals (1.5s, 2.5s, 
3.5s, 4.5s and 6s; n = 5) over 128 trials were recorded. 
3.2.3 Data analysis 
The AERs from the CA3 and DG were initially displayed as peri-event averaged 
LFPs and the peaks and troughs of LFPs in response to stimuli were identified 
according to the polarity and the order of occurrence (see chapter 2). 
Conditioning amplitudes (CAMP), test amplitudes (TAMP), conditioning 
response latericies (CLAT), test response latencies (TLAT) and TIC ratios of the 
N2 wave were analysed using a Matlab script (Amplat). An electrode from each 
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area demonstrating the highest CAMP was selected for further analysis of 
LFPs. The TIC ratios of the N2 wave at different inter-stimuli intervals were 
obtained using another Matlab script (Amplatlong) and the TIC ratio of different 
ISI were compared with each other. Statistical analysis was carried out using 
Student t test or one way analysis of variance (AN OVA) with post hoc Tukey t 
test when appropriate. Linear regression coefficient was used to assess the 
relationship of the amplitude and latency parameters to the TIC ratios. Data are 
expressed as mean ± SEM (standard error of mean) with P<0.05 considered 
statistically significant. 
3.3 Results 
The CA3 region of the hippocampus and dentate gyrus demonstrated robust 
auditory-evoked LFP responses consisting of positive and negative complexes 
(i.e. N1, P1, N2, P2, N3; Fig. 3.1). The N2 wave, which demonstrated constant 
gating and occurred within the mid latency range, so comparable to the P50, 
was used for further analysis (see chapter 2). Some rats (n = 25) showed N2 
TIC ratios S 50% in CA3 and DG (CA3 TIC ratio = 28 ± 3 %; DG TIC ratio = 30 
± 3 %) and were identified as gating rats and rats demonstrating N2 TIC ratios 
>50% (n = 17; CA3 TIC = 106 ± 11 %, DG TIC = 105 ± 13 %) were identified as 
non-gating rats. The amplitudes (CAMP, TAMP), TIC ratios and latencies 
(CLAT and TLA T) were analysed in the CA3 and DG of the gating and the non-
gating rats separately and then compared between the two groups. 
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Fig. 3.1 Representative peri-event averaged LFPs from (A) CA3 and (8) DG 
in a gating rat in response to 128 auditory conditioning-test trials. 
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(A) The peri-event averaged LFPs from CA3 in response to the conditioning and test 
stimuli (timing of the stimuli are indicated by the triangles) demonstrated positive 
and negative AER complexes with gating of the N2 wave (TIC = 44%). 
(8) The peri-event averaged LFPs from DG in response to the conditioning and test 
stimuli demonstrated positive and negative AER complexes with gating of the N2 
wave (TIC = 46%). 
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3.3.1 Auditory evoked N2 responses of the gating rats 
The CA3 region and the DG of the hippocampus of the gating rats 
demonstrated varying conditioning response amplitudes ranging from 21 - 456 
!-IV in CA3 (Fig. 3.2 A) and 14 - 329 !-IV in DG (Fig. 3.2 B). The CA3 region 
exhibited a higher mean conditioning response amplitude than that from the DG 
(CA3 = 182 ± 27 !-IV; DG = 135 ± 19 !-IV; mean ± SEM). Both regions exhibited a 
significant reduction in the test response amplitudes compared to conditioning 
response amplitudes (CA3 TAMP = 48 ± 9 !-IV; DG, TAMP = 43 ± 9 !-IV; 
P<0.0001; Fig. 3.2 A & B) resulting in gating of the N2 wave (CA3 TIC ratio = 28 
± 3 %; DG TIC ratio = 30 ± 3 %). 
The conditioning N2 response of the CA3 region was detected at a latency 
range of 46 - 93 ms with a mean latency of 65 ± 3 ms (Fig. 3.2 C). The DG 
showed a similar CLAT range (46 - 90 ms) with a slightly shorter mean latency 
of 63 ± 2 ms (Fig. 3.2 D). There was no significant difference between 
conditioning response latencies and test response latencies in either CA3 or DG 
(CA3 TLAT = 61 ± 3 ms, P = 0.3; DG TLAT = 60 ± 1 ms, P = 0.4). 
Evidence for a correlation between either amplitude or latency and the TIC 
ratios was determined using linear regression analysis in CA3 (Fig. 3.3) and DG 
(Fig. 3.4). In CA3, the changes in CAMP had no effect on TIC ratio. In contrast 
a significant positive correlation was detected between the TAMP and TIC ratio 
(F = 8; P= 0.007). Neither CLAT nor TLAT showed a Significant correlation with 
the TIC ratio in the CA3. In the DG, no significant correlation was found 
between TIC ratio and CAMP. But similar to the relationship observed in the 
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CA3, TAMP of the DG exhibited a significant positive correlation with the TIC 
ratio (F = 15; P= 0.0007). Neither CLAT nor TLAT showed a significant 
correlation with the TIC ratio in the DG. 
3.3.1.1 Gating at different inter-stimuli intervals 
In both CA3 and DG an increase in the TIC ratio was observed with an increase 
in the inter-stimuli interval (Fig. 3.4). In the CA3, a significant increase in the TIC 
ratio was detected at all tested inter-stimuli intervals (F5. 35 = 45, P<0.0001) and 
the post hoc t tests revealed the highest significant change in the TIC ratios 
(P<0.0001) at 1.5s, 2.5s, 3.5s, 4.5s and 6s inter-stimuli intervals when 
compared with the 0.5s ISI (Fig. 3.4A). However the reduction in TAMP 
compared to CAMP was maintained even up to 4.5s inter-stimuli intervals 
resulting in TIC ratios <100%, at 1.5s (TIC ratio = 59 ± 3 %), 2.5s (TIC ratio = 62 
± 2 %), 3.5s (TIC ratio= 77 ± 3 %) and 4.5s (TIC ratio = 93 ± 3 %). Nonetheless, 
the a b i l i ~ y y to decrease the TAMP was completely abolished at 6s (TIC = 103 ± 
5%). 
The DG also demonstrated a significant increase in the TIC ratio at all tested 
inter-stimuli intervals (F5. 35 = 50, P<0.0001) when compared with the TIC ratio 
at 0.5 s (Fig. 3.48). However, the reduction in TAMP compared to CAMP was 
maintained even up to 6s delay from the onset of the conditioning stimulus 
resulting in TIC ratios <100%, at 1.5s (TIC ratio = 69 ± 3 %), 2.5s (TIC ratio = 65 
± 2 %), 3.5s (TIC ratio = 83 ± 2 %), 4.5s (TIC ratio = 93 ± 2 %) and 6s (TIC ratio 
= 97 ± 1 %). 
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Fig. 3.2 Scatter plots demonstrating the distribution of amplitudes and latencies of 
the N2 wave in (A & C) CA3 and (8 & D) DG of the gating rats (n = 25) in response 
to auditory stimuli. 
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(A) The CA3 region demonstrated a wide variation of CAMP compared to lesser 
variations in TAMP and TIC ratios. The TAMP was significantly smaller (-- = P<0.0001) than CAMP resulting in a mean TIC ratio of 28 ± 3 % (mean ± 
SEM). 
(8) The DG demonstrated a wide variation of CAMP compared to lesser variations 
in TAMP and TIC ratios. The TAMP was significantly smaller ( ... = P<0.0001) 
than CAMP resulting in a mean TIC ratio of 30 ± 3% (mean ± SEM). 
(C) The CLAT values varied between 46 - 93 ms while TLAT ranged between 36-
90 ms. No significant difference was observed between CLA T and TLAT in 
CA3. 
(0) The CLA T values in DG were between 46- 90 ms while TLA T ranged between 
33 - 90 ms. No significant difference was observed between CLA T and TLA T in 
DG. 
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Fig. 3.3 Linear regression lines (dark lines) with 95% confidence limits (dashed 
lines) demonstrating the relationship of (A) CAMP, (8) TAMP, (C) CLAT and (D) 
TLAT with the TIC ratios of the N2 wave in the CA3 region of the gating rats (n 
= 25). 
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(A) Linear regression analysis examining the relationship between AER parameters 
with the TIC ratios revealed that changes in CAMP had no effect on the TIC 
ratios in the CA3. 
(B) A significant positive correlation was observed between TAMP and the TIC 
ratios (P = 0.007). 
(C & D) Neither CLAT nor TLAT latency correlated with changes in the TIC ratios. 
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Fig. 3.4 Linear regression lines (dark lines) with 95% confidence limits (dashed 
lines) demonstrating the relationship of (A) CAMP, (8) TAMP, (C) CLAT and (D) 
TLAT with the TIC ratios of the N2 wave in the DG of the gating rats (n = 25). 
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(A) Linear regression analysis revealed that changes in CAMP had no effect on the 
TIC ratios in the DG. 
(8) A significant positive correlation was observed between TAMP and the TIC 
ratios (P = 0.0007) 
(C & D) Neither CLAT nor TLAT latencies correlated with changes in the TIC ratios. 
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Fig. 3.5 Graphs comparing the TIC ratios of the N2 wave at different inter-
stimuli interval (ISI) in (A) CA3 and (8) DG of the gating rats (n = 5; TIC ratios = 
mean ± SEM). 
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(A) The CA3 region exhibited significant increases in the TIC ratios at a/l ISI 
compared to the 0.55 ISI ( ••• = P < 0.001). The lowest TIC ratio was observed at 
0.5s ISI (33 ± 5 %) and the highest at 6s (103 ± 5 %). 
(8) The DG region exhibited significant increases in the TIC ratios at a/l ISI 
compared to the 0.5s ISI ( ••• = P < 0.001) with the lowest TIC ratio observed at 
0.55 ISI (40 ± 3 %) and the highest at 6s (97 ± 1 %). 
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3.3.2 Auditory evoked N2 responses of the non-gating rats 
Large amplitude responses to both the conditioning and test stimuli with 
absence of gating were detected in the CA3 and DG in the non-gating rats (Fig. 
3.5). The CAMP varied from 28 - 343 I.N (Fig. 3.6 A) in CA3 and 23 - 292 jJV in 
DG (Fig. 3.6 B). In CA3, no significant difference was detected between the 
CAMP and TAMP (CAMP = 203 ± 24 jJV, TAMP = 185 ± 23 jJV; P = 0.2) 
resulting in a mean TIC ratio of 106 ± 11%. The DG exhibited a similar 
response to the CA3 with no significant difference between CAMP and TAMP 
(CAMP = 154 ± 18 jJV, TAMP = 140 ± 15 jJV; P = 0.2) resulting in a mean TIC 
ratio of 105 ± 10 %. 
The CLAT in CA3 ranged from 47 - 63 ms (Fig 3.6 C).and CLAT of DG was 
observed from 46 - 65 ms (Fig 3.6 D). The mean CLA T in both CA3 and DG in 
non-gating rats was 55 ± 1 ms. Interestingly the TLA T of both regions was 
significantly longer than their CLAT (CA3 TLAT = 59 ± 1 ms; P= 0.0005; DG 
TLAT = 59 ± 1 ms; P= 0.0004) 
Linear regression analysis was used to assess whether there were correlations 
between either amplitude or latency and the TIC ratio in CA3 (Fig. 3.7) and DG 
(Fig. 3.8) of the non-gating rats. In the CA3, a Significant negative correlation 
was detected between the TIC ratio and CAMP (F = 9, P = 0.007). However, 
changes in TAMP did not affect the TIC ratio in CA3. Changes in CLAT or TLAT 
had no significant effect on the TIC ratio in CA3. The DG of non-gating rats 
also showed a significant negative correlation between TIC ratio and CAMP (F 
, 
= 11; P = 0.004). But similar to the relationship observed in the CA3, changes in 
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TAMP of the DG had no effect on the TIC ratio. The changes in CLAT or TLAT 
had no significant effect on the TIC ratio in the DG of the non-gating rats. 
3.3.3 Comparison of LFP parameters of the gating rats and the 
non-gating rats 
Based on the results which showed non-gating rats responding differently to 
auditory stimuli, we compared the amplitudes, latencies and TIC ratios between 
the gating rats and non-gating rats in the CA3 and DG to study whether there 
were significant differences between the two groups to allow us to classify them 
as two distinct groups with different sensitivities and responses to auditory-
conditioning test paradigm (Fig. 3.9). 
There were no significant differences in CAMP between gating and non-gating 
rats in either CA3 (P = 0.6) or DG (P = 0.4). Non-gating rats demonstrated a 
significantly higher TAMP in both regions compared to gating rats (CA3 = 
P<0.0001; DG = P<0.0001). Significantly higher TIC ratios were also detected 
in non-gating rats in both areas compared to gating rats (CA3 = P<0.0001; DG 
= P<0.0001). According to the above findings higher amplitude responses to the 
test stimuli appeared to contribute to the higher TIC ratios in non-gating rats 
compared to gating rats. Non-gating rats also showed significantly shorter CLAT 
in CA3 and DG compared to those of gating rats (CA3, P = 0.002; DG, P = 
0.004). No significant difference of TLAT was observed between gating and 
non-gating rats either in the CA3 or DG. In non-gating rats the changes in TIC 
ratios were negatively correlated with CAMP while in gating rats CAMP had no 
effect on the TIC ratio. Moreover, the TIC ratio of gating rats increased with 
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increases in TAMP while TAMP of non-gating rats had no effect on the TIC 
ratio. 
Fig. 3.6 Representative peri-event averaged LFPs from (A) CA3 and (8) DG of 
a non-gating rat in response to 128 auditory conditioning-test trials. 
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(A) The peri-event averaged LFPs from CA3 in response to the conditioning and 
test stimuli (timing of the stimuli are indicated by the triangles) -demonstrated 
positive and negative AER complexes with absence of gating of the N2 wave 
(TIC = 104%). 
(8) The peri-event averaged LFPs from DG demonstrated positive and negative 
AER complexes with absence of gating of the N2 wave (TIC = 90%). 
83 
Fig. 3.7 Scatter plots demonstrating the distribution of amplitudes and latencies 
of the N2 wave in the non-gating rats in (A & C) CA3 and (8 & D) DG in 
response to auditory stimuli (n = 17). 
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(A) The CA3 region demonstrated a wide variation of CAMP and TAMP. No 
significant differences between CAMP and TAMP were OBserved resulting in a 
mean TIC ratio of 106 ± 11 % (mean ± SEM). 
(8) The DG demonstrated a wide variation of CAMP, TAMP and TIC ratios. No 
significant differences between CAMP and TAMP were observed resulting in a 
mean TIC ratio of 105 ± 13 %. 
(C) The CLAT values were between 47 - 63 ms while TLAT ranged from 50 - 71 
ms. The TLA T was significantly longer than CLA T in the CA3 (.- = P = 0.0005). 
(0) In the DG, the CLAT values were between 46 - 65 ms while TLAT ranged from 
47 - 71 ms. The TLA T was significantly longer than CLA T ( ••• = P = 0.0004). 
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Fig. 3.8 Linear regression lines (dark lines) with 95% confidence limits (dashed 
lines) demonstrating the relationship of (A) CAMP, (8) TAMP, (C) CLAT and (0) 
TLAT with the TIC ratios of the N2 wave in the CA3 of the non-gating rats (n = 
17). 
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(A) Linear regression analysis demonstrated that CAMP of non-gating rats had a 
significant negative correlation with the TIC ratios in CA3 (P = 0.007). 
(8) The changes in TAMP were not associated with the changes in the TIC ratios. 
(C & D) Neither CLA T nor TLA T latencies significantly correlated with changes in 
the TIC ratios. 
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Fig. 3.9 Linear regression lines (dark lines) with 95% confidence limits (dashed 
lines) demonstrating the relationship of (A) CAMP, (8) TAMP, (C) CLAT and (0) 
TLAT with the TIC ratios of the N2 wave in the OG of the non-gating rats (n = 
17). 
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(A) The CAMP demonstrated a significant negative correlation with the TIC ratios in 
the DG (P = 0.004). 
(8) The changes in TAMP were not associated with the changes in the TIC ratios. 
(C & D) Neither CLA T nor TLA T latencies significantly correlated with changes 
in the TIC ratios. 
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Fig. 3.10 Bar graph depicting CAMP, TAMP and the TIC ratios of the N2 wave 
in the CA3 and DG of the gating rats (n = 25) compared with the findings of the 
non-gating rats (n = 17). 
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There was no significant difference in CAMP (P > 0.05) between gating and non-gating 
rats in either CA3 or DG. The non-gating rats had significantly higher TAMP and TIC 
ratios compared to the gating rats in both CA3 and DG (*** = P < 0.0001 ; values = 
mean ± SEM). 
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3.4 Discussion 
Robust auditory evoked potentials were recorded from the CA3 and DG of rat 
hippocampus with some rats demonstrating auditory gating and some exhibiting 
absence of gating. 
In agreement with the previous studies, auditory gating was observed in the 
CA3 region (Bickford et al., 1990; 1993; Miller et al., 1992; Krause et al., 2003). 
This region also displayed a higher sensitivity to auditory stimuli with higher 
amplitude responses compared to the dentate gyrus. The CA3 of rat 
hippocampus has been shown to have the highest conditioning amplitude 
responses compared to the other areas of the non-Ieminiscal pathway allowing 
the researchers to suggest that CA3 as the central area of auditory gating 
(Bickford et al., 1990; Moxon et al., 1999). However, in the current study the N2 
wave recorded from the CA3 region had a higher conditioning response latency 
range compared to the latencies of the "N40" wave recorded from the CA3 
region in the previous studies (Adler et al., 1986, CLAT = 50.8 ± 2.8 ms; 
Bickford-Wimer et al., 1990, CLAT = 41 ± 1 ms; Moxon et al., 1999, CLAT = 
33.1 ± 2.2 ms). This disparity could be attributable to the differences in 
methodology. We used Lister hooded rats under isoflurane anaesthesia, while 
previous studies used Sprague-Dawley or Wistar rats that were either freely 
moving with implanted electrodes (Adler et al., 1986; Moxon et al., 1999) or 
anesthetized with chloral hydrate (Bickford-Wimer et al., 1990). Isoflurane is an 
easily maintainable gaseous anaesthetic, which minimizes the fluctuation of the 
level of anaesthesia. Several studies have shown that isoflurane prolongs the 
latencies of the AERs in both humans and rats and the prolonged latencies 
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correlate with the depth of anaesthesia (Heneghan et al. 1987; Madler et al. 
1991; Santarelli et al. 2003). It is quite likely that the use of isoflurane underlies 
the latency difference observed in this study compared to other studies. 
We observed auditory gating in the DG with similar findings to the CA3 
suggesting an important role played by the DG in the auditory gating process. 
Presence of auditory gating in the DG also suggests the possibility of auditory 
gating in the lemniscal pathway. 
The N2 wave of CA3 and DG regions demonstrated maximum gating at 0.5s 151 
with an increase in the TIC ratios with increments in 151, which is similar to the 
changes observed in the rat N40 (Bickford et al.,1993; Krause et al., 2003) and 
human P50 (Freedman et al., 1983; Dolu et al., 2001). However, the findings of 
the studies, regarding the 151 at which the reduction of the test response is 
completely abolished, are inconclusive. Human studies have studied 151 up to 
8s with some studies showing complete abolition of gating at and above 2s 
( F r e e d ~ a n n et al., 1983), 6s (Adler et al., 1982) or 8s (Fruhstorfer et aI., 1970). 
Some rat studies have shown complete absence of N40 test amplitude 
reduction at 4s 151 (Adler et al., 1986) while others have shown TIC ratio >100% 
using an 151 of 5s (Bickford et al., 1993). Different neuronal mechanisms may 
be responsible for reductions in TAMP at different ISls and the findings from this 
and previous studies advocate the use of an 151 of <1s, ideally 0.5s, to obtain 
maximum gating and a longer inter-trial interval (>8s) to allow the recovery of all 
the neuronal mechanisms responsible for gating in the conditioning-testing 
paradigm. 
A significant positive relationship was observed between TAMP and TIC ratio 
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both in the CA3 and DG, suggesting that auditory gating in both areas was 
dependent on neuronal mechanisms activated following the conditioning 
stimulus with resultant inhibitory effects on the response to the test stimulus. 
Moxon et al (1999) observed the same relationship between the TIC ratio and 
TAMP of N40 in the CA3 of freely moving rats. The same group reported that 
auditory gating in CA3 was not dependent on CAMP, CLAT or TLAT, which is 
similar to our findings from both CA3 and DG. 
In accordance with previous studies, some rats demonstrated gating of the test 
response while others demonstrated enhancement of the test response, 
resulting in non-gating (Adler et al., 1986; Miller & Freedman, 1995; Moxon et 
al., 1999). No explanation was given to the consistently non-gating state of the 
rats recorded in previous studies. This effect cannot be attributed to 
anaesthesia as it has been documented in freely moving rats (Moxon et al., 
1999). Some studies have shown gating and non-gating instances in the same 
rat, both under anaesthesia (Miller and Freedman, 1995) and in freely moving 
rats (Moxon et al., 1999). 
We observed a higher percentage of non-gating rats compared to other studies 
and this allowed us to characterize their AERs. Non-gating rats had similar 
amplitude responses to both the conditioning and test stimuli in CA3 and DG 
indicating the dysfunctions in neuronal mechanisms responsible for gating of 
the test response. Non-gating rats also had significantly longer TLA T compared 
to their CLA T highlighting possible derangements in the neuronal circuitry in 
eliciting the test response. 
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Interestingly, the TIC ratio of the non-gating rats negatively correlated with 
CAMP in both CA3 and DG, suggesting that the lack of gating in this rat group 
is also associated with the inability to respond normally to the first stimulus in 
the paired stimulus paradigm. This finding with non-gating rats is similar to the 
non-gating states induced by dopaminergic agonists which disrupt gating by 
decreasing the CAMP in rats (Adler et al., 1986; de Bruin et al., 2001). Lower 
CAMP and shorter CLAT have been shown to be associated with higher TIC 
ratios observed in schizophrenic patients (Adler et al., 1982; Freedman et al., 
1983; Siegel et aI., 1984), an interesting similarity to our findings with the non-
gating rats. However, in the present study, no significant difference in CAMP 
was observed between gating and non-gating rats in contrast with the findings 
from human studies which found schizophrenic patients exhibited lower CAMP 
than controls (Adler et al., 1982; Freedman et al., 1983). Schizophrenic patients 
have been shown to have shorter CLA T than controls which is similar to the 
findings. of our study between gating and non-gating rats (Adler et al., 1982; 
Freedman et al., 1983). 
Non-gating rats had significantly higher TAMP and TIC ratio than gating rats, 
highlighting again the deficits in neural inhibitory mechanisms required to gate 
the test response in the non-gating rat group. 
By examining AERs in the CA3 and DG regions of the hippocampus in Lister-
hooded rats under isoflurane anaesthesia, we have been able to identify the N2 
wave which exhibits auditory gating similar to rat N40 and human P50. We have 
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also found a group of rats exhibiting non-gating with some AER properties 
comparable to those recorded from schizophrenic patients. The next step was 
to examine the AERs and auditory gating in the medial prefrontal cortex, with 
simultaneous recording from the CA3 and DG of hippocampus, which would 
expand this model of sensory gating to a brain area that has importantly been 
implicated in the pathogenesis of schizophrenia (Knight et al., 1989; Tregellas 
et al., 2007). 
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Chapter Four 
Characterization of sensory gating in the 
medial prefrontal cortex of the rat 
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4. Characterization of sensory gating in the 
medial prefrontal cortex of the rat 
4.1 Introduction 
Prefrontal cortex (PFC) is a crucial brain area for executive functions, memory 
and attention. The rat PFC consists of cytoarchitecturally and functionally 
distinct areas located over the medial, orbital and insular surfaces of the rostra I 
cerebral hemispheres (see chapter 1) and the medial prefrontal cortex (mPFC) 
is posited to be involved in the cognitive processes such as memory and 
attention (Gabbott et aI., 2005). 
Anatomical and functional alterations in the human PFC are implicated in the 
pathophysiology of schizophrenia. Early imaging studies suggested a decrease 
in the tonic activity in the PFC (i.e. hypofrontality) and a reduction in the 
prefrontal cortical volume in patients with schizophrenia compared to controls 
(Weinberger et al., 1992; Harvey et al., 1993). Some recent studies contradict 
the state of hypofrontality and suggest that deficits in other cortical regions (e.g. 
hippocampus, amygdala) interconnecting with the PFC may produce the 
functional changes elicited in the PFC of schizophrenic patients (Grace et aI., 
2000). 
Recent human studies using intracerebral electrodes have shown gating of 
auditory evoked responses in the PFC (Knight et aI., 1989; Grunwald et aI., 
2003; Kurthen et al., 2007). Imaging studies have reported prefrontal 
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involvement in auditory gating with increased activity in the PFC, in response to 
auditory conditioning-testing paradigm (Tregellas et al., 2007). Knight et al 
(1989) reported that patients with frontal lobe lesions have larger P50 
responses compared to controls, pointing to a frontal modulation of P50 
auditory evoked responses. 
Two studies have reported auditory gating in the medial prefrontal cortex of 
freely moving rats with implanted electrodes (Mears et al., 2006; Yang et al., 
2006). Mears et al (2006) reported a conSistently 'gating' positive wave, 
occurring around 60 ms following auditory stimuli (P60) in the rat mPFC and 
Yang et al (2006) observed three AERs (designated P2, N2 & P3) 
demonstrating gating in the rat mPFC. No studies have examined the AERs and 
auditory gating in the mPFC of Lister hooded rats under isoflurane anaesthesia, 
with simultaneous recording from the hippocampus. 
The m a ~ n n objective of this chapter was to examine AERs and characterize the 
basic properties of auditory gating in the medial prefrontal cortex (mPFC) by 
analyzing the LFP responses to auditory conditioning-test paradigm in Lister 
hooded rats under isoflurane anaesthesia. It was also aimed to observe the 
AERs and gating in the mPFC with simultaneously recorded results from CA3 
and dentate gyrus (DG) of the hippocampus. 
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4.2 Methods 
4.2.1 Animals 
Of the forty two male Lister hooded rats described in chapter 3, twenty five 
animals (weight 250g - 400g) had electrodes placed in the mPFC and 
simultaneous recordings from the hippocampus and mPFC were carried out as 
described in chapter 2. Only the animals with electrodes placed in the mPFC, 
CA3 and DG, confirmed by histology, were used for analysis. 
4.2.2 Experimental protocol 
Basal activity of the mPFC was recorded for 5 minutes prior to the auditory 
stimuli. Auditory stimuli (90dB intensity, 0.5s ISI, 10s inter-trial interval) were 
presented over 128 trials and aUditory-evoked LFP and unit responses were 
recorded simultaneously. Following detection of auditory gating in the mPFC, 
responses to five different inter-stimuli intervals (1.5s, 2.5s, 3.5s, 4.5s and 6s; n 
= 5) over 128 trials were recorded. 
4.2.3 Data analysis 
The AERs in the mPFC was initially displayed as peri-event averaged LFPs and 
the peaks and troughs of LFPs in response to stimuli were identified according 
to the polarity and the order of occurrence i.e. N1, P1, N2, P2, N3 (see chapter 
2). Conditioning amplitudes (CAMP), test amplitudes (TAMP), conditioning 
response latencies (CLAT) , test response latencies (TLAT) and TIC ratio of the 
96 
N2 wave was analysed using a matlab script (amplat). An electrode from each 
animal demonstrating the highest conditioning response amplitude was selected 
for further analysis. The TIC ratios at different inter-stimuli intervals were 
obtained using another Matlab script (Amplatlong). Statistical analysis was 
carried out using Student t test or one way analysis of variance (ANOVA) with 
post hoc Tukey t test when appropriate. Linear regression coefficient was used 
to assess the relationship of the amplitude and latency parameters to the TIC 
ratios. The gating and non-gating rats were identified according to the TIC ratio 
in the simultaneously recorded CA3 region (Moxon et al., 1999). The animals 
demonstrating TIC ratio S 50% in the CA3 were identified as gating rats and 
animals with TIC ratio> 50% were identified as non-gating rats. Data are 
expressed as mean ± SEM (standard error of mean) with P<0.05 considered 
statistically significant. 
4.3 Results 
The mPFC demonstrated prominent positive and negative waveform complexes 
(as shown in chapter 2) in response to the auditory stimuli (Fig. 4.1). The 
amplitudes (CAMP, TAMP), TIC ratios and latencies (CLAT and TLAT) of the 
N2 wave were analysed in the gating (n = 15) and the non-gating rats (n = 10) 
and then compared between the two groups. 
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4.3.1 Auditory evoked N2 responses of the gating rats 
The N2 wave in the mPFC exhibited widely varying conditioning response 
amplitudes ranging from 9 - 139 IJV (Fig. 4.2A). A significant reduction in the 
test response amplitudes was observed compared to conditioning response 
amplitudes (TAMP = 28 ± 5 IJV; P= 0.02; Fig. 4.2 A) resulting in gating of the N2 
wave (TIC = 45 ± 3%). However, TIC ratio in the mPFC of the gating rats 
ranged from 22 - 62% with some rats (n = 7) exhibiting TIC ratios between 50-
62%. 
The conditioning response occurred at a latency range of 45 - 70 ms with a 
mean latency of 57 ± 1 ms (Fig. 4.2 8). There was no significant difference 
between conditioning response latencies and test response latencies (TLAT = 
57 ± 2 ms, P = 0.9). 
Evidence for a correlation between either amplitude or latency and the TIC 
ratios was determined using linear regression analysis in the mPFC (Fig. 4.3). 
The changes in CAMP had no effect on the TIC ratio. In contrast a Significant 
positive correlation was detected between the TAMP and the TIC ratio (F = 4.9; 
P = 0.04). Neither CLAT nor TLAT showed a significant correlation with the TIC 
ratios. 
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Fig. 4.1 Representative peri-event averaged LFPs in the mPFC of a gating rat 
in response to 128 auditory conditioning-test trials. 
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The perievent averaged LFPs from the mPFC in response to the conditioning (Cs) and 
test (Ts) stimuli (timing of the stimuli are indicated by the triangles) demonstrated 
positive and negative AER complexes (i.e. N1, P1, N2, P2, N3) with gating of the N2 
wave (TIC ratio= 48%) . 
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Fig. 4.2 Scatter plots demonstrating the distribution of (A) amplitudes, TIC ratios 
and (8) latencies of the N2 wave in the mPFC of the gating rats (n = 15) in 
response to auditory stimuli. 
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(A) The mPFC demonstrated a wide variation in the CAMP of N2 compared to 
lesser variations in TAMP and TIC ratios. The TAMP was significantly smaller (* 
= P= 0.02) than CAMP resulting in a mean TIC ratio of 45 ± 3 % (mean ± SEM). 
(8) The CLA T values of N2 varied between 45 - 70 ms while TLA T ranged between 
42 - 72 ms. No significant difference was observed between CLA T and TLA T in 
the mPFC. 
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Fig. 4.3 Linear regression lines (dark lines) with 95% confidence limits (dashed 
lines) demonstrating the relationship of (A) CAMP, (8) TAMP, (C) CLAT and (0) 
TLAT with the TIC ratios of the N2 wave in the mPFC of the gating rats (n = 15). 
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(A) The changes in CAMP of the N2 wave had no effect on the TIC ratios in the 
mPFC. 
(8) A significant positive correlation was observed between the TAMP and the TIC 
ratios (P = 0.04). 
(C & D) Neither CLA T nor TLA T significantly correlated with changes in the TIC ratios. 
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4.3.1.1 Gating at different inter-stimuli intervals 
The TIC ratio in the mPFC increased with the increases in the inter-stimuli 
interval (Fig. 4.4). A significant increase in the TIC ratio was detected at all 
tested inter-stimuli intervals (F5, 35 = 7.6, P<0.0001) and the post hoc t tests 
revealed that the significant change was due to the significant increases in the 
TIC ratios at 1.5s, 2.5s, 3.5s, 4.5s and 6s inter-stimuli intervals when 
compared with the 0.5 s inter-stimuli interval. Maximum mean TIC ratio was 
observed at 1.5s inter-stimuli interval (TIC = 109 ± 22 %). However, there was 
no significant difference between the TIC value at 1.5s inter-stimuli interval and 
the TIC ratios at higher inter-stimuli intervals (2.5s, 3.5s, 4.5s, 6s; P>0.05), 
indicating absence of the ability to decrease the test response amplitude from 
the 1.5s inter-stimuli interval onwards. 
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Fig. 4.4 Comparison the TIC ratios of the N2 wave at different inter-stimuli 
intervals (ISI) with the TIC ratio at 0.5s inter-stimuli interval in the mPFC of the 
gating rats (n = 5; values = mean ± SEM). 
The mPFC exhibited significant increases in the TIC ratios at all ISI compared 
to the TIC ratio at 0.5s ISI « .. = P < 0.01, ... = P < 0.001). The lowest TIC ratio 
was observed at 0.5s ISI (44 ± 8 %; n = 4) and highest TIC ratio at 1.5s (109 ± 
22 %). 
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4.3.2 Auditory evoked N2 responses of the non-gating rats 
Prominent N2 responses to both the conditioning and test stimuli with absence 
of gating were detected in the mPFC of the non-gating rats (Fig. 4.5). The 
CAMP varied from 6 - 95 IJV and no significant difference was detected 
between the CAMP and the TAMP (CAMP = 47 ± 10 IJV, TAMP = 55 ± 131JV; P 
= 0.4) resulting in a mean TIC ratio of 153 ± 20 % (Fig. 4.6A). 
The CLAT in mPFC ranged from 50 - 58 ms (Fig 4.68) with a mean CLAT of 53 
± 1 ms. The TLAT was significantly longer compared to CLA T (TLA T = 62 ± 
1 ms; P < 0.0001). 
Linear regression analysis in the mPFC of the non-gating rats demonstrated a 
significant negative correlation between the TIC ratio and CAMP (Fig. 4.7; F = 
8.6, P = 0.01). However, changes in TAMP did not affect the TIC ratio. Neither 
CLAT nor TLAT showed a significant correlation with the TIC ratios in the non-
gating rats. 
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Fig. 4.5 Representative peri-event averaged LFPs in the mPFC of a non-gating 
rat in response to 128 auditory conditioning-test trials. 
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The peri-event averaged LFPs from mPFC in response to the conditioning (Cs) and 
test (Ts) stimuli (timing of the stimuli are indicated by the triangles) demonstrated 
positive and negative AER complexes (Le. N1, P1, N2, P2, N3) with absence of 
gating of the N2 wave (TIC ratio = 124%), 
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Fig. 4.6 Scatter plots demonstrating the distribution of amplitudes, TIC ratios 
and latencies of the N2 wave in the mPFC of the non-gating rats (n = 10) in 
response to auditory stimuli. 
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(A) The mPFC demonstrated a variation of CAMP, TAMP and TIC ratios of the N2 
wave with a few outliers exhibiting TC ratios >200%. No significant difference 
between CAMP and TAMP was observed resulting in TIC ratio of 107% ± 8 
(mean ± SEM). 
(8) The CLAT values were between 50 - 58 ms while TLAT ranged from 57 -70ms. 
The TLAT was significantly longer than the CLA T (P<0.0001). 
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Fig. 4.7 Linear regression lines (dark lines) with 95% confidence limits (dashed 
lines) demonstrating the relationship of (A) CAMP, (8) TAMP, (C) CLAT and (0) 
TLAT with TIC ratios of the N2 wave in the mPFC of the non-gating rats (n = 
10). 
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(A) The CAMP of the N2 wave in the non-gating rats had a significant negative 
correlation with the TIC ratios (P = 0.01). 
(8) The changes in TAMP were not associated with the changes in the TIC ratios. 
(C) & (0) Neither CLA T nor TLA T significantly correlated with the TIC ratios. 
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4.3.3 Comparison of the AER parameters of the gating rats and 
the non-gating rats 
The AER parameters in the mPFC between the gating and the non-gating rats 
were compared (Fig. 4.7) and the differences were examined with the changes 
observed in the CA3 and DG (Table 4.1). 
There were no significant differences in CAMP between the gating and the non-
gating rats (Fig. 4.8; Table 4.1). The non-gating rats demonstrated a 
significantly higher TAMP (P = 0.04) resulting in a significantly higher TIC ratio 
(P<0.0001) compared to the gating rats. Non-gating rats also showed 
significantly shorter CLAT compared to that of gating rats (P= 0.03). No 
significant difference in TLA T was observed between the gating and the non-
gating rats. In the non-gating rat group, the changes in the TIC ratios were 
negatively correlated with CAMP while in the gating rats CAMP had no effect on 
the TIC .ratio. However, the TIC ratio of gating rats increased with increases in 
TAMP while TAMP of non-gating rats had no effect on the TIC ratio. 
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Fig. 4.8 Bar graph depicting CAMP, TAMP and TIC ratios (mean ± SEM) of the 
N2 wave in the mPFC of the gating rats (n = 15) compared with the findings of 
the non gating rats (n =10) . 
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There was no significant difference in CAMP (P > 0.05) between the gating and the 
non-gating rats. The non-gating rats had significantly higher TAMP and TIC ratios in 
the mPFC compared to the gating rats (.= P = 01, ... = P < 0.0001). 
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4.3.4 The AER parameters recorded from the CA3, DG and 
mPFC in the gating and the non-gating rats 
The CAMP, TAMP, TIC ratio, CLAT and TLAT in the CA3, DG and mPFC of the 
gating (n = 15) and the non-gating (n = 10) rats were examined for any region 
specific differences (Table 4.1). Each animal within the rat group (n =15) which 
demonstrated gating in CA3 also exhibited gating of the test response in DG 
and mPFC while each of the non-gating rats (n = 10) demonstrated absence of 
gating in all three areas. 
In the gating rat group, the mPFC exhibited a lower CAMP and TAMP and a 
higher TIC ratio compared to the recordings from the CA3 and DG . The CLA T 
and TLAT of the mPFC were shorter than the CLAT and TLAT of the CA3 and 
DG in the gating rats. 
The nOf)-gating rats also had lower CAMP and TAMP with higher TIC ratios in 
their mPFC compared with the amplitudes and the TIC ratios of CA3 and DG. 
The mean CLAT was shorter and the mean TLAT was l o n ~ e r r in the mPFC of 
the non-gating rats than those recorded from their CA3 and DG. Neither CLA T 
nor TLAT showed a significant correlation with the TIC ratios in both groups. 
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Table 4.1 The summary table of the N2 wave parameters (mean ± SEM) in the 
CA3, DG and mPFC of the gating (n = 15) and the non-gating (n = 10) rats 
(gating values were compared to the non-gating values in each region; * = P 
<0.05; *** = P<0.0001). 
Area CAMP hN) TAMP (IN) TIC ratio CLAT (ms) TLATlmsl 
CA3 
Gating 165 ± 33 50 ± 13 28±4 66 ± 3 64±4 
Non-gating 203 ± 32 188 ± 26*** 103 ± 12*** 55 ± 1* 59 ± 2 
DG 
Gating 116 ± 23 47 ± 13 35±4 64± 3 63 ± 2 
Non-gating 154 ± 27 134 ± 21*** 100 ± 16*** 56 ± 2* 59 ± 1 
mPFC 
Gating 58 ± 11 28 ± 7 45 ± 3 57 ± 1 57 ± 2 
Non-gating 47 ± 10 55 ± 13* 153 ± 20*** 53 ± 1* 62 ± 1 
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4.4 Discussion 
Prominent auditory evoked potentials were recorded from the mPFC in both 
gating and non-gating rats. The gating rats exhibited a significant reduction in 
the test response amplitudes compared to the conditioning response amplitudes 
and the changes in the test response amplitudes were positively correlated with 
the TIC ratio. The non-gating rats showed a significantly longer test response 
latencies compared to their conditioning response latencies and their 
conditioning response amplitude was negatively correlated to the TIC ratio. The 
mPFC demonstrated lower amplitudes, shorter latencies and higher TIC ratio 
compared to the CA3 and DG in the gating rats. 
The findings of the current study agree with previous human studies which have 
recorded AERs and auditory gating in the PFC (Grunwald et al., 2003; Kurthen 
et al., 2007). Studies by Mears et al (2006) and Yang et al (2006) demonstrated 
AERs and 'gating' in the rat mPFC. Neither of these studies discussed non-
gating states of the PFC responses nor used a cut-off TIC value to identify 
gating states. Both studies used the term 'gating' for the reduction of TAMP and 
had not observed an enhancement of TAMP (TIC> 100%) which could have 
been classified as a non-gating state. Mears et al (2006) analysed a positive 
wave occurring around 60 ms in freely moving rats, which had shown a 
constant reduction of test response amplitudes, with TIC ratios between 53 -
64%. We observed constant gating of a negative wave occurring at a slightly 
shorter latency but with lower TIC ratios. However, some gating animals (n = 7) 
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exhibited TIC ratios comparable to the values observed by the Mears group. 
Mears et al (2006) also observed an increase in the TIC ratios with increases in 
the ISI, similar to the observations made in the current study. However, their 
report does not mention the rat strain or the gender that they have used for their 
study which, if different to our rats, could account for some of the differences 
observed. 
Yang et al (2006) observed AERs similar to the AERs recorded in the present 
study and observed constant reduction of the test response amplitude of three 
waves i.e. P2, N2 and P3. Unfortunately, Yang et al (2006) did not report the 
basal TIC ratios or latency values (only the percentage changes of post-drug 
values compared to basal) of the AERs, making it difficult to compare their 
results with the current findings. 
However, based on the present findings and those of Mears and Yang, it could 
be a r g u ~ d d that different criteria (to those used for the hippocampus) to separate 
gating from non-gating rats need to be employed when assessing auditory 
gating in the mPFC. This could be also emphasized with the findings in the 
mPFC of the non-gating rats, which demonstrated a test: conditioning response 
ratio of 153 ± 20% which was markedly different from those observed in CA3 
(TIC ratio = 103 ± 12%) or DG (TIC ratio = 100 ± 16%). Based on the above 
finding, it is possible to argue that the higher TIC ratios observed in mPFC (45 ± 
3%) compared to those in CA3 (28 ± 7%) and DG (35 ± 4%) in the gating rats 
may not be due to less effective gating in the area, but a result of a higher 
baseline test response. Thus a higher cut-off TIC ratio may need to be used 
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when identifying gating and non-gating instances in the mPFC. 
Examination of the findings from the mPFC, CA3 and the DG of the current 
study provides some interesting observations. The mPFC of gating rats 
demonstrated similar response patterns to those recorded from their CA3 and 
DG with significant reduction of TAMP compared to CAMP. The results also 
showed a positive correlation between TIC ratio and TAMP and TIC ratio 
increased with increases in the inter-stimuli interval, emphasizing that mPFC 
responds to auditory conditioning-test paradigm in a similar manner to the CA3 
and DG in the gating rats. 
Similar to the responses observed in the CA3 and DG, the mPFC of the non-
gating rats exhibited no significant difference between CAMP and TAMP and a 
longer TLA T compared to CLAT, highlighting the dysfunctions in the neuronal 
mechanisms in mediating gating of the test response in this rat group . The 
mPFC followed the response pattern in the CA3 and DG in the non-gating rats, 
demonstrating increases in the TIC ratio with decreases in the CAMP, a finding 
reported in some schizophrenic patients (Adler et aI., 1982; Freedman et aI., 
1983; Siegel et al., 1984). Non-gating rats had higher TAMP and higher TIC 
ratios in the mPFC compared to the mPFC of the gating rats, indicating a 
widespread deficits in inhibitory processes mediating the reduction in TAMP, 
involving both the hippocampus and the mPFC. Schizophrenic patients have 
shown increased activity in the PFC in response to the auditory conditioning-
testing paradigm in a functional magnetic resonance study (fMRI) compared to 
controls, suggesting diminished inhibitory functions in the PFC in schizophrenia 
(Tregellas et al., 2007) , which could relate to the increased TAMP and TIC 
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ratios observed in the non-gating rats in the current study. 
The mPFC showed the AERs of lowest amplitudes, shortest response latencies 
and the highest basal TIC ratio compared to the CA3 and DG in the gating rats, 
suggesting an early phase of auditory gating in the mPFC, which may later be 
modulated by the hippocampus. This finding parallels that from a human study 
using intra-cerebral electrodes, which demonstrated a positive AER with gating 
at a shorter latency value from PFC compared to a negative peak at a longer 
latency value from hippocampus (Grunwald et al., 2003). Based on their results 
Grunwald and co-workers suggested that sensory gating is a multi-step process 
with an initial stage in the PFC and a late stage in the hippocampus. The 
present study suggests that rats also have different phases of sensory gating 
with an initial stage in the mPFC and a late modulatory stage in the DG and 
CA3. Prolonged TLA T in the mPFC in the non-gating rats, compared to their 
TLAT in the CA3 and DG, suggests the possibility of a dysfunction in the neural 
circuitry" which may be crucial for the gating of the test response. 
The auditory information flow to the mPFC could be via the auditory pathway 
with the auditory cortex sending projections to the mPFC. However, as 
mentioned in chapter 3, important structures in the auditory system such as 
medial geniculate body and the auditory cortex do not demonstrate gating 
suggesting the possibility of a different pathway mediating auditory gating 
(Bickford-Wimer et al., 1993; Moxon et al., 1999). Mears et al (2006) suggested 
that the brain stem reticular region could be sending auditory gating information 
directly to the mPFC. Auditory gating has been observed in brain stem reticular 
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region (Bickford-Wimer et aI., 1993; Moxon et aI., 1999) and the presence of 
direct connections between the brain stem and the mPFC (Gabbott et al., 
2005), supports the role of ascending brainstem inputs to the mPFC to activate 
the neural circuits mediating auditory gating. 
It has been shown that the prelimbic and the medial-orbital areas of the rat PFC 
receive monosynaptic excitatory inputs from the hippocampus modulating the 
activity of the mPFC neural circuitry (Thierry et al., 2000; Tierney et al., 2005). 
Despite the direct innervations of the hippocampus on the mPFC, there is little 
or no evidence to suggest the presence of direct return projections from the rat 
mPFC to the hippocampus (Laroche et al., 2000; Vertes et al., 2006). However, 
the mPFC has efferents to parahippocampal structures including the enterohinal 
cortex (Laroche et al., 2000; Vertes et al., 2006), which is the likely thoroughfare 
for gating information from the mPFC to the DG and then to the CA3 of 
hippocampus. 
By examining auditory gating in the mPFC of Lister-hooded rats under 
isoflurane anaesthesia with simultaneous recordings from the CA3 and DG, we 
have expanded our animal model, which now includes three crucial areas of the 
brain for information processing that are implicated in the pathophysiology of 
schizophrenia. Moreover, we have emphasized the presence of a non-gating rat 
population which responds differently to the gating rats in response to the 
auditory conditioning-test paradigm in the hippocampus as well as in the mPFC. 
The next step was to examine the effects of pharmacological manipulations on 
auditory gating in the hippocampus and the mPFC in both gating and non-
I 16 
gating rats. 
Chapter Five 
Effects of phencyclidine on auditory gating 
in the rat hippocampus and medial 
prefrontal cortex 
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5. Effects of phencyclidine on auditory gating in 
the rat hippocampus and medial prefrontal cortex 
5.1 Introduction 
Phencyclidine (pep) was developed in the 1950s as a surgical anaesthetic. 
Despite its efficacy, pep produced some disturbing side effects such as 
confusion, hallucinations, disordered speech and disoriented behaviour and 
was discontinued from medical use. However, it has continued to be used 
illicitly as a recreational drug and marketed as capsules, tablets, powder and in 
liquid form which is either taken orally or smoked. For smoking, pep is very 
commonly spread on to marijuana leaves. pep has attracted neuroscientists 
and psychiatrists due to the remarkable resemblance of the symptoms of 
abusers .to those exhibited by patients suffering from schizophrenia. 
pep is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) 
glutamate receptors and produces a variety of neurochemical effects in the 
brain secondary to NMDA dysfunction (see 1. 7.2.1). In addition to the effects 
on the NMDA receptors, pep has been found to exert dopaminergic, 
noradrenergic and serotonergic effects which may explain some of the 
psychotic and behavioral effects of the drug (see 1.7.2.1; Jentsch & Roth, 
1999). 
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As mentioned before, both PCP and the structurally related drug ketamine, 
have been shown to have the ability to mirror the symptomatology of 
schizophrenia including negative symptoms and neurocognitive deficits in 
otherwise healthy individuals and to exacerbate symptoms in schizophrenic 
patients (Malhotra et al., 1996; Murray, 2002., Morris et al., 2005;). 
Acute or chronic administrations of PCP disrupt performance in attention tasks, 
working memory tasks and behavioural changes in rats resembling the 
behaviuoral and cognitive deficits observed in schizophrenia (Bakshi et aI., 
1994; Sams-Dodd., 1999; Martinez et al., 1999; Marcotte et al., 2001). 
However, the effects of acute or chronic administration of PCP on auditory 
gating have not being studied widely. Adler et al (1986) showed that single dose 
PCP disrupted gating of skull recorded AERs in freely moving rats and Miller et 
al. (1992) showed that single dose PCP disrupted sensory gating in the CA3 
region of the hippocampus under chloral hydrate anesthesia. 
In this chapter we sought to determine if sensory gating in the rat CA3, DG and 
mPFC could be disrupted by a single dose PCP administration and if disrupted 
whether the atypical antipsychotic clozapine, which is currently one of the most 
effective drugs in treating schizophrenia, could prevent the disruption. 
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5.2 Methods 
5.2.1 Animals 
Male Lister hooded rats (n = 25; weight 250g - 400g) were anaesthetised with 
isoflurane; N20:02 and all the electrophysiological procedures were carried out 
as described in chapter 2. Simultaneous recordings from the CA3, DG and 
mPFC were carried out and only the animals with electrodes placed in the CA3, 
DG and mPFC, confirmed by histology, were used for analysis. 
5.2.2 Experimental protocol 
The auditory stimuli (90dB intensity, 0.5s ISI, 10s inter-trial interval) were 
presented over 128 trials and aUditory-evoked LFP and unit responses were 
recorded simultaneously from the CA3, DG and mPFC using multiple electrode 
arrays for the CA3 and DG (2x 8) and a multiple electrode bundle for the mPFC 
(1 x 8). 
pep experiments 
Following basal recording of the auditory responses to 128 trials of auditory 
stimuli, the vehicle (saline) was administered (1ml/kg, Lp; n = 14) and the effect 
on auditory gating assessed by recording the responses to 128 auditory 
conditioning-test trials 15min after administration (Box 5.1). PCP (1 mg/kg, Lp) 
was administered 40 min after the injection of the vehicle and the effect on 
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auditory gating assessed by recording auditory responses to 128 stimuli trials, 
beginning 15 min and 45 min after drug administration. 
Box 5.1 Protocol for pep experiments 
Saline (1 ml/kg, i.p) 
Recording of basal continuous recording PCP (1mglkg,i.p) continuous Recording of auditory 
auditory responses to .. and auditory stimuli .. recording and auditory .. rtsponsesto 128 trials, 
128 trials - 128 trials- 15mln stimuli -128 trials- 15min 45min following PCP 
following saline following pep 
Clozapine experiments 
Following basal recording of the auditory responses to 128 trials of auditory 
stimuli, the clozapine vehicle was administered (1ml/kg, Lp; n = 11) and the 
effect on auditory gating assessed by recording the responses to 128 auditory 
conditioning-test trials 15min after vehicle administration (Box 5.2). Clozapine 
was injected (5mg/kg, Lp) 40 min after the vehicle. The effect of clozapine on 
auditory gating was assessed by recording the responses to 128 auditory 
conditioning-test trials 15min after administration. Phencyclidine was injected in 
the same animals 40 min after clozapine injection and the effect on auditory 
gating was assessed over 128 stimuli trials, 15 and 45 min following PCP 
administration. 
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Box 5.2 Protocol for Clozapine experiments 
Clozapine vehicle (1 mllkg, Clozapinl (5mwkg, l.p) PCP (1 mglkg,i.p) continuous 
Recording of basal It I.p) continuous recording It continuous recording and 
,. recording and auditory 
auditory responses to and auditory stimull- 128 aUditory stimuli -128 
128trlals trials- 15 mln foDowing trills- 15min following stimuli -128 trials- 15min 
clozapine vehicle clozaplne 
following PCP , 
Recording of auditory 
responses to 128 trials, 
45min following PCP 
5.2.3 Data analysis 
Data were analysed off-line using NeuroExplorer (v3; NEX technologies Inc., 
USA) with evoked response amplitudes, latencies and TIC ratios computed 
using a custom-designed Matlab script (v7.0 with associated Matlab Signal 
Processing, Neural Network, Statistics and Image Processing Toolboxes; The 
Mathworks). Statistical analysis used Prism (v4.03; GraphPad, USA) and within 
region changes of all the parameters at different time points were analysed 
using one-way analysis of variance (AN OVA) for repeated measures with post 
hoc Tukey Hest. Data are expressed as mean ± SEM (standard error of mean), 
statistical significance was taken when P < 0.05. 
5.2.4 LFP analysis 
Auditory evoked potentials were initially visualized as peri-event averaged LFPs 
(Fig. 5.1). The AERs were identified according to the polarity and the order of 
occurrence, i.e. N1, P1, N2, P2, N3 peaks (Van Luijtelaar et al., 2001; Boutros 
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et al., 2004). An electrode with the highest N2 wave conditioning amplitude 
response from each area was selected for further analysis (see chapter 2). The 
ratio of the test amplitude to the conditioning amplitude (TIC ratio) of the N2 
wave was calculated for each averaged response and the TIC ratio in the CA3 
was used to separate gating and non-gating rats. A TIC ratio of S50% in the 
CA3 was indicative that gating was present (Joy et al., 2004; Miller et al., 1992). 
5.3. Results 
5.3.1 Auditory Evoked Responses from CA3, DG and mPFC 
Averaged LFPs recorded from the CA3 region, DG and mPFC in response to 
auditory stimuli exhibited complex AERs (Le. N1, P1, N2, P2 and N3) with 
gating (n = 14) and non-gating (n = 11) of the N2 wave. In the PCP group eight 
animals exhibited gating of the N2 wave (n = 3 in the CA3 & DG, n = 5 in the 
CA3, DG and mPFC) and six showed non-gating (n = 2 in the CA3 & DG, n = 4 
in the CA3, DG and mPFC). In the clozapine group six animals demonstrated 
gating (n = 3 in the CA3 & DG, n = 3 in the CA3, DG and mPFC) and five 
showed non-gating (n = 5 in the CA3, DG and mPFC). Neither saline nor 
clozapine vehicle had any effect on the N2 TIC ratios in any of the three regions 
in the gating or the non-gating rats (Table 5.1 and Table 5.2). 
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5.3.2 Effects of pep on the gating rats 
5.3.2.1 Effects of PCP on the conditioning amplitudes 
The CA3 region, exhibited an increase in CAMP (F 2,23 = 5.1, P = 0.02) 45 min 
(P<0.05) following PCP administration (Fig. 5.1 & Fig. 5.2). PCP had no 
significant effect on CAMP in either DG (P = 0.07) or mPFC (P = 0.06) in the 
gating rats. 
5.3.2.2 Effects of PCP on the test amplitudes 
PCP increased the TAMP in all three regions both 15 and 45min following 
administration (Fig. 5.1 & Fig. 5.2). In the CA3, TAMP was increased 
significantly (F 2,23 = 10.8, P = 0.001) both 15 (P<0.05) and 45 min (P<0.01) 
following PCP administration. The DG demonstrated a similar response with a 
significant increase in TAMP (F 2,23 = 23.7, P = 0.0001) both 15 (P<0.01) and 
45 min (P<0.001) after PCP. The mPFC also exhibited an increase in TAMP 
(F 2, 14= 32, P = 0.0009) 15 (P<0.01) and 45 min (P<0.001) after PCP 
administration. 
5.3.2.3 Effects of PCP on the TIC ratios 
Administration of a single dose of PCP disrupted auditory gating in all three 
regions both 15 and 45 min after administration when compared to basal values 
for each region (Fig. 5.1 & Fig 5.2). PCP disrupted gating in the CA3 (F 2, 23 = 
124 
14, P = 0.0004), 15 (P<0.01) and 45 min (P<0.001) after administration. In the 
DG, PCP significantly increased the TIC ratio (F 2.23 = 10, P = 0.001) with 
disruption of gating seen at both 15 (P<0.05) and 45 min (P<0.01) after 
administration. Disruption of gating was detected in the mPFC following PCP 
(F 2. 14= 9.6, P = 0.007), 15 (P<0.05) and 45 min (P<0.01) after drug 
administration. 
5.3.2.4 Effects of pep on the conditioning and test response latencies 
There were no significant changes in CLAT (P>0.05) or TLAT (P>0.05) in the 
CA3, DG or mPFC following PCP administration (Table 5.1) 
125 
Fig. 5.1 Representative peri-event averaged LFPs from (A & D) CA3, (8 & E) 
DG and (C & F) mPFC demonstrating the effects of PCP (45min after 
administration) on auditory gating compared to basal recordings in a gating rat. 
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Basal recordings from (A) CA3 (TIC ratio = 14 %), (B) DG (TIC ratio = 25 % and (C) 
mPFC (41 %) demonstrated gating of the N2 wave. The mPFC demonstrated the 
lowest basal amplitude responses compared to the response amplitudes in the CA3 
and DG. PCP disrupted gating of the N2 wave in (D) CA3 (TIC ratio = 98 %), (E) DG 
(TIC ratio = 96 %) and (F) mPFC (TIC ratio = 82 %) 45min following drug 
administration. 
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Fig. 5.2 Bar graphs demonstrating the effect of PCP on (A) conditioning 
amplitude (B) test amplitude and (C) TIC ratios of the N2 wave in the gating rats 
in the CA3 (n = 8), DG (n = 8) and mPFC (n = 5 ); values = mean ± SEM. 
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A. PCP increased the CAMP in the CA3 45 min following administration, but had 
no effect on the CAMP of the DG or mPFC. 
B. PCP increased the TAMP in the CA3, DG and mPFC both 15 and 45 min 
following administration. 
C. TIC ratios in the CA3, DG and mPFC increased significantly both 15 and 45 min 
following PCP administration. 
(. = P<O.05, .. = P<O.01, ... = P<O.001). 
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5.3.3 Effects of pep on the non-gating rats 
5.3.3.1 Effects of PCP on the conditioning amplitudes 
The CA3 region, exhibited an increase in conditioning response amplitudes (F 2, 
17 = 6.4, P = 0.02) both 15 (P<0.05) and 45 min (P<0.05) following PCP 
administration (Fig. 5.4 and Fig. 5.5). PCP had no significant effect on CAMP in 
either DG (P = 0,3) or mPFC (P = 0.4) in the non-gating rats (Table 5.2). 
5.3.3.2 Effects of PCP on the test amplitudes 
In the CA3, TAMP was increased Significantly (F 2, 17 = 4.7, P = 0.04) only 45 
min (P<0.05) following PCP administration. PCP had no significant effect on 
TAMP in either DG (P = 0.07) or mPFC (P = 0.2) in the non-gating rats (Fig. 5.3 
and Fig. 5.4). 
5.3.3.3 . Effects of PCP on the TIC ratios 
Administration of a single dose of PCP had no significant effect on the TIC 
ratios in the CA3 (P = 0.2), DG (P = 0.4) or mPFC (0.9) either 15 or 45 min after 
administration when compared to basal values for each region in the non-gating 
rats (Fig. 5.3 and Fig. 5.4). 
5.3.3.4 Effects of PCP on the conditioning and test response latencies 
There was no significant changes in CLAT (P>0.05) or TLAT (P>0.05) in the 
CA3, DG or mPFC following PCP administration (Table 5.2). 
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Fig. 5.3 Representative peri-event averaged LFPs from (A & D) CA3, (8 & E) 
DG and (C & F) mPFC demonstrating the effects of PCP (4Smin after 
administration) on auditory gating (N2 wave) compared to basal recordings in a 
non-gating rat. 
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Basal recordings from (A) CA3 (TIC ratio = 97 %), (B) OG (TIC ratio = 98 %) and (C) 
mPFC (TIC ratio = 99 %) demonstrated absence of gating of the N2 wave. The mPFC 
demonstrated the lowest basal amplitude responses compared to the basal response 
amplitudes in the CA3 and OG. PCP had no significant effect on the TIC ratios 
(P>0.05) in the (0) CA3 (TIC ratio = 95 %), (E) OG (TIC ratio = 100 %) or (F) mPFC 
(TIC ratio = 125 ?/o) 45 min after administration. 
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Fig. 5.4 Bar graphs demonstrating the effect of PCP on (A) conditioning 
amplitude (B) test amplitude and (C) TIC ratios of the N2 wave in non-gating 
rats in the CA3 (n = 6), DG (n = 6) and mPFC (n = 4); values = mean ± SEM. 
A Conditioning AmplitUde 
400 
* 
* 
~ 3 0 0 0
C 120 
100 
o 80 
·i 
... 60 
u 
i== 40 
20 
Basal 
B 
315 
>. 300 
:i 
--~ ~ 225 
"tS 
== 
-~ ~ 150 
E 
cc 15 
TIC ratio 
PCP 15 
Basal 
PCP45 
Test Amplitude 
PCP 15 PCP 45 
Bm!iJCA1 
gmDG 
Sni'FC 
A. PCP increased the CAMP in the CA3, 15 and 45 min following administration, but 
had no effect on the CAMP in the DG or mPFC. 
B. PCP increased the TAMP in the CA3, 45 min following administration but had no 
effect on the TAMP in the DG or mPFC. 
C. TIC ratios showed no significant changes (P>O.05) in the CA3, DG or mPFC 
following PCP administration in the non-gating rats. 
(. = P<O.05) 
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5.3.4 Effect of clozapine on PCP induced changes in the gating 
rats 
Clozapine alone caused a significant enlargement in the TIC ratios in the CA3 
(F 3,23 = 4, P = 0.02) but not in the DG (P = 0.13) or mPFC (P = 0.4; Fig. 5. 6A, 
Table 5.1). The increase in the TIC ratio following clozapine was due to the 
increases in TAMP in the CA3 (P = 0.03). Clozapine had no significant effect on 
CAMP (P>0.05) in all three regions (Table 5.1 ).There were no significant 
changes (P>0.05) in the TIC ratios in any of the regions, either 15 or 45 min 
after PCP in rats pre-treated with clozapine (Fig. 5.5A). The reversal of the TIC 
ratios by clozapine was due to the prevention of the increase in the TAMP 
observed following PCP (Fig 5.5A and Table 5.1). 
5.3.5 Effect of clozapine on PCP induced changes in the non-
gating rats 
Clozapine alone demonstrated no significant effect on the TIC ratios in the CA3 
(P = 0.4), DG (P = 0.07) or mPFC (P = 0.7) in the non-gating rats (Fig. 5.58 and 
Table 5.2). The CA3 region exhibited an increase in CAMP (F 3, 19 = 4.6, P = 
0.02) 45 min (P<0.05) after PCP and increase in TAMP (F 3, 19 = 10.6, P = 
0.001) both 15 (P<0.01) and 45 min (P<0.01) following PCP in the non-gating 
rats pre-treated with clozapine. Neither DG nor mPFC demonstrated any 
significant changes in CAMP (P>0.05) or TAMP (P>0.05) following PCP. No 
significant effects on the TIC ratios were observed following PCP in the CA3, 
DG or mPFC in the non-gating rats pre-treated with clozapine (Fig. 5.58 and 
Table 5.2). 
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Fig. 5.5 Bar graphs depicting N2 TIC ratios 15 min ( PCP 15) and 45 min (PCP 
45) after PCP administration in (A) gating rats (n = 6 in CA3 & DG, n = 3 in 
mPFC) and (B) non-gating rats (n = 5 in CA3, DG and mPFC) pre-treated with 
clozapine (CLOZ) compared to basal values (mean ± SEM). 
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A. The TIC ratio in the CA3 demonstrated a significant increase following clozapine. 
However, pre-treatment with clozapine prevented the increases in TIC ratios following 
PCP in the CA3, DG and mPFC in the gating rats (. = P<O.05). 
B. Neither clozapine nor PCP had any effects on the TIC ratios in the CA3, DG or mPFC 
in the non-gating rats. 
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Table 5.1 Summary table of the amplitudes, TIC ratios and latencies 15 min after 
saline and 45 min after PCP administration (PCP 45) in the gating rats not 
treated with clozapine (n = 8 in CA3 & DG, n =5 in mPFC) and the gating rats 
pre-treated with clozapine (n = 6 in CA3 & DG, n = 3 in mPFC; clozapine vehicle 
= CLOZ veh; clozapine = CLOZ) compared to the basal values of the respective 
groups (Basal). 
Region Basal Saline PCP45 Basal CLOZveh CLOZ PCP45 
CA3 
CAMP ON) 167 ± 45 170 ± 27 258 ±46 . 251 ± 42 250 ± 34 264 ± 55 304 ± 55 
TAMPON) 56 ± 15 50 ±9 261± 59" 56 ± 12 55 ± 18 130 ± 28 109 ± 31 
TIC ratio 33±4 28 ±6 78 ± 6*** 26± 8 26 ± 5 50 ± 5* 38±8 
CLAT (ms) 6U2 6U 1 58 ± 1 66±6 67±4 61 ± 2 59 ± 1 
TLAT (ms) 60±5 62±4 62 ±3 65± 7 69±4 67 ± 1 66±3 
DG 
CAMP (IJV) 123 ± 28 132 ± 18 198 ± 30 198 ± 29 196 ± 15 242 ± 65 264 ± 54 
TAMP (IJV) 42 ± 10 42 ±7 165 ± 19"· 54 ± 15 5U9 114±34 110±31 
TIC ratio 39 ± 2 35 ±6 103 ± 16** 30± 8 28 ±7 48 ± 5 43± 8 
CLAT (ms) 60± 2 60 ± 3 63 ± 6 62 ± 1 63 ± 1 63 ± 3 61 ± 1 
TLAT (ms) 58± 5 60 ± 5 66±4 60 ± 7 60 ± 3 66 ± 5 68 ± 3 
mPFC 
CAMP (IJV) 77 ± 10 80 ± 10 90 ± 13 116 ± 22 118 ± 9 112 ± 9 143 ± 24 
H. 
TAMP (IJV) 42 ±8 40±6 93 ± 16 43 ± 16 40 ± 10 61 ± 20 56 ± 27 
TIC ratio 47 ±2 46 ± 5 105 ± 16** 39 ± 8 36± 9 49 ± 10 35 ± 13 
CLAT (ms) 58 ± 1 58 ± 1 60 ± 0.4 57 ± 3 58 ± 1 67 ±7 66 ± 11 
TLAT (ms) 6U3 60± 3 67 ±3 60 ±6 60±4 68 ± 1 69 ±6 
(* = P<O.05; ** = P<O.01; *** = P<O.001) 
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Table 5.2 Summary table of the amplitudes, TIC ratios and latencies, 15 min after 
saline and 45 min after PCP administration (PCP 45) in the non-gating rats not 
treated with clozapine (n = 6 in CA3 & DG, n =4 in mPFC) and the non-gating rats 
pre-treated with clozapine (CLOZ: n = 5 in CA3, DG and mPFC) compared to pre-
drug values of the respective groups (8asal). 
Region Basal Saline PCP45 Basal CLOZ CLOZ PCP45 
veh 
CA3 
CAMP (IN) 239 ± 27 235 ± 49 342 ± 19* 225 ± 31 234 ± 45 326 ± 19* 339 ± 35* 
TAMP (IN) 233 ±43 237 ± 40 306 ± 35* 179 ± 25 170 ± 28 259± 16** 306± 28** 
TIC ratio 91 ± 10 95 ± 16 92 ± 11 80±6 77 ± 10 80± 5 90 ±4 
CLAT(ms) 56±2 57 ± 1 56 ±2 53±2 55±2 52 ±2 59 ±2 
TLAT (ms) 61±2 62 ±2 61±2 56 ±2 56 ±2 55± 3 60 ±8 
DG 
CAMP (IN) 207 ± 41 191 ± 30 249 ± 17 184 ± 25 204 ± 35 255 ±43 232 ± 41 
TAMP (IN) 170 ± 15 176 ± 15 165 ± 19 155 ± 24 154 ± 34 193 ± 19 226 ± 24 
TIC ratio 90 ± 10 97 ± 8 96 ± 9 87 ± 10 80 ±8 83 ±7 95 ± 5 
CLAT(ms) 55 ± 2 56 ±2 54 ±2 53 ±2 53 ±4 52 ±2 53 ± 2 
TLAT(ms) 61 ± 2 63± 2 55±2 56 ±2 56± 3 55 ± 1 58± 2 
mPFC 
CAMP(jN) 79±6 80 ± 10 93 ± 16 65 ± 18 74 ± 12 68 ±22 87 ± 13 
TAMP (!-IV) 66 ± 15 69± 8 96 ± 31 59 ± 15 60 ± 10 58 ± 18 65± 29 
TIC ratio 97 ± 10 96±6 100 ± 8 105 ± 9 98±8 87 ± 14 96 ± 13 
CLAT (ms) 53± 2 54 ±2 52 ±2 52 ± 1 53 ± 1 58 ± 7 55 ± 2 
TLAT (ms) 63 ± 3 62 ± 2 61 ± 5 61±2 64 ± 1 62 ± 7 67 ± 2 
(* = P<O.05; ** = P<O.01; *** = P<O.001) 
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5.4. Discussion 
In the present study the NMDA receptor antagonist, PCP (1 mg/kg, i.p), 
disrupted auditory gating of N2 wave in the CA3, DG and mPFC, but had no 
effect on the TIC ratios in the non-gating rats. Pre-treatment with the atypical 
antipsychotic, clozapine (5mg/kg, i.p), prevented the disruption of gating 
induced by PCP in the CA3, DG and mPFC in the gating rats, but showed no 
effect on the TIC ratios in the non-gating rats. 
Our findings in the CA3 region agree with the study by Miller et al (1992) which 
showed that acute administration of PCP disrupts auditory gating in the CA3. 
The current study also demonstrates PCP induced disruption of gating in both 
DG and mPFC, suggesting a widespread alteration of information processing 
caused by PCP. Our findings also agree with human studies showing ketamine, 
a structllrally similar but low-potent NMDA antagonist, induces schizophrenic 
symptoms in healthy volunteers and affects auditory gating in a dose dependent 
manner (Duncan et aI., 2001; Oranje et aI., 2002). PCP has also been shown to 
disrupt prepulse inhibition (PPI) in rodents, another unrelated behavioural model 
of schizophrenia (Bakshi et aI., 1994; Martinez et aI., 1999; Schwabe et aI., 
2005). Moreover, the present study demonstrates that PCP disrupts gating in 
the hippocampus and the mPFC by affecting the ability to suppress the test 
response amplitude which is similar to the gating deficits found in schizophrenic 
patients (Boutros et al., 1999; 2004). Adler et al (1986) compared the effect the 
dopaminergic psychoactive drug amphetamine with PCP on gating, using skull 
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recorded AERs, and showed that the disruption of gating with PCP by increases 
in test response amplitude was more representative of human deficits 
compared to the disruption with amphetamine which was mediated mainly via 
decreases in CAMP; findings supported by the current study. 
The precise mechanism as to how PCP disrupts gating in the hippocampus and 
mPFC and produce schizophrenic symptoms in humans is yet to be elucidated. 
Use of NMDA antagonists to model schizophrenic symptoms is based on the 
glutamate hypothesis of schizophrenia which suggests hypofunction of the 
glutamatergic neurotransmission in the pathophysiology of the disease. This 
hypothesis was strengthened by the findings of reduced concentrations of 
glutamate in the cerebrospinal fluid in patients with schizophrenia (Kim et al., 
1980) and decreased concentrations of glutamate in the PFC and hippocampus 
in postmortem tissues from schizophrenic patients compared to controls (Tsai et 
al., 1995). Although PCP has a rich pharmacology being a sympathomimetic, a 
sigma r ~ c e p t o r r and nicotine acetylcholine receptor antagonist, the most potent 
effect of clinical and pharmacological doses of the drug has been shown to be 
the NMDA antagonism (Morris et al., 2005). However, dopaminergic drugs and 
nicotine receptor antagonists also disrupt auditory gating (Adler et al., 1986; Joy 
et al., 2004; Martin et al., 2004) and Miller et al (1992) suggested that the PCP 
induced disruption of gating in CA3 was due to its sympathomimetic properties. 
Thus sympathomimetic and anti-nicotinic properties of PCP may at least 
partially contribute to its unique ability to induce schizophrenic symptoms along 
with the disruption of auditory gating. 
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The reciprocal connections between GABAergic interneurones and 
glutamatergic pyramidal neurons in the CA3 of hippocampus are important for 
auditory gating in CA3 (Flach et al., 1996; Moxon et al., 2003) with GABAergic 
interneurons mediating the reduction in the test response amplitude and 
regulating auditory gating (Miller et al., 1995). The NMDA antagonism has been 
shown to inhibit the activity of GABAergic neurons via these reciprocal 
connections thus resulting in the release of inhibition on major excitatory 
pathways leading to hyperstimulation of corticolimbic neurons (Olney et al., 
1999). This hyperstimulation may affect information processing and disrupt 
inhibitory processes such as sensory gating in hippocampus and PFC. 
Interestingly in the present study, PCP had no significant effect on the non-
gating rats except for the small increases in conditioning response amplitude 
and test response amplitude in the CA3, which indicates a resistance to NMDA 
antagonism in this group of rats. It is possible to postulate that the non-gating 
rats c o ~ l d d be having an inherent dysfunction in the glutamatergic 
neurotransmission accompanied with a functional disturbance of NMDA 
receptors which may also explain the absence of auditory gating in this rat 
group. 
The atypical antipsychotic, clozapine, prevented the auditory gating deficits 
induced by PCP in the CA3, DG and mPFC in the gating rats. Several human 
studies have confirmed the ability of clozapine to reverse auditory gating deficits 
in schizophrenic patients (Adler et al., 2004; Light et al., 2000; Nagamoto et al., 
1996). However, the efficacy of clozapine on reversing gating deficits in animal 
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models has not been established. Joy et al (2004) reported that chronic and 
acute clozapine administration failed to reverse auditory gating deficits induced 
by a single dose of amphetamine suggesting not only that amphetamine may 
not be useful in modeling gating deficits in schizophrenia but also the reversal of 
gating deficits by clozapine in humans may not be mediated via dopamine 
receptors. Clozapine reversed the gating deficits by stimulating nicotine 
actetylcholine receptors in DBAl2 mice who spontaneously exhibit gating 
deficits similar to those seen in schizophrenics (Simosky et al., 2003). 
Clozapine has been shown to have an agonistic effect on NMDA receptors 
similar to those seen with the agonists of the glycine modulatory site on the 
receptor (Goff and Joseph, 2001). It is quite likely that the reversal of PCP 
induced gating deficits by clozapine is mediated via the glycine modulatory site 
on the NMDA receptor resulting in enhanced glutamatergic neurotransmission 
and thus preventing PCP induced NMDA antagonism in the CA3, DG and 
mPFC. Enhanced glutamatergic neurotransmission which probably creates a 
slight im.balance between glutamatergic and GABAergic activities may explain 
the increased TIC ratios observed following clozapine in the CA3 in the gating 
rats. Our findings with clozapine in the gating rats agree with the findings from 
PPI studies which have shown that clozapine reverses PCP induced PPI 
deficits in rats (Bakshi et al., 1994) and disrupts PPI when administered alone 
(Dirks et al., 2003). Clozapine has been reported to worsen PPI when 
administered to rats pre-treated with PCP (Schwa be et al., 2005), which may be 
comparable to the increases in TAMP in the non-gating rats following clozapine. 
Though clozapine prevented PCP induced deficits in the gating rats it failed to 
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reverse the auditory gating deficits in the non-gating rats. It could be possible 
that the non-gating rats are a result of neuro-developmental deficits beyond 
receptor level, which can not be remedied by altering neurotransmission with 
exogenous chemicals. 
The ability of the NMDA antagonist, PCP, to produce widespread disruption of 
auditory gating in areas implicated in the pathophysiology of schizophrenia, 
especially following acute administration under isoflurane anaesthesia, makes it 
a potential pharmacological model with a high predictive validity, substantiated 
by the fact that the atypical antipsychotic, clozapine, reversed the gating deficits 
induced by PCP. 
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Chapter Six 
Effects of WIN55,212-2 on auditory gating 
in the rat hippocampus and medial 
prefrontal cortex 
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6. Effects of WIN55,212-2 on auditory gating in 
the rat hippocampus and medial prefrontal cortex 
6.1. Introduction 
Cannabis is one of the most widely abused drugs in the world and is also used 
commonly with other recreational drugs such as Phencyclidine (PCP). 
Cannabinoids, including Ll9-THC, the active compound of the plant Cannabis 
sativa, produce neuropsychiatric effects by binding to specific endogenous 
receptors (mainly the CB1 receptors) in the central nervous system (see 1.8). 
In 1997, Emrich et al proposed that the pathophysiology of schizophrenia may 
be related to a functional disturbance of the endocannabinoid system. Since 
then evidence has been accumulating to support the cannabinoid hypothesis of 
schizophrenia. Several studies have shown that the administration of 
cannabinoid agonists either acutely (Em rich et aI., 1997) or chronically (Patrick 
et al., 1999) can produce schizophrenic symptoms in healthy individuals and 
exacerbate symptoms in schizophrenic patients. A recent meta analysis on 
cannabis and psychosis by Moore et al (2007) reports 'There was an increased 
risk of any psychotic outcome in individuals who had ever used cannabis 
(pooled adjusted odds ratio=1·41, 95% Cl 1·20-1·65). Findings were consistent 
with a dose-response effect, with greater risk in people who used cannabis 
most frequentl,v (2·09, 1-54-2·84)' highlighting the ominous link between 
cannabis and schizophrenia. 
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Patrick et al (1999) and Rentzsch et al (2007) reported that chronic cannabis 
abuse, in otherwise healthy individuals, disrupts auditory gating in scalp 
recorded AERs. Recent studies have also shown that cannabinoid agonists 
disrupt auditory gating in the rat CA3 (Zachariou et al., 2007, 2008; Hajos et al., 
2008). 
In this chapter we conducted simultaneous recordings from the DG, CA3 and 
mPFC in rat and sought to determine if auditory gating in these regions could be 
disrupted by a single administration of the synthetic non-selective cannabinoid 
agonist WIN55,212-2 and whether any effects observed were reversed by the 
CB1 receptor antagonist SR141716A. 
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6.2. Methods 
6.2.1 Animals 
Experiments were performed on male Lister hooded rats (n = 20) weighing 300-
400 g at the time of surgery and anaesthetised with isoflurane; N20:02 and all 
the electrophysiological procedures were carried out as described in chapter 2. 
Simultaneous recordings from the CA3, DG and mPFC were carried out and 
only the animals with electrodes placed in the CA3, DG and mPFC, confirmed 
by histology, were used for analysis. 
6.2.2 Experimental protocol 
The auditory stimuli (90dB intensity, 0.5s ISI, 10s inter-trial interval) were 
presented over 128 trials and auditory-evoked LFP and unit responses were 
recordecj simultaneously from the CA3, DG and mPFC. 
6.2.3 Drug administration 
WIN55,212-2 experiments 
Following basal recording of the auditory responses to 128 trials of auditory 
stimuli, the vehicle was administered (1 ml/kg, i.p; n = 10) and the effect on 
auditory gating assessed by recording the responses to 128 auditory 
conditioning-test trials 15min after administration (Box 6.1). WIN55,212-2 was 
administered to the same animals 40 min after the vehicle and the effect on 
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auditory gating was again assessed by recording auditory responses to 128 
stimuli trials, begining15 and 45 min after drug administration. 
Box 6.1 Protocol for WIN55,212-2 (WIN) experiments 
WIN vehicle (1mllkg, 
Recording of basal i.p) continuous WlN55,212-2 (1.2mglkg, i.p) Recording of auditory 
a U d i t o ~ r e s p o n s e s t o o .. recording and .. continuous recording and .. responses to 128 trials, 
128 trials a u d i t o ~ ~ stimuli -128 a u d i t o ~ ~ stimuli -128 trlals- 45min following WIN 
trlals- 15min 15minfoUowingWIN 
following saline 
SR141716A experiments 
Following basal recording of the auditory responses to 128 trials of auditory 
stimuli, the vehicle for SR141716A was administered (1mllkg, Lp; n = 10 rats) 
and the effect on auditory gating assessed by recording the responses to 128 
auditory conditioning-test trials 15min after administration (Box 6.2). 
SR141716A was then administered as a single dose (1mg/kg, Lp) 40 min after 
the vehicle. The effect of SR141716A on auditory gating was assessed by 
recording the responses to 128 auditory conditioning-test trials 15min after 
administration. WIN55,212-2 (1.2mg/kg, i.p) was administered to the same 
animals 40 min after SR141716A and the effect on auditory gating assessed 
over 128 stimuli trials, 15 and 45 min following WIN55,212-2 administration. 
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Box 6.2 Protocol for SR141716A (SR) experiments 
. SR ~ h i c l e e ( 1 m l ~ , , i.p) S R 1 ~ 1 7 1 6 A A ( 1 m g ~ g , , i.p) WlN55,212-2 (1.2mg/1(g, i.p) 
Rec.ordang of baslIl ,. c O ~ l n u o u s s recordang and l.,j continuous recordang and continuous recording IInd 
lIuditory responses to lIuditory stimuli - 128 1""1 auditory stimuli -128 I. lIuditory stimuli -128 trillls-
128trillls trials- 15 min following trlals-15minfollowingSR 15minfoUowlngWlN 
clozllpine vehicle 
6.2.4 Data analysis & statistics 
• Recording of auditory 
responses to 128 trials, 
45min following WIN 
Data were analysed off-line using NeuroExplorer (v3; NEX technologies Inc., 
USA) with evoked response amplitudes, latencies and TIC ratios computed 
using a custom-designed Matlab script (v7.0 with associated Matlab Signal 
Processing, Neural Network, Statistics and Image Processing Toolboxes; The 
Mathworks). Statistical analysis used Prism (v4.03; GraphPad, USA) and within 
region changes of all the parameters at different time points were analysed 
using one-way analysis of variance (AN OVA) for repeated measures with post 
hoc Tukey t-test. Data are expressed as mean ± SEM (standard error of mean), 
statistical significance was taken when P < 0.05. 
6.2.5 LFP analysis 
Auditory evoked potentials were initially visualized as peri-event averaged LFPs 
(Fig. 6.1). The AERs were identified according to the polarity and the order of 
occurrence, i.e. N1, P1, N2, P2, N3 peaks (Van Luijtelaar et al., 2001; Soutros 
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et al., 2004). An electrode with the highest N2 wave conditioning amplitude 
response from each area was selected for further analysis (see chapter 2). The 
ratio of the test amplitude to the conditioning amplitude (TIC ratio) of the N2 
wave was calculated for each averaged response and the TIC ratio in the CA3 
was used to separate gating and non-gating rats. A TIC ratio of :S;50% in the 
CA3 was indicative that gating was present (Joy et al., 2004; Miller et al., 1992). 
6.3. Results 
6.3.1 Auditory Evoked Responses in the CA3, DG and mPFC 
Averaged LFPs recorded from the CA3 region, DG and mPFC in response to 
auditory stimuli exhibited complex AERs responses as discussed in chapter 3 
and 4. Evaluation of the TIC ratios of the N2 wave in the CA3 identified the 
gating rats (TIC :s; 50%; n = 12) and the non-gating rats (TIC >50%; n = 8). 
Auditory evoked N2 responses in the CA3, DG and mPFC were studied in 
gating rats and non-gating rats separately in relation to their conditioning 
amplitudes (CAMP), test amplitudes (TAMP), TIC ratios, conditioning response 
latencies (CLAT) and test response latencies (TLAT). In the group of rats given 
WIN55,212-2, six animals exhibited gating of the N2 wave and four showed 
non-gating before drug administration. In the group of rats pre-treated with 
SR141716A, six animals demonstrated gating and four showed non-gating 
before drug administration. Neither WIN55,212-2 vehicle nor SR141716A 
vehicle had any effect on the N2 TIC ratios in any of the three regions in the 
gating or the non-gating rats (Table 6.1 and Table 6.2). 
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6.3.2 Effects of WIN55,212-2 on the gating rats 
6.3.2.1 Effects of WIN55,212-2 on the conditioning amplitudes 
WIN55,212-2 increased CAMP in all three areas, 15 and 45 min following drug 
administration (Fig. 6.1, 6.2 and Table 6.1). In the CA3 an increase in CAMP 
was observed (F 2, 17 = 4.9, P = 0.03) which was significant 15 min post-
WIN55,212-2 (P<0.05). In the DG there was a significant increase in CAMP (F 2, 
17 = 7.9, P = 0.008) with increases in amplitudes both 15 (P<0.05) and 45 min 
(P<0.05) after WIN55,212-2 administration. A significant increase of CAMP in 
the mPFC was also found with WIN55,212-2 (F 2,17 = 4.6, P = 0.03) which was 
significant 15 min post-WIN55,212-2 (P<0.05). 
6.3.2.2 Effects of WIN55,212-2 on the test amplitudes 
There were significant increases in TAMP following WIN55,212-2 administration 
in the CA3, DG and mPFC (Fig. 6.1, 6.2 and Table 6.1). In the CA3 region 
TAMP increased (F 2,17 = 9.8, P = 0.004) both 15 (P<0.01) and 45 min (P<0.01) 
post-WIN55,212-2. The DG showed a significant increase in TAMP following 
WIN55,212-2 (F 2,17 = 13, P = 0.001) both 15 (P<0.01) and 45 min (P<0.01) 
after administration. Test amplitudes in the mPFC were also increased by 
WIN55,212-2 (F 2, 17 = 18, P = 0.0005), 15 (P<0.01) and 45 min (P<0.001) 
following injection. 
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6.3.2.3 Effects of WIN55,212-2 on the TIC ratios 
Administration of a single dose of WIN55,212-2 disrupted gating in all three 
regions both 15 and 45 min after administration when compared to basal values 
for each region (Fig. 6.1, 6.2 and Table 6.1). WIN55,212-2 disrupted gating in 
CA3 (F 2, 17 = 21.5, P = 0.0002), 15 (P<0.05) and 45 min (P<0.001) after 
injection. In the DG, WIN55,212-2 increased the TIC ratio (F 2, 17 = 7.7, P = 
0.009) with disruption of gating seen at both 15 (P<0.05) and 45 min (P<0.01) 
after administration. Disruption of gating was detected in the mPFC following 
WIN55,212-2 (F 2, 17 = 10.8, P = 0.003) with an increase in TIC ratio at 15 (TIC 
= 93 ± 23 %; P>0.05) and 45 min (P<0.01) after administration. 
6.3.2.4 Effects of WIN55,212-2 on the conditioning latencies and test 
latencies 
WIN55,212-2 caused a significant shortening of CLAT in the CA3 (F 2,17 = 6.8, 
P = 0.03) and DG (F 2,17 = 9.7, P = 0.004). However, WIN55,212-2 had no 
significant effect on CLAT in the mPFC (P = 0.5). WIN55,212-2 produced no 
significant changes in TLAT in all three regions (Table 6.1). 
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Fig. 6.1 Representative peri-event averaged LFPs from (A & D) CA3, (B & E) 
DG and (C & F) mPFC demonstrating the effects of WIN55,212-2 (45min after 
administration) on auditory gating compared to basal recordings in a gating rat. 
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Basal recordings from (A) CA3 (TIC ratio = 38 %), (B) OG (TIC ratio = 40 %) and (C) 
mPFC (TIC ratio = 48 %) demonstrated gating of the N2 wave. WIN55,212-2 disrupted 
gating of the N2 wave in (0) CA3 (TIC ratio = 82 %), (E) OG (TIC ratio = 85 %) and (F) 
mPFC (TIC ratio = 89 %) 45min following drug administration. 
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Fig. 6.2 Graphs depicting conditioning amplitudes (CAMP), test amplitudes 
(TAMP) and TIC ratio from the CA3, DG and mPFC of the gating rats (n = 6), 
15min and 45min following WIN55,212-2, compared to basal values (mean ± 
SEM). 
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A. W155,212-2 increased the CAMP in the DG, but had no effect on the CAMP of 
the CA3 or mPFC 45 min following administration. 
B. W155,212-2 increased the TAMP in the CA3, DG and mPFC both 15 and 45 
min following administration. 
C. TIC ratios in the CA3, DG and mPFC increased significantly both 15 and 45 
min following W155,212-2 administration. 
(. = P<O.05, •• = P<O.01, ••• = P<O.001) 
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6.3.3 Effects of WIN55,212-2 on the non-gating rats 
6.3.3.1 Effects of WIN55,212-2 on the conditioning amplitudes 
A significant elevation of CAMP in all three regions was detected following 
WIN55,212-2 administration compared to the respective basal values (Fig. 6.3, 
6.4 and Table 6.2). The CA3 region demonstrated an increase in CAMP 
following WIN55,212-2 (F 2, 11 = 43.7, P = 0.0003) at 15 (P<0.001) and 45 min 
(P<0.001) and the response to WIN55,212-2 in the DG was similar with a 
significant increase in CAMP (F 2, 11 = 20.8, P = 0.002) 15 (P<0.01) and 45 min 
(P<0.01) after drug administration. The mPFC also exhibited a similar response 
pattern with an increase in CAMP (F 2, 11 = 26, P = 0.001) 15 (P<0.01) and 45 
min (P<0.01) after WIN55,212-2 administration. 
6.3.3.2 Effects of WIN55,212-2 on the test amplitudes 
A significant increase of TAMP in the three regions was detected following 
WIN55,212-2 compared to the basal values (Fig. 6.3, 6.4 and Table 6.2). The 
CA3 region demonstrated an increase in TAMP following WIN55,212-2 (F 2, 11 = 
18, P = 0.003) 15 (P<0.01) and 45 min (P<0.01) after administration with a 
similar response in the DG, a significant increase in TAMP (F 2, 11 = 22, P = 
0.002) 15 (P<0.01) and 45 min (P<0.01) post drug administration. The mPFC 
showed the same response pattern with an increase in TAMP (F 2, 11 = 11.8, P = 
0.008) 15 (P<0.05) and 45 min (P<0.05) after WIN55,212-2. 
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6.3.3.3 Effects of WIN55,212-2 on the TIC ratios 
Interestingly administration of WIN55,212-2 had no significant effect on the TIC 
ratios (P>0.05) in the non-gating rats in the CA3, DG or mPFC (Fig. 6. 3 and 
Table 1). A reduction in TIC ratio was observed in all three regions possibly due 
the comparatively higher increase in CAMP than TAMP following WIN55,212-2 
(Fig. 6.3, Fig. 6.4 and Table 6.2). 
6.3.3.4 Effects of WIN55,212-2 on the conditioning latencies and test 
latencies 
WIN55,212-2 caused a significant increase in CLAT in the DG (F 2,11 = 8.3, P = 
0.01) and mPFC (F 2, 11 = 5.5, P = 0.04). However, WIN55,212-2 had no 
significant effect on CA3 conditioning latencies (P>0.05). WIN55,212-2 
produced no significant changes in TLAT in the three regions (P>0.05; Table 
6.2). 
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Fig. 6.3 Representative peri-event averaged LFPs from (A & D) CA3, (8 & E) 
DG and (C & F) mPFC demonstrating the effects of WINSS,212-2 (4Smin after 
administration) on auditory gating (N2 wave) compared to basal recordings in a 
non-gating rat. 
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Basal recordings from (A) CA3 (TIC ratio = 93 %), (B) OG (TIC ratio = 97 %) and (C) 
mPFC (TIC ratio = 108 %) demonstrated absence of gating of the N2 wave. 
WIN55 212-2 had no significant effect on the TIC ratios (P>0.05) in the (0) CA3 (TIC 
ratio = '82 %), (E) OG (TIC ratio = 83 %) or '(F) mPFC (TIC ratio = 80 %) 45 min after 
administration. 
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Fig. 6.4 Graphs showing conditioning amplitudes (CAMP), test amplitudes 
(TAMP) and TIC ratio from CA3, DG and mPFC of the non-gating rats (n = 4), 
following 15min and 45min of WIN55,212-2 administration, compared to basal 
(mean ± SEM). 
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A. WIN55,212-2 increased the CAMP in the CA3, DG and mPFC, 15 and 45 min 
following administration. 
B. WIN55,212-2 increased the TAMP in the CA3, DG and mPFC, 15 and 45 min 
following administration. 
C. TIC ratios showed no significant changes (P>O.05) in the CA3, DG or mPFC 
following WIN55,212-2 administration in the non-gating rats. 
(. = P<O.05, •• = P<O.01, ... = P<O.001) 
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6.3.4 Effect of SR141716A on WIN55,212-2 induced changes in 
the gating rats 
Neither SR141716A alone, nor its vehicle, had any significant effect (P>0.05) on 
the TIC ratios when compared with the basal values in the CA3, DG and mPFC 
(Fig. 6.5A & table 6.1). In addition there were no significant changes (P>0.05) in 
the TIC ratios in any of the regions, either 15 or 45 min after WIN55,212-2 in 
rats pre-treated with SR141716A (Fig. 6.5A) indicating antagonism of the 
effects of WIN55,212-2. SR141716A prevented the WIN55,212-2 induced 
changes. SR141716A prevented the effects ofWIN55,212-2 on the TIC ratio by 
preventing the increases in the TAMP (P>0.05) following WIN55,212-2 
administration (Table 6.1). 
6.3.5 Effect of SR141716A on WIN55,212-2 induced changes in 
the nor:t-gating rats 
Neither SR141716A alone, nor its vehicle, had any significant effect (P>0.05) on 
the TIC ratios when compared with the basal values in the CA3, DG and mPFC 
(Fig. 6.58 & Table 6.2) in the non-gating rats. In addition there were no 
significant changes (P>0.05) in the TIC ratios in any of the regions, either 15 or 
45 min after WIN55,212-2 in rats pre-treated with SR141716A (Fig. 6.58). 
There were significant increases in the CAMP in the CA3 (F4,29 = 16.6, 
P<0.0001) and DG (F4,29 = 15.7, P<0.0001) both 15min (P<0.001) and 45min 
(P<0.001) following WIN55,212-2 administration. A significant increase in the 
CAMP was observed in the mPFC (F4 ,29 = 3.9, P = 0.02) 45min (P<0.05) 
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following WIN55,212-2 in this rat group. TAMP also increased significantly in 
the CA3 (F4,29 = 14, P<0.0001), DG (F4,29 = 13.7, P<0.0001) and mPFC (F4,29 = 
7.7, P= 0.0006) following WIN55,212-2 administration in the non-gating rats 
pre-treated with SR141716A. There were increases in CLAT in the DG (P<0.05) 
and mPFC (P<0.05) 45min following WIN55,212-2. The effects of WIN55,212-2 
on the AER parameters in the non-gating rats pre-treated with SR141716A 
were similar to the results obtained when WIN55,212-2 was administered alone 
(Table 6.2), indicating that SR141716A had no effect on the changes produced 
by WIN55,212-2 in the non-gating rats. 
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Fig. 6. 5 Bar graphs depicting N2 TIC ratios 15 min (WIN 15) and 45 min (WIN 
45) after WIN55,212-2 administration in (A) gating rats (n = 6) and (B) non-
gating rats (n = 4) pre-treated with SR141716A (SR) compared to basal values 
(mean ± SEM). 
A 
0 
+I 
cu 
... 
0 20 
-t-
10 
0 
B 
0 
+I 
cu 100 ... 
0 
-t-
50 
Basal SR 
Basal SR 
SR+ 
WIN 15 
SR+ 
WIN 15 
SR+ 
WIN 45 
SR+ 
WIN 45 
';:::;:#=. CA3 
~ D G G
~ m P F C C
A. SR141716A alone had no significant effect on the TIC ratios (P>O.05) in the CA3, 
DG and mPFC. Pre-treatment with SR141716A prevented the increases in TIC 
ratios following WIN55,212-2 in the CA3, DG and mPFC in the gating rats. 
B. Neither SR141716A nor WIN55,212-2 had any effect on the TIC ratios in the CA3, 
DG or mPFC in the non-gating rats. 
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Table 6.1 Summary table of the amplitudes, TIe ratios and latencies 15 min after 
WIN55,212-2 vehicle (WIN veh) and 45 min after WIN55,212-2 (WIN 45) 
administration in the gating rats not treated with SR 141716A (n = 6) and the 
gating rats pre-treated with SR141716A (SR; n = 6; SR141716A vehicle = SR 
veh) compared to the basal values of the respective groups (8asal-1 and 8asal-
2). 
Region Basal-1 WINveh WIN 45 Basal-2 SR veh SR WIN 45 
CA3 
CAMP ( ~ N ) ) 159 ± 36 164 ± 47 277 ± 79 100 ± 13 121 ± 23 152 ± 60 281 ± 41* 
TAMPON) 59±22 60 ± 12 264± 24" 45 ± 21 67 ±22 50 ± 24 78 ± 14 
TIC ratio 28± 7 27 ± 6 109 ± 8"** 24 ± 7 27 ± 9 23 ±6 27 ± 9 
CLAT (ms) 73 ±6 70 ± 1 58 ± 3* 70±4 71±6 75 ± 7 73±6 
TLAT (ms) 67 ±8 62 ±4 66 ±5 66±7 63 ±5 67 ±6 56 ± 5 
DG 
CAMP ON) 110 ± 36 122 ± 24 202 ± 46 88 ±29 101 ± 17 120 ± 33 223 ± 42* 
TAMP ( ~ v ) ) 39 ± 21 35± 7 184 ± 33 
H 
48 ± 15 61 ± 20 54±22 84 ± 33 
TIC ratio 31± 6 29± 6 105 ± 10 ...... 33 ±5 38 ± 14 35 ± 12 22 ± 9 
CLAT(ms) 72 ±6 70± 3 58 ± 2* 69 ± 1 67 ±6 65 ± 7 70± 7 
TLAT (ms) 60± 7 60± 5 65 ± 5 67 ±8 65 ±5 63 ±8 60±4 
mPFC 
CAMP ( ~ v ) ) 73 ±28 98 ± 15 163 ± 40 50 ± 18 61 ± 17 72 ± 25 157 ± 97 
TAMP ( ~ v ) ) 38 ± 15 41±4 145 ± 18 
... 
31 ± 20 32 ±26 37 ±22 57 ± 12 
TIC ratio 42 ± 5 44± 5 139 ± 24** 41 ± 6 28± 8 38±6 46 ± 15 
CLAT (ms) 65 ± 3 65 ± 1 70 ± 6 63 ± 11 53 ± 10 60± 7 63 ± 6 
TLAT (ms) 60 ± 5 60 ±3 65 ±6 60 ± 10 62 ±7 61 ± 4 60 ±4 
( .. = P<O.05; *'" = P<O.01; ...... = P<O.001) 
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Table 6.2 Summary table of the amplitudes, TIC ratios and latencies, 15 min 
after WIN55,212-2 vehicle (WIN veh) and 45 min after WIN55,212-2 (WIN 45) 
administration in the non-gating rats not treated with SR141716A (SR; n = 4 ) 
and the non-gating rats pre-treated with SR141716A (n = 4 ) compared to pre-
drug values of the respective groups (8asal-1 and 8asal-2). 
Region Basal·1 WINveh WIN 45 Basal-2 SRveh SR WIN 45 
CA3 
CAMP (j.N) 189 ± 40 194 ± 28 341 ± 30*** 138 ± 11 169 ± 27 176 ± 34 341 ± 30*** 
TAMP (j.N) 189 ± 33 190 ± 30 306 ± 34** 134 ± 8 148 ± 14 159 ± 27 331± 44*** 
TIC ratio 107 ± 18 98 ± 14 90±6 112 ± 24 143 ± 48 102 ± 18 93 ± 10 
CLAT (ms) 55 ± 1 55 ± 1 56 ± 1 56 ± 1 56 ± 1 57 ±2 58 ± 1 
TLAT (ms) 58 ± 1 57 ±2 59 ± 1 60± 3 62 ±2 65 ±3 60 ± 1 
DG 
CAMP (j..IV) 137 ± 25 141 ± 26 273 ± 13** 133 ± 13 161 ± 23 186 ± 28 283 ± 24*** 
TAMP (j..IV) 148 ± 16 145 ± 24 243 ± 27** 132 ± 16 138 ± 10 180 ± 22 268 ± 29*** 
TIC ratio 118 ± 24 107 ± 18 89 ± 10 116 ± 36 83 ± 11 94 ±23 91 ± 7 
CLAT (ms) 55 ± 1 55 ± 2 58 ± 1* 52 ± 3 53±6 55 ± 1 59 ± 1* 
TLAT (ms) 58 ± 1 58 ± 1 60 ± 1 60±2 64±3 65 ± 1 60 ± 1 
mPFC 
CAMP (j..IV) 63 ± 11 70 ± 18 124 ± 5** 70 ± 11 87 ± 16 95 ± 25 126 ± 11* 
TAMP (j..IV) 93 ± 10 90 ± 8 145 ± 22* 76 ± 14 79 ± 12 97 ± 18 170 ± 26*** 
TIC ratio 164 ± 42 160 ± 15 119±18 172 ± 48 112 ± 23 130 ± 29 163 ± 28 
CLAT(ms) 53 ± 0.3 54±2 57 ± 1* 48 ± 1 50±4 50 ±2 54 ± 1* 
TLAT (ms) 61±2 62 ± 1 64 + 2 47 ±2 48 ± 1 50 ±7 48 ± 2 
(* = P<O.05; ** = P<O.01; *** = P<O.001) 
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6.4 Discussion 
In the present study robust auditory evoked potentials were recorded from the 
CA3 region, DG and mPFC with some rats showing gating of the N2 wave while 
others showed a lack of gating. WIN55,212-2 disrupted auditory gating of N2 in 
the gating rats, but had no effect on the TIC ratios of the non-gating rat group. 
The CB1 receptor antagonist SR141716A prevented the disruption of gating 
induced by WIN55,212-2 in the CA3, DG and mPFC. 
Studies examining the effect of cannabinoids on rodent behaviours relevant to 
schizophrenia have produced contrasting results. Schneider and Koch (2002) 
showed that a single administration of WIN55,212-2 impaired prepulse inhibition 
(PPI), a paradigm used to model deficits in sensorimotor gating, while in 
contrast the cannabinoid agonist CP 55,940 augmented PPI (Stanley-Cary et 
al., 2002). Schneider and Koch (2003) showed that chronic treatment with 
WIN55,212-2 impaired PPI in pubertal, but not in adult rats while Bortolato et al 
(2005) showed that acute or chronic administration of WIN55,212-2 failed to 
change PPI. The same group also found that prenatal exposure to WIN55,212-2 
failed to affect the sensory motor gating of adult offspring (Bortolato et al., 
2006). The partial cannabinoid agonist b,9_ Tetrahydrocannabinol (THC) has 
been shown to disrupt PPI in socially isolated rats, a neurodevelopmental model 
of schizophrenia, but not in normal rats (Malone and Taylor, 2005). 
Our observations with WIN55,212-2 agree with the findings from human and rat 
studies showing systemic administration of cannabinoid receptor agonists 
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induce schizophrenic symptoms and disrupt auditory gating (Emrich et al., 
1997; Rentzsch et al., 2007; Hajos et al., 2008). The mechanisms by which 
cannabinoids bring about these effects are unclear though previous studies 
have shown that endocannabinoids modulate the activity of several 
neurotransmitters in the brain, mainly via CB1 receptors located presynaptically 
on GABAergic interneurones (Wilson and Nicoll, 2002). Acute systemic 
administration of cannabinoid agonists increases extracellular mesolimbic 
dopamine levels via activation of CB 1 receptors on the GABAergic terminals 
resulting in the disinhibition of the dopamine neurones in the ventral tegmental 
area (Gardner and Voral, 1998). Dysregulation of several neurotransmitters, 
including GABA, dopamine and glutamate are implicated in the pathogenesis 
and symptomatology of schizophrenia, effects that could result from 
dysregulation of the endocannabinoid system (see 1.8). Lewke et al (1999) 
found increased levels of endocannabinoids in the CSF of schizophrenic 
patients which supports the hypothesis of endocannabinoid dysregulation in 
schizophrenia. 
The reciprocal connections between GABAergic interneurones and 
glutamatergic pyramidal neurons in the CA3 region of the hippocampus and the 
external inputs from the medial septum (nicotinic and GABAergic) and the 
entorhinal cortex (glutamatergic) are important for auditory gating in the CA3 
(Miller & Freedman., 1993; Flach et al., 1996; Moxon et al., 2003a). Either a 
dysfunction or a blockade of the connections affecting the fine tuning of these 
neurotransmitters can disrupt gating (Flach et al., 1996; Moxon et al., 2003a). A 
cannabinoid agonist administered systemically may bind to the presynaptic CB1 
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receptors on the hippocampal and possibly prefrontal interneurones so reducing 
GABA release and thus GABA inhibition. The absence of GABAergic inputs on 
excitatory glutamatergic neurons could lead to hyperactivity of the excitatory 
circuits resulting in deficits in inhibitory processes such as auditory gating. 
WIN55,212-2 increased both the conditioning and test amplitudes in the CA3, 
DG and mPFC in the gating rats, suggesting a hypersensitive/hyperactive state 
created by cannabinoids in the three regions either by activating or recruiting 
more stimuli sensitive neurons. The increase in auditory test response 
amplitudes were relatively greater than that of the conditioning amplitudes 
resulting in disruption of gating following WIN55,212-2. This finding is similar to 
the effect of phencyclidine (as observed in chapter 5), which disrupts gating by 
increasing response amplitudes (Miller et aI., 1992). The fact the disruption of 
gating by WIN55,212-2 is brought about by the inability to suppress the test 
responses and not by reduction in conditioning responses makes it a potential 
pharmaGological agent to model the information processing deficits in 
schizophrenia. WIN55,212-2 also shortened the response latencies in the CA3 
and DG in the gating rats which could indicate disrupted information processing 
following cannabinoid administration. 
WIN55,212-2 increased the conditioning amplitudes and test amplitudes in the 
non-gating rats in the CA3, DG and mPFC but the T/C ratios were smaller 
possibly due to comparatively higher increases in CAMP than TAMP. It is 
interesting that WINS5,212-2 had a differential selectivity on the response 
amplitudes in non-gating rats compared to the gating rats, due possibly to an 
162 
action of the cannabinoid agonist on the dysfunctional neural circuits in the non-
gating rats. WIN55,212-2 also delayed the response latencies of the non-gating 
rats in the CA3, DG and mPFC, opposite to the effect it had on the gating rats, 
which further illustrates the innate neurophysiological differences between the 
two groups. Interestingly WIN55,212-2 produced opposite effects on these 
parameters in the gating and non-gating rats for which an explanation is 
required from future studies. 
The potent and selective CB1 receptor antagonist SR141716A prevented the 
WIN55,212-2 induced disruption of gating in the CA3, DG and mPFC, 
suggesting the disruption of auditory gating by WIN55,212-2 was mediated via 
CB1 receptors. The results from the CA3 measurements agree with the study 
by Hajos et al (2008) showing that disruption of gating in the CA3 region by the 
CB1 agonist CP-55940 was reversed by the CB1 receptor antagonist AM-251. 
Considering the endocannabinoid hypothesis of schizophrenia and that the 
cannabinoid agonists produce gating deficits similar to those seen in 
schizophrenics, the prevention of gating deficits by SR141716A makes the 
endocannabinoid system a potential target for future clinical research in the 
treatment of schizophrenia. 
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Chapter Seven 
Auditory-evoked single-unit responses in 
the rat hippocampus and the medial 
prefrontal cortex 
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7. Auditory-evoked single-unit responses in the 
rat hippocampus and the medial prefrontal cortex 
7.1 Introduction 
In the previous chapters the LFP activity in response to auditory conditioning-
test paradigm indicated that the neural processes mediating auditory gating in 
the CA3, DG and mPFC are inter-related and can be disturbed by NMDA 
antagonists and CB1 agonists. However, the neuronal mechanisms underlying 
the sensory gating process are still unclear. Auditory-evoked LFP responses, 
the primary measure of sensory gating, pool information from a large number of 
neural elements and the results obtained can not be directly extrapolated to the 
cellular level. Studying the gating mechanism at the single-unit level not only 
improves the understanding of the underlying neural mechanisms crucial for 
sensory, gating but provides a valuable tool to study the neurobiology of 
schizophrenia and other neurological diseases in which sensory gating process 
is dysfunctional. 
Single-unit responses to auditory gating paradigm have been examined in the 
CA3 region of the rat hippocampus (Bickford et al., 1990; Miller et al., 1992; 
Miller and Freedman., 1995; Moxon et al., 1999). These studies have 
demonstrated robust single-unit responses to auditory conditioning-test 
paradigm with gating of the unit responses in the CA3 under chloral hydrate 
anaesthesia (Bickford et al., 1990; Miller et al., 1992; Miller and Freedman., 
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1995) and in freely moving rats (Moxon et al., 1999). 
Mears et al (2006) examined the single-unit responses in the mPFC to the 
auditory conditioning-test paradigm in freely moving rats and observed three 
different types of tone responses to the conditioning stimulus (excitatory short 
duration, excitatory long duration and inhibitory) which were gated following the 
test stimulus. They also reported that the gating of the unit responses were 
stable between different recording sessions. 
Auditory gating at the single-unit level has been observed in several other 
regions in the rat CNS including the medial septum (Miller and Freedman., 
1993; Moxon et al., 1999), brain stem (Moxon et al., 1999), reticular nucleus of 
the thalamus (Krause et al., 2003), amygdala (Cromwell et al., 2005), striatum 
(Cromwell et al., 2007) and the midbrain (Anstrom et al., 2007). However, the 
dentate gyrus of the hippocampus has not yet been explored in relation to 
auditory ,gating at the single-unit level. 
The effects of pharmacological manipulations on the single-unit gating 
responses have not been studied widely. Miller et al (1992) demonstrated that 
PCP disrupts auditory gating of the single-unit responses in the CA3 of rat 
hippocampus under chloral hydrate anaesthesia. Krause et al (2003) 
demonstrated that amphetamine (a dopamine agonist) disrupts gating of the 
reticular thalamic neurons in chloral hydrate anaesthetised rats. We have 
shown that WIN55,212-2 disrupts gating at the single-unit level in the CA3 of 
the rat hippocampus under isoflurane anaesthesia (Zachariou et al 2007, 2008). 
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Cromwell and Woodward (2007) examined the effects of ketamine (a NMDA 
antagonist), haloperidol (a dopamine antagonist) and nicotine on the single-unit 
gating responses in the amygdala in freely moving rats and showed that these 
three different drugs affected gating in partially over-lapping ways, suggesting 
the existence of multiple and diverse neural circuits mediating auditory gating. 
In this chapter the single-unit responses were analysed and compared with 
simultaneously recorded LFP responses to the auditory conditioning-test 
paradigm in both gating and non-gating rats in the CA3, DG and mPFC under 
isoflurane anaesthesia. We also studied the effects of PCP and WIN55,212-2 
on the single-unit responses to the auditory conditioning-test paradigm in the 
gating rats with the aim of correlating the results with those obtained with LFPs. 
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7.2 Methods 
Single-unit activity was recorded simultaneously with LFPs in the CA3, DG and 
mPFC in the male Lister hooded rats (n = 21) in response to the auditory 
conditioning-test paradigm, before and after pharmacological manipulations. 
Neuronal action potential activity recorded from the three areas were validated 
and sorted off-line (see chapter 2). Within Neuroexplorer data were 
subsequently analysed as peri-stimulus time histograms and epoch counts. 
7.2.1 Single-unit analysis 
Single-units recorded from the three regions were examined separately for 
auditory-evoked responses using peri-event I peri-stimulus time histograms 
(10ms bin; ± 500ms peri-stimuli period). Only the neurons with significant 
responses (above 95% confidence limit from the mean basal firing rate in the 
peri-stimulus time histograms; P<0.05) to the auditory stimuli (conditioning I test 
I both) were considered as auditory-responsive (see chapter 2, Fig. 2.10). 
Auditory-responsive single-units in the CA3, DG and mPFC were grouped in to 
two main types according to their stimuli-related responses using peri-stimulus 
time histograms. Single-units that exhibited the highest peak activity within 
100ms of the conditioning stimulus delivery were classified as early excitatory 
(Fig. 7.1) and the units which demonstrated highest peak activity following 100 
ms of the conditioning stimulus delivery were classified as late excitatory (Fig. 
7.2). Epoch count analYSis of the auditory responsive cells was used to obtain 
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the average unit activity (spike count (number of action potentials) I epoch) 
during specified time periods (epochs) and the values obtained were used to 
calculate the TIC ratios of the units. The TIC ratio for the early excitatory cells 
was calculated as the ratio of the average unit activity during 100ms following 
the onset of the test stimulus to the average unit activity during 100 ms following 
the onset of the conditioning stimulus. For late excitatory cells, the TIC ratio was 
calculated as the ratio of the average unit activity during 500ms following the 
onset of the test stimulus to the average unit activity during 500 ms following the 
onset of the conditioning stimulus. A Matlab script (TCpsth.m) was used to 
obtain the latencies (from the timing of the stimulus to the peak firing in the peri-
stimulus histogram) of the peak activities. 
TIC ratios of the unit responses were compared to the TIC ratios of the N2 LFPs 
recorded from the same electrode where possible. The TIC ratios of the LFPs 
were obtained using a Matlab script as described in the previous chapters. The 
N2 LFP rlC ratio in the CA3 was used to separate gating and non-gating rats. A 
TIC ratio of ~ 5 0 % % in the CA3 was indicative that gating was present (Joy et al., 
2004; Miller et aI., 1992). Single-unit activity in the gating (n = 16) and the non-
gating rats (n = 5) were analysed separately. 
Since the auditory gating process at the LFP level (Le. the N2 TIC ratio) in the 
gating rats appeared to be more sensitive to pharmacological manipulations 
compared to the non-gating rats, the single-unit spike activity and the TIC ratios 
of the gating rats were analysed further to examine the drug related changes in 
the unit activity in response to the auditory conditioning-test paradigm. The pre-
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drug unit activity following auditory stimuli (basal) were compared to the activity 
45 min after PCP (1mg/kg, i.p) or 45 min after WIN55,212-2 (1.2mg/kg, i.p) 
administration. The effects of clozapine (5mg/kg, i.p) on the basal unit activity 
15 min after administration and also the effects of pre-administration of 
clozapine (5mg/kg, i.p) on PCP (1mg/kg, i.p) induced changes in the unit 
activity were examined. The effects of SR141716A (1mg/kg, i.p) on the basal 
unit activity 15 min after administration and the effects of pre-administration of 
SR141716A (1mg/kg, i.p) on WIN55,212-2 (1.2 mg/kg, i.p) induced changes in 
the unit activity were also examined. 
7.2.2 Statistical analysis 
Statistical analysis used Prism (v4.03; GraphPad, USA) and within region 
changes in the TIC ratios and latencies were analysed using Student t-test or 
one way analysiS of variance (AN OVA) for repeated measures with post hoc 
Tukey t-test when appropriate. Data are expressed as mean ± SEM (standard 
error of mean), statistical significance was taken when P < 0.05. 
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7.3 Results 
A total of 704 single-units were recorded from both gating rats (n = 16) and non-
gating rats (n = 5). Of the units recorded from the gating rats (n = 527; CA3, n = 
202; OG, n = 178; mPFC, n = 147), in the CA3, 52% (105/202), in the OG, 46% 
(821178) and in the mPFC, 78% (115/147) demonstrated significant responses 
to auditory stimuli. Of the units from the non-gating rats (n = 177; CA3, n = 78, 
OG, n = 33; mPFC = 66), in the CA3, 45% (35/78), in the OG, 70% (23/33) and 
in the mPFC, 53% (35/66) responded to auditory stimuli. Auditory responsive 
cells from the gating and the non-gating rats were examined separately. 
7.3.1 Auditory-evoked single-unit activity in the gating rats 
Of the aUditory-responsive units recorded in the CA3 of the gating rats 43% (n = 
45) were early excitatory units (Fig. 7.1A) and 57% (n = 60) were late excitatory 
units (Fig. 7.2A). In the OG, 34% (n = 28) were early excitatory (Fig. 7.18) while 
66% were (n = 54) late excitatory units (Fig. 7.28). The auditory responsive 
cells in the mPFC demonstrated a high percentage of late excitatory units (77%, 
n = 88; Fig. 7.1C) compared to early excitatory units 18% (n = 27; Fig. 7.2C). 
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7.3.1.1 The early excitatory cells in the gating rats 
The TIC ratios of the early excitatory cells in the gating rats 
The majority of early excitatory cells in the gating rats (CA3, 87%, n = 39; DG, 
93%, n =26; mPFC, 86%, n = 23) exhibited a significant decrease in unit activity 
(spike count I epoch) following the test stimulus compared to the activity 
following the conditioning stimulus in the CA3 (P<0.001), DG (P<0.001) and 
mPFC (P<0.01; Fig.7.1). All the early excitatory regions had a small percentage 
of early excitatory units with increased activity following the test stimulus 
compared to the conditioning stimulus (TIC >100%; CA3, 13%, n = 6; DG, 7%, 
n = 2; mPFC, 14%, n = 4) and they were excluded from further analysis due to 
the small (n) number. 
The early excitatory cells in the CA3 of the gating rats had a lower TIC ratio (45 
± 4%) compared to the TIC ratios in the DG (50 ± 5 %) and mPFC (54 ± 5%). 
There were no significant differences between the early excitatory single unit 
TIC ratios and the N2 LFP TIC ratios recorded from the same recording 
electrodes in the CA3 (36 ± 3%; P= 0.1), DG (38 ± 6%; P = 0.06) or mPFC (43 
± 5%;P = 0.2; Fig. 7.1). 
The peak latencies of the early excitatory cells in the gating rats 
The peak unit activity of the early excitatory cells in the CA3 started at 27 ± 2 
ms and peaked at 33 ± 1 ms following the conditioning stimuli (Fig. 7.1). The 
DG demonstrated peak activity with the onset at 27 ± 3 ms and peaking at 32 ± 
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0.4 ms following the conditioning stimuli. In the mPFC, the onset of the 
significant activity following the conditioning stimuli was at 26 ± 1 ms and 
demonstrated the highest peak at 30 ± 1 ms. The peak latency of the early 
excitatory units following the conditioning stimUli in the CA3, DG and mPFC 
were significantly shorter than the N2 LFP conditioning response latencies (Fig. 
7.1; CA3, N2 CLAT = 66 ± 2 ms, P<0.001; DG, N2 CLAT = 64 ± 1 ms, P<0.001; 
mPFC, N2 CLAT = 59 ± 1 ms ,P<0.01). However, the peak unit latencies were 
comparable to the P1 LFP latencies recorded from the three regions (CA3, P1 
CLAT = 40 ± 6 ms, P>0.05; DG P1 CLAT = 35 ± 2 ms, P>0.05; mPFC P1 CLAT 
= 32 ± 2 ms, P>0.05). 
The peak early excitatory unit activity following the test stimuli, started at 29 ± 2 
ms and peaked at 33 ± 1 ms in the CA3, started at 27 ± 1 ms and peaked at 32 
± 0.4 ms in the DG and started at 26 ± 2 ms and peaked at 31 ± 1 ms in the 
mPFC. 
Very small peak activities were observed in the early excitatory cells during the 
100ms - 300ms periods following the conditioning stimulus in the CA3 and the 
DG and between the 100ms-500ms in the mPFC (Fig. 7.1). These peaks were 
less prominent following the test stimuli in the three areas. 
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Fig. 7.1 Representative peri-stimulus time histograms (upper panels; 10ms bin, 
± 500ms peri-stimuli period) of the early excitatory cells and averaged LFPs 
(lower panels) obtained from the same recording electrodes used to record cells 
in (A) CA3, (8) DG and (C) mPFC of a gating rat. The dashed lines in the 
histograms indicate the mean firing rate (smaller lower line) and the 95% confidence 
limit (bigger-upper line). 
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The peri-stimulus histograms of the early excitatory cells in the (A) CA3 (B) DG and (C) mPFC 
demonstrated an early peak activity following the conditioning stimulus which was decreased 
following the test stimulus. The unit TIC ratios were comparable to the TIC ratios of the N2 wave in 
the averaged LFPs. The latencies of the peak unit activity following stimuli (CA3 peak =33 ms; DG 
peak = 32 ms; mPFC peak = 29 ms) were shorter than the N2 LFP latencies (CA3 CLAT = 58 ms; 
DG CLAT = 56 ms; mPFC CLAT=49 ms). 
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7.3.1.2 The late excitatory cells in the gating rats 
The TIC ratios of the late excitatory cells in the gating rats 
The majority of late excitatory cells in the gating rats (CA3, 83%, n = 50; DG, 
91 %, n =49; mPFC, 72%, n = 63) exhibited a significant decrease in the unit 
activity following the test stimuli compared to the activity following the 
conditioning stimuli in the CA3 (P<0.01), DG (P<0.01) and mPFC (P<0.01; 
Fig.7.2). All three regions had a small percentage of late excitatory cells with 
increased activity following the test stimuli compared to the conditioning stimuli 
(TIC >100%; CA3, 17%, n = 10; DG, 9%, n = 5; mPFC, 28%, n = 25) and these 
cells were excluded from further analysis due to the small (n) number. 
The late excitatory cells in the mPFC exhibited lower TIC ratios (54 ± 7%) 
compared to the TIC ratios in the CA3 (57 ± 5%) and DG (60 ± 3%). The unit 
TIC ratio was significantly higher than the N2 LFP TIC ratio in the CA3 (39 ± 
3%; P<0.001) and DG (41 ± 3%; P<0.001) recorded from the same recording 
electrodes (Fig. 7.2). No significant difference was observed between the late 
excitatory unit TIC ratio and the N2 LFP TIC ratio in the mPFC (44 ± 4%; 
P>0.05). 
The peak latencies of the late excitatory cells in the gating rats 
The late excitatory cells in the CA3 and the DG demonstrated a prominent peak 
activity in the 100 - 250 ms period following the onset of the conditioning stimuli 
with no prominent peak activities following the test stimuli (Fig. 7.2). The onset 
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of the peak activity in the CA3 was at 114 ± 3 ms which peaked at 151 ± 6 ms 
and in the DG the peak activity occurred later than the CA3 (DG onset = 131 ± 2 
ms, peak = 175 ± 3 ms). In the mPFC two prominent peak activities were 
observed following the conditioning stimuli which showed a significant decrease 
in activity following the test stimuli. The first peak started at 115 ± 7 ms and 
peaked at 152 ± 2 ms coinciding with the peak LE activity in the CA3. The 
second LE peak started at 252 ± 44 ms and peaked at 334 ± 7 ms. In some of 
the late excitatory cells recorded from the mPFC the first peak demonstrated a 
higher firing rate than the second peak (Fig. 7.3A; 63%; n = 38) and in another 
group of cells the second peak was higher than the first (Fig. 7.38; 24%; n = 15) 
while in some cells both peak activities were similar (Fig. 7.3C; 13%; n = 10). 
However, there were no significant differences between the TIC ratios of the 
three different LE cell response types (P>0.05) and were analysed together for 
basal and pharmacologically induced changes. 
There w ~ r e e no prominent peak activities in late excitatory cells coinciding with 
the P1 or N2 LFP peaks within the 100 ms period following the onset of the 
conditioning stimuli. The late excitatory peaks appeared to coincide with the P2 
LFP peak in the CA3 and DG and P2 and N3 wave in the mPFC (Fig. 7.2 and 
see chapters 2, 3 &4). 
There were no prominent peaks in late excitatory unit activity following the test 
stimuli in the CA3 and DG (Fig 7.2). In the mPFC a small increase in the unit 
activity was observed following the test stimuli, starting at 100 ± 2 ms with peak 
activity at 142 ± 24 ms. 
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Fig. 7.2 Representative peri-stimulus time histograms (upper panels; 10rns bin, 
± 500ms peri-stimuli period) of the late excitatory cells and averaged LFPs 
(lower panels) obtained from the same recording electrodes used to record cells 
in (A) CA3, (8) DG and (C) mPFC in a gating rat. 
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The peri-stimulus histograms of the late excitatory cells in the (A) CA3 (8) DG demonstrated a 
prominent peak activity during the mid inter-stimuli period (CA3 peak = 150 ms; DG peak = 168 
ms) which was decreased following the test stimulus. The TIC ratios in the CA3 and DG were 
higher than the TIC ratios of the N2 wave. The mPFC demonstrated two main peak activities, one 
during the mid inter-stimuli period (peak at 150 ms) and the other just before the test stimulus 
(peak at 340 ms) . No prominent peaks were observed following the test stimulus. The unit TIC 
ratio was similar to the N2 LFP TIC ratio . The dashed lines in the histograms indicate the mean 
firing rate (small lower line) and the 95% confidence limit (bigger upper line). 
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Fig. 7.3 Representative peri-stimulus time histograms (upper panels; 10ms bin, 
± 500ms peri-stimuli period) demonstrating different response types of late 
excitatory cells (A) high-Iow peaks (8) Low-high peaks (C) equal peaks in the 
mPFC of gating rats . 
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The peri-stimulus histograms of the late excitatory cells in the mPFC demonstrated two prominent 
peak activities following the conditioning stimulus; one during the mid inter-stimuli period (peak = 
152 ± 3 ms) and the other just before the test s'timulus (peak 334 ± 7 ms) . Some cells (n = 38) 
exhibited the highest peak activity during the mid inter-stimuli period (A), some had the highest 
peak just before the test stimulus (n = 15; 8) while other exhibited equal peak responses at both 
time points following the conditioning stimulUS (n = 10; C). There were no significant differences in 
the TIC ratios (P>(J.05). The dashed lines in the histograms indicate the mean firing rate (small 
dashes) and the 95% confidence limit (bigger- upper line) . 
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7.3.2 Auditory-evoked single unit activity in the non-gating rats 
Of the aUditory-responsive units recorded in the CA3 of the non-gating rats 43% 
(n = 15) were early excitatory and 57% (n = 20) were late excitatory units. In the 
DG 35% (n = 8) were early excitatory while 65% (n = 15) were late excitatory 
units. In the mPFC 23% (n = 8) were early excitatory while 77% (n = 27) were 
late excitatory units. 
7.3.2.1 The early excitatory cells in the non-gating rats 
The TIC ratios of the early excitatory cells in the non-gating rats 
The non-gating rats exhibited no significant changes in the unit activity following 
the test stimuli compared to the activity following the conditioning stimuli in the 
CA3, DG and mPFC (P>0.05; Fig.7.4). All three regions had a small 
percentage of early excitatory cells which demonstrated decreased activity 
following the test stimuli compared to the conditioning stimuli (CA3, 20%, n = 3; 
DG, 25%, n = 2; mPFC, 25%, n = 2) and were excluded from further analysis 
due to the small (n) number. 
The early excitatory cells in the CA3 of the non-gating rats had a lower TIC ratio 
(117 ± 6%) compared to the TIC ratios in the DG (138 ± 15%) and mPFC (125 ± 
35%). There were no significant differences between the single unit TIC ratios 
and the LFP TIC ratios (Fig. 7.4) recorded from the same recording electrodes 
in the CA3 (98 ± 10%; P = 0.07), DG (99 ± 38%; P = 0.09) or mPFC (118 ± 
20%; P = 0.7). 
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The peak latencies of the early excitatory cells in the non-gating rats 
The peak unit activity of the early excitatory cells in the CA3 started at 24 ± 2 
ms following the conditioning stimuli and peaked at 29 ± 2 ms. The DG 
demonstrated peak activity with the onset at 20 ± 0.3 ms and peaking at 29 ± 
0.3 ms. In the mPFC the onset of the significant activity following the 
conditioning stimuli was at 29 ± 0.4 ms and demonstrated the highest peak at 
34 ± 1 ms. The peak latency of the early excitatory units following the 
conditioning stimuli in the CA3, DG and mPFC were significantly shorter than 
the N2 LFP conditioning response latencies in the non-gating rats (CA3, N2 
CLAT = 55 ± 1 ms, P<0.001; DG, N2 CLAT = 55 ± 1 ms ,P<0.001; mPFC N2 
CLAT = 53 ± 1 ms, P<0.001). However, the peak unit latencies were 
comparable to the P1 LFP latencies recorded from the three regions (CA3, P1 
CLAT = 33 ± 5 ms, P>0.05, DG P1 CLAT = 32 ± 3 ms, P>0.05; mPFC, P1 
CLAT = 30 ± 4 ms, P>0.05). 
The peak early excitatory unit activity following the test stimuli, started at 20 ± 1 
ms and peaked at 32 ± 0.4 ms in the CA3, started at 23 ± 3 ms and peaked at 
31 ± 1 ms in the DG and started at 32 ± 0.3 ms and peaked at 33 ± 0.6 ms in 
the mPFC. 
There was an increased firing rate during 200 - 500ms inter-stimuli period which 
extended following the test stimuli in the CA3 and DG (Fig. 7.4 A&B). No 
increased unit activity was detected in the mPFC in the 200ms-500ms inter-
stimuli period (Fig. 7.4C). 
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7.3.2.2 The late excitatory cells in the non-gating rats 
The TIC ratios of the late excitatory cells in the non-gating rats 
The late excitatory cells (n = 62; CA3, n = 20; DG, n = 1S; mPFC, n = 27) in the 
non-gating rats exhibited multiple peak activities following both the conditioning 
and the test stimuli. There was no significant change in the unit activity following 
the test stimuli compared to the activity following the conditioning stimuli in the 
CA3, DG or mPFC (P>O.OS; Fig.7.S). All three regions had a small percentage 
of late excitatory cells with decreased unit activity following the test stimuli 
compared to the conditioning stimuli (CA3, 2S%, n = 4; DG, 20%, n = 3; mPFC, 
30%, n = 8) and were excluded from further analysis due to the small (n) n 
umber. 
The late excitatory cells in the DG exhibited lower mean TIC ratio (92 ± 6%) 
compared to the TIC ratios in the CA3 (98 ± 6%) and mPFC (97 ± S%). There 
were no significant differences between the single unit TIC ratios and the LFP 
TIC ratios (P>O.OS) recorded from the same recording electrodes in the CA3 (94 
± 6%; P = 0.3), DG (90 ± 8%; P = 0.8) or mPFC (104 ± 14%; P = 0.1) (Fig. 7.S). 
The peak latencies of the late excitatory cells in the non-gating rats 
The late excitatory cells in the CA3, DG and mPFC of the non-gating rats 
demonstrated multiple peak activities following the onset of the conditioning 
stimulus and the test stimulus with the highest peak activities observed during 
181 
the 200 -500ms inter-stimuli period and! or during 150 ms period following the 
onset of the test stimulus (Fig. 7.5). In the CA3 the peak activity started at 109 
± 5 ms and demonstrated the highest peak at 241 ± 22 ms following the 
conditioning stimulus and the second peak at 41 ± 9 ms following the test 
stimulus. In the DG a significant firing rate of the late excitatory cells started at 
143 ± 26 ms and peaked at 337 ± 47 ms following the conditioning stimulus and 
the second peak at 44 ± 5 ms following the test stimulus. In the mPFC the peak 
activity had a late onset compared to the CA3 and DG with a significant 
increase in the firing rate starting at 182 ± 25 ms and peaking at 408 ± 15 ms 
and 75 ± 19 ms following conditioning and test stimuli respectively. 
The peak unit activity did not appear to coincide with the LFP peaks in the CA3, 
DG or mPFC in the non-gating rats. 
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Fig. 7.4 Representative peri-stimulus histograms (upper panels; 10ms bin, ± 
500ms peri-stimuli period) of the early excitatory cells and averaged LFPs 
(lower panels) obtained from the same recording electrodes used to record cells 
in (A) CA3, (8) DG and (C) mPFC in a non-gating rat. 
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The peri-stimulus histograms of the (A) CA3 (8) DG and (C) mPFC demonstrated prominent peak 
activities following both conditioning and test stimuli. The unit TIC ratios were comparable to the 
TIC ratios of the N2 wave in the averaged LFPs. The latencies of the peak activi!y following stimuli 
(CA3 peak = 28 ms; DG peak = 30 ms; mPFC peak = 35 ms) were shorter than the N2 LFP 
latencies (CA3 CLAT = 54 ms; DG CLAT = 56 ms; mPFC CLAT= 53 ms). Increased peak activities 
were observed in ,the CA3 and DG during the later part of the inter-stimuli period . No increased 
neuronal firing compared to basal was observed during the inter-stimuli period following the initial 
peak response to the conditioning and test stimuli in the mPFC. The dashed lines in the 
histograms indicate the mean firing rate (small dashes) and the 95% confidence limit (bigger-
upper line) 
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Fig. 7.5 Representative peri-stimulus histograms (upper panels; 10ms bin, ± 
500ms peri-stimuli period) of the late excitatory cells and averaged LFPs (lower 
panels) obtained from the same recording electrode used to record cells in (A) 
CA3, (8) DG and (C) mPFC in a non-gating rat. 
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The peri'stimulus histograms of the (A) CA3 (8) DG and (C) mPFC demonstrated multiple peak 
activities during the inter·stimuli period which continued with increased peak activity following 
the test stimulus. The TIC ratios were comparable to the TIC ratios of the N2 wave in the 
averaged LFPs. Very little peak unit activities were observed during the 200ms period following 
the conditioning stimuli but there were multiple peaks during 200ms period following the test 
stimuli in the CA3/ DG and mPFC. Increased spike activity was also detected just before the 
onset of the test stimulus in the CA3, DG and mPFC of the non·gating rats. The dashed lines in 
the histograms indicate the mean firing rate (small dashes) and the 95% confidence limit 
(bigger- upper line) 
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7.3.3 Comparison of single-unit activity between gating and non 
gating rats 
The early excitatory and late excitatory unit activities in the gating (early 
excitatory cells: CA3, n = 26; DG n = 16; mPFC, n = 7; late excitatory cells: 
CA3, n = 22; DG, n = 25; mPFC, n = 21) and non-gating (early excitatory cells: 
CA3, n = 12; DG n = 6; mPFC, n = 6; late excitatory cells: CA3, n = 16; DG, n = 
12; mPFC, n = 19) rats were compared to assess whether there were any 
significant differences in the cell response types between the two rat groups. 
Statistical analysis used the Student t-test to compare the unit activity and 
response latency between the gating and the non-gating rats. 
7.3.3.1 Comparison of the early excitatory cell activity 
The basal early excitatory unit activity (pre-stimulus epoch count analysis) in the 
CA3 in tl:le non-gating rats was significantly higher than the basal unit activity of 
the gating rats (P = 0.0001; Fig. 7.6A). However, there were no significant 
differences in the basal early excitatory activity in the DG and mPFC of the non-
gating rats compared with the basal activity of the gating rats (DG, P = 0.3; 
mPFC, P = 0.1).The early excitatory spike activity following the conditioning 
stimuli was significantly higher in the CA3 (P = 0.002) but not in the DG (P = 
0.12) or mPFC (P = 0.9) of the non-gating rats compared to the early excitatory 
unit activity following the conditioning stimulus in the gating rats. Non-gating rats 
demonstrated significantly higher early excitatory unit activities following the test 
stimuli in all three areas (CA3, P<0.0001; DG, P = 0.007; mPFC, P = 0.02) 
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compared to the test stimuli-evoked activities in the gating rats. Moreover, the 
TIC ratios of the early excitatory unit activities were significantly higher in the 
CA3 (gating TIC = 46 ± 4%, non-gating TIC = 117 ± 6%; P<0.0001), DG (gating 
TIC = 59 ± 5%, non-gating TIC = 180 ± 14%; P<0.0001) and mPFC (gating TIC 
= 62 ± 25%, non-gating TIC = 79 ± 26%; P = 0.01) of the non-gating rats 
compared to the TIC ratios of the gating rats (Fig. 7. 6A). 
Comparison of the response latencies revealed that the peak of the spike 
activity following the conditioning stimulus in the non-gating rats occurred 
significantly earlier in the CA3 (P = 0.001) and DG (P = 0.01) compared to the 
gating rats. However, the conditioning peak latency in the mPFC of the non-
gating rats was significantly delayed than that of the gating rats (P = 0.001). The 
onset of the peak activity following the conditioning stimulus was not 
significantly different in the CA3 (P =0.2), but was significantly earlier in the DG 
(P = 0.01) and significantly delayed in the mPFC (P = 0.03) in the non-gating 
rats compared to the gating rats. 
The onset of the peak activity following the test stimuli was earlier in the CA3 (P 
= 0.002), delayed in the mPFC (P = 0.002) and not significantly different in the 
DG (0.2) in the non-gating rats compared to the gating rats. The latency of the 
peak activity following the test stimulus was not significantly different in the CA3 
(P = 0.4) or DG (P = 0.07) but was significantly delayed in the mPFC (P = 0.02) 
in the non-gating rats compared to the gating rats. 
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7.3.3.2 Comparison of the late excitatory cell activity 
The basal late excitatory unit activity (prior to auditory stimulation) in the non-
gating rats was significantly higher than the basal unit activity of the gating rats 
in the CA3 (P = 0.04), DG (P = 0.0005) and mPFC (P<0.0001; Fig. 7. 68). The 
LE spike activity following the conditioning stimuli was significantly higher in the 
DG (P = 0.003) but not in the CA3 (P = 0.2) and mPFC (P = 0.8) of the non-
gating rats compared to the late excitatory unit activity following the conditioning 
stimulus in the gating rats. Non-gating rats demonstrated significantly higher 
late excitatory unit activities following the test stimuli in all three areas (CA3, P= 
0.02; DG, P = 0.002; mPFC, P = 0.007) compared to the test stimuli-evoked 
activities in the gating rats resulting in significantly higher TIC ratios in the CA3 
(gating TIC = 57 ± 2%, non-gating TIC = 98 ± 6%; P<0.0001), DG (gating TIC = 
61 ± 3%, non-gating TIC = 92 ± 6%; P<0.0001) and mPFC (gating TIC = 56 ± 
3%, non-gating TIC = 97 ± 5%; P < 0.0001) of the non-gating rats compared to 
the TIC ratios of the gating rats (Fig. 7. 68). 
Comparison of the response latencies revealed that the peak latency of the 
spike activity following the conditioning stimulus in the non-gating rats was 
significantly delayed in the CA3 (P = 0.001), DG (P = 0.004) and mPFC (P = 
0.02) compared to the gating rats. The peak activity following the test stimulus 
was not significantly different in the CA3 (P =0.6) and DG (P = 0.3) but was 
significantly delayed in the mPFC (P<0.001) in the non-gating rats compared to 
the gating rats. 
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Fig. 7.6 Pooled epoch count data depicting the changes in the (A) early 
excitatory unit and (8) late excitatory unit activities (spike counts / epoch) in the 
non-gating rats (early excitatory cells : CA3, n = 12; DG n = 6; mPFC, n = 6; late 
excitatory cells: CA3, n = 16; DG, n = 12; mPFC, n = 19) compared to the gating 
rats (early excitatory cells: CA3, n = 26; DG n = 16; mPFC, n = 7; late excitatory 
cells: CA3, n = 22; DG, n = 25; mPFC, n = 21). Values = mean ± SEM. CACT = unit 
activity following the conditioning stimulus; TACT = unit activity following the test stimulus. 
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A. The basal activity and CACT of the early ex citatory cells were significantly higher in the CA3, 
but not in the DG or mPFC in the non-gating rats compared to the gating rats . The TACT and 
the TIC ratio were significantly higher in the CA3, DG and mPFC of the non-gating rats 
compared to the gating rats (* := P<O.01 ; ** := P<O.001 , *** := P<O.0001) . 
B. The basal activity of the late excitatory cells were significantly higher in the CA3, DG and 
mPFC, in the non-gating rats compared to the gating rats . The CACT in the DG, (but not in the 
CA3 or mPFC) was significantly higher in the non-gating rats compared to the gating rats. ~ h e e
TACT and the T/O ratio were significantly higher in the CA3, DG and mPFC of the non-gatlng 
rats compared to the gating rats (* := P<O.01 ; ** := P<O.001, *** := P<O.0001) . 
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7.3.4 Effects of pharmacological manipulations on the auditory-
evoked single unit activity in the gating rats 
Effects of PCP (1mg/kg, i.p) and WIN55,212-2 (1.2mg/kg, i.p) on the early 
excitatory and late excitatory unit activity (spike count I epoch) in the CA3, DG 
and mPFC were examined following auditory stimuli. Both PCP and 
WIN55,212-2 abolished the auditory responses in a small percentage of early 
excitatory cells and late excitatory cells in the CA3 (PCP, 19%, n = 3; 
WIN55,212-2, 27%, n = 4), DG (PCP, 25%, n = 2; WIN55,212-2, 22%, n = 2), 
and mPFC (PCP, 30%, n = 3; WIN55,212-2, 17%, n = 3), and only the cells 
which exhibited significant responses to auditory stimuli before and after drug 
administration were included in the subsequent analysis. 
7.3.4.1 Effects of PCP on the single-unit activity in the gating rats 
Effects of PCP on the early excitatory cells 
A total of 26 auditory responsive early excitatory cells (CA3, n = 13; DG, n = 6; 
mPFC, n = 7) were examined for the PCP induced changes in the unit activity 
(Fig. 7.7A & B, Fig. 7.8 A & B, Fig. 7.9 A & B). 
The early excitatory units exhibited no significant changes in activity following 
conditioning stimulus (CA3, P = 0.06; DG, P = 0.6; mPFC, P = 0.7) with PCP. 
However, PCP increased spike activity following the test stimulus in the CA3 
(P<0.0001; Fig. 7.7 A & B), DG (P = 0.003: 7.8 A & B) and mPFC (P = 0.004; 
7.9 A & B) resulting in significantly increased TIC ratios in the CA3 (Basal TIC = 
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46 ± 4%; PCP TIC = 105 ± 7%; P<0.0001), DG (Basal TIC = 44 ± 2%; PCP TIC 
= 102 ± 2%; P<0.0001) and mPFC (Basal TIC = 63 ± 7%; PCP TIC = 144 ± 
22%; P = 0.004) 45 min following drug administration (Table 7.1). 
Effects of pep on the late excitatory cells 
Thirty six auditory responsive late excitatory cells (CA3, n = 11; DG, n = 10; 
mPFC, n = 15) were studied for the changes in auditory-evoked responses 
following PCP (Fig. 7.7 C & D, Fig. 7.8 C & D, Fig. 7.9 C & D and Table 7.1). 
PCP had no significant effects on the unit activity following the conditioning 
stimulus in the CA3 (P = 0.2) or DG (P = 0.08), but increased the activity 
following the test stimulus (CA3, P = 0.009; DG, P = 0.04) resulting in significant 
increases in the TIC ratios in the CA3 (basal TIC = 60 ± 3%; PCP TIC = 115 ± 
8%; P<0.0001: Fig. 7.7 C & D) and DG (basal TIC = 62 ± 5%; PCP TIC = 97 ± 
7%; P = 0.0007; Fig. 7.8 C & D). In the mPFC, late excitatory unit activity 
following the test stimulus was not altered significantly (P = 0.6) following PCP. 
However, PCP decreased the unit activity following the conditioning stimulus (P 
=0.03) resulting in a significant increase in the late excitatory unit TIC ratio 
(Basal TIC = 59 ± 3%; PCP TIC = 97 ± 6%; P<0.0001) in the mPFC (Fig. 7.9 C 
& D and Table 7.1). 
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Fig. 7.7 Effects of PCP on the single-unit activity in the CA3 of a gating rat; 
representative peri-stimulus histograms (left panels; 10ms bin, ± SOOms peri-stimuli 
period) and the epoch counts (right panels; 10ms bin, peri-stimuli period ± 100ms for 
early excitatory and ± SOOms for late excitatory cells; y axis = spike counts per epoch) 
of the (A & B) early excitatory and (C & 0) late excitatory cells, basal activity 
compared to the activity 45 min following PCP. 
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A. Increased unit activity (spike counts/epoch) was observed in the early excitatory cells during 
the 100ms period following the conditioning stimulus (Epoch Number 2) compared to the 100ms 
pre-stimulus period (Epoch Number 1) with a reduction in peak response following the test 
stimulus (Epoch Number 3) . 
B. The early excitatory peak activity following the test stimulus increased resulting in an 
increase in the T/C ratio following PCP (1 mg/kg, i.p) administration . 
C. Late excitatory cells exhibited peak activity in the mid inter-stimuli period in the peri-stimulus 
histogram with increased activity in the 500ms period following the conditioning stimulus (Epoch 
2) compared to the 500ms pre-stimulus period (Epoch 1). There was a reduction in the peak 
activity following the test stimulus (Epoch 3). 
I 
D. The peak activity following the test stimulus increased resulting in an increase in the TIC ratio 
following PCP (1 mglkg, i.p) administration. There was also an increase in activity in the late 
inter-stimuli period (300 - 500 ms) in the histograms of the late excitatory cells following PCP. 
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Fig. 7.8 Effects of PCP on the single-unit activity in the DG of a gating rat; 
representative peri-stimulus histograms (left panels; 10ms bin, ± 500ms peri-stimuli 
period) and the epoch counts (right panels; 10ms bin, peri-stimuli period ± 100ms for 
early excitatory and ± 500ms for late excitatory cells; y axis =spike counts per epoch) 
of the (A & 8) early excitatory and (C & 0) late excitatory cells, basal activity 
compared to the activity 45 min following PCP. 
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A. Increased unit activity was observed in the early excitatory cells during the 1 DDms period 
following the conditioning stimulus (Epoch Number 2) compared to the 1 DDms pre-stimulus 
period (Epoch Number 1) with a reduction in peak response following the test stimulus (Epoch 
Number 3) . 
B. The peak activity following the test stimulus increased resulting in an increase in the TIC ratio 
following PCP (1 mglkg, Lp) administration. 
c. Late excitatory cells exhibited peak activity in the mid inter-stimuli period in the peri-stimulus 
histogram and increased activity in the 5DDms period following the conditioning stimulus (Epoch 
2) compared to .the 5DDms pre-stimuli period (Epoch 1). There was a reduction in the spike 
counts following the test stimulus (Epoch 3) . 
D. The spike count following the test stimulus increased resulting in an increase in the TIC ratio 
following PCP (1 mglkg , Lp) administration. 
192 
Fig. 7.9 Effects of PCP on the single-unit activity in the mPFC of a gating rat; 
representative peri-stimulus histograms (left panels; 10ms bin, ± 500ms peri-stimuli 
period) and the epoch counts (right panels; 10ms bin, peri-stimuli period ± 100ms for 
early excitatory and ± 500ms for late excitatory cells; y axis = spike counts per bin) of 
the (A & 8) early excitatory and (C & D) late excitatory cells, basal activity 
compared to the activity 45 min following PCP. 
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A. Increased un it activity was observed in the early excitatory cells during the 100ms period 
following the conditioning stimulus (Epoch Number 2) compared to the 100ms pre-stimulus 
period (Epoch Number 1) with a reduction in peak response following the test stimulus (Epoch 
Number 3). 
B. The peak activity following the test stimulus increased resulting in an increase in the TIC ratio 
following PCP (1 mglkg, Lp) administration. 
C. Late excitatory cells exhibited peak activity in the mid inter-stimuli period in the peri-stimulus 
histogram and increased activity in the 500ms period following the conditioning stimulus (Epoch 
2) compared to the 500ms pre-stimuli period (Epoch 1). There was a reduction in the peak 
activity following the test stimulus (Epoch 3) . 
D. The peak activity following the conditioning stimulus decreased resulting in an increase in the 
TIC ratio following PCP (1 mglkg, Lp) administration. 
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7.3.4.2 Effects of clozapine on the pep induced changes in the single-unit 
activity of the gating rats 
Effects of clozapine on the early excitatory cells 
A total of 17 auditory responsive early excitatory cells (CA3, n = 6; DG, n = 8; 
mPFC, n = 3) were examined for the effects of clozapine on the PCP-induced 
changes in the unit activity (spike count/epoch) using one way ANOVA followed 
by Tukey t- test (Table 7.1). 
Clozapine had no significant effect on the TIC ratios in the CA3 (P>0.05) or the 
DG (P>0.05) and prevented the PCP induced changes in the early excitatory 
unit activity following the test stimulus (CA3, P>0.05; DG, P>0.05) and in the 
TIC ratios in the CA3 (Basal TIC = 45 ± 11%; PCP TIC = 65 ± 12%; P>0.05) 
and DG (Basal TIC = 58 ± 3%; PCP TIC = 60 ± 9%; P>0.05). In the mPFC, 
clozapine significantly decreased early excitatory cell activity following the 
conditioning stimuli (P<0.05) and the test stimuli (P<0.05) compared to basal 
values. PCP increased the unit activity following the conditioning stimulus 
(P<0.01) and Test stimulus (P<0.01) of the early excitatory cells in the mPFC of 
the animals pre-treated with clozapine. Nevertheless, the alteration in the 
activities in response to both conditioning and test stimuli following clozapine 
resulted in no significant change in the early excitatory unit TIC ratio (Basal TIC 
= 58 ± 6%; CLOZ TIC = 77 ± 17%; P>0.05) and prevented the PCP induced 
changes in the TIC ratios (Basal TIC = 58 ± 6%; PCP TIC = 71 ± 15%; P>0.05) 
compared to basal values. 
194 
Effects of clozapine on the late excitatory cells 
A total of 56 aUditory-responsive late excitatory cells (CA3, n = 19; DG, n = 17; 
mPFC, n = 20) were examined for the effects of clozapine on the PCP induced 
changes in the unit activities using one-way ANOVA followed by Tukey t-test 
(Table 7.1). The late excitatory units in the CA3 and DG exhibited a decrease in 
the activities following the conditioning stimulus (CA3, P<0.001; DG, P>0.05) 
and Test stimulus (CA3, P<0.01; DG, P>0.05) resulting in a significant increase 
in the TIC ratio (CA3, Basal TIC = 58± 3%; CLOZ TIC = 73 ± 2%; P<0.001; DG, 
Basal TIC = 64 ± 3%; CLOZ TIC = 82 ± 6%; P<0.01) following clozapine. The 
late excitatory cells in the mPFC exhibited a significant reduction in the unit 
activities following the conditioning stimulus (P<0.001) and test stimulus 
(P<0.001) following clozapine administration, but no significant changes in the 
TIC ratios (Basal TIC = 59 ± 2%; CLOZ TIC = 62 ± 4%; P>0.05). However, PCP 
had no significant effects on the activities following the conditioning stimulus 
(P>0.05), the test stimulus (P>0.05) or the unit TIC ratio in the CA3 (Basal TIC = 
58 ± 3%; PCP TIC = 64 ± 3%; P>0.05), DG (Basal TIC = 64 ± 3%; PCP TIC = 
69 ± 3%; P>0.05) or mPFC (Basal TIC = 59 ± 2%; PCP TIC = 62 ± 2%; P>0.05) 
in the rats pre-treated with clozapine (Table 7.1) suggesting that clozapine 
prevented the PCP induced changes in the auditory-evoked late excitatory unit 
responses. 
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Table 7.1 Summary table of the unit activities (spikes count/epoch; epoch = 100ms for 
early excitatory cells and SOOms for late excitatory cells) following conditioning stimulus 
(CACT) and test stimulus (TACT) with the TIC ratios, 4S min after PCP administration 
(1 mg/kg; Lp; PCP 4S) in the gating rats not treated with clozapine and the gating rats 
pre-treated with clozapine (Smg/kg, Lp; CLOZ) compared to the basal values of the 
respective groups (8asal-1 and 8asal-2; * = P<O.OS, ** = P<O.01, *** = P<O.001). 
Region Basal-1 PCP45 Basal-2 CLOZ PCP45 
CA3 
Early excltatory 
cells (n = 13) (n = 6) 
CACT 98 ± 15 122 ± 23 144 ±27 142 ± 82 169 ± 65 (spikes/epoch) 
TACT 46 ± 10 112 ± 23*** 78± 30 113 ± 68 125 ± 61 
(spikes/epoch) 
TIC ratio (%) 46±4 105 ± 7*** 45 ± 10 43 ± 15 65 ± 11 
Late excltatory (n = 19) 
cells (n = 11) 
CACT 183 ± 25 231 ± 29 263 ± 55 133 ± 32*** 197 ± 25 
TACT 92 ± 9 201 ± 37** 166 ± 39 98 ± 24*** 133 ± 20 
TIC ratio 60± 3 115 ± 8*** 58 ±3 73 ± 2** 68 ±2 
~ ~
Early excltatory (n = 8) 
cells (n = 6) 
78 ±23 
CACT 148 ± 39 170 ± 26 159 ± 36 
119 ± 42 
TACT 62 ± 15 171 ± 26** 97 ± 24 81 ± 30 45 ± 13 
TIC ratio 44 ± 2 102 ± 2*** 58 ± 3 60 ±9 62 ± 3 
Late excltatory (n = 17) 
cells (n = 10) 
CACT 182 ± 32 379 ± 103 147 ± 35 79±27 63± 3 
TACT 122 ± 24 410 ± 131* 98 ± 28 55 ± 14 66 ± 5 
TIC ratio 62 ± 5 92 ± 5*** 64± 3 82 ± 6* 69± 3 
mPFC 
Early excltatory (n = 3) 
cells (n = 7 ) 
CACT 98 ± 18 109 ± 23 159 ± 27 64 ± 1** 216 ± 3* 
TACT 64 ± 16 150±28* 90 ± 10 48 ± 12* 158 ± 5** 
TIC ratio 63 ± 7 144 ± 22** 58 ± 6 77±17 71±3 
Late excitatory (n = 20) 
cells (n = 15 ) 
506 ± 65 
CACT 497 ± 84 277 ± 47* 476 ± 57 173 ± 22*** 
TACT 305 ± 59 263 ± 56 341 ± 48 123 ± 15*** 
372 ± 53 
59 ± 3 97 ± 6*** 59 ± 2 62 ±4 62 ± 2 TIC ratio 
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7.3.4.3 Effects of WIN55,212-2 on the single-unit activity in the gating rats 
Effects of WIN55,212-2 on the early excitatory cells 
A total of 30 auditory responsive early excitatory cells (CA3, n = 14; DG, n = 7; 
mPFC, n = 9) were examined for the WIN55,212-2 induced changes in the unit 
activities (Fig. 7.10 A & B, Fig. 7.11 A & B, Fig 7.12 A & B). 
The early excitatory units demonstrated no significant changes in the activity 
following the conditioning stimulus (CA3, P = 0.2; DG, P = 0.3; mPFC, P = 0.8) 
45min following WIN55,212-2 administration in the CA3, DG and mPFC (Table 
7.2). However, WIN55,212-2 increased unit activity following the test stimulus in 
the CA3 (P= 0.04), DG (P = 0.03) and mPFC (P = 0.01) resulting in significantly 
increased TIC ratios in the CA3 (Basal TIC = 41 ± 5%; WIN TIC = 75 ± 11 %; P 
= 0.009; Fig. 7.10 A & B), DG Basal TIC = 41 ± 10%; WIN TIC = 106 ± 9%; P < 
0.0001; Fig. 7.11 A & B) and mPFC (Basal TIC = 54 ± 2%; WIN TIC = 141± 
17%; P < 0.0001; Fig 7.12 A & B) 45 min following drug administration (Table 
7.2). 
Effects of WIN55,212-2 on the late excitatory cells 
Thirty two auditory responsive late excitatory cells (CA3, n = 6; DG, n = 9; 
mPFC, n = 17) were studied for the changes in basal and auditory-evoked 
responses following WIN55,212-2 (Fig. 7.10 C & D, Fig. 7.11 C & D, Fig 7.12 C 
& D). 
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WIN55,212-2 administration had no significant effect on the activity following the 
conditioning stimulus (P>0.05) or the test stimulus (P>0.05) in the CA3, DG and 
mPFC. However, there were significant increases in the TIC ratios of the late 
excitatory cells in the CA3 (Basal TIC = 51 ± 5%; WIN TIC = 73 ± 4%; P = 0.02; 
Fig. 7.10 C & D) and mPFC (Basal TIC = 52 ± 13%; WIN TIC = 71 ± 4%; P = 
0.009; Fig 7.12 C & D) but not in DG (Basal TIC = 53 ± 2%; WIN TIC = 57 ± 3%; 
P = 0.2; Fig. 7.11 C & D) following WIN55,212-2 (Table 7.2). 
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Fig. 7.10 Effects of WIN55,212-2 on the single unit activity in the CA3 of a 
gating rat; representative peri-stimulus histograms (left panels; 10ms bin, ± 500ms 
peri-stimuli period) and the epoch counts (right panels; 10ms bin, peri-stimuli period ± 
100ms for early excitatory and ± 500ms for late excitatory cells; y axis = spike counts 
per bin) of the (A & 8) early excitatory and (C & D) late excitatory cells, basal 
activity compared to the activity 45min following WIN55,212-2 (WIN) . 
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A. Increased unit activity was observed in the early excitatory cells during the 100ms period 
following the conditioning stimulus (Epoch Number 2) compared to the 100ms pre-stimulus 
period (Epoch Number 1) with a reduction in peak response following the test stimulus (Epoch 
Number 3) . 
B. The peak activity following the test stimulus increased resulting in an increase in the TIC ratio 
following WIN55,212-2 (1 .2mg/kg, i.p) administrati'on. 
C. Late excitatory cells exhibited peak activity in the mid inter-stimuli period in the peri-stimulus 
histogram and increased activity in the 500ms period following the conditioning stimulus (Epoch 
2) compared to the 500ms pre-stimuli period (Epoch 1). There was a reduction in the peak 
activity following the test stimulus (Epoch 3) . 
D. The peak activity following the test stimulus increased resulting in an increase in the TIC ratio 
following WIN55,212-2 (1 .2mg/kg, i.p) administration. 
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Fig. 7.11 Effects of WIN55,212-2 on the single unit activity in the DG of a 
gating rat; representative peri-stimulus histograms (left panels; 10ms bin, ± 500ms 
peri-stimuli period) and the epoch counts (right panels; 10ms bin, peri-stimuli period ± 
100ms for early excitatory and ± 500ms for late excitatory cells; y axis = spike counts 
per bin) of the (A & 8) early excitatory and (C & D) late excitatory cells, basal 
activity compared to the activity 45min following WIN55,212-2 (WIN). 
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A. Increased unit activity was observed in the early excitatory cells during the 100ms period 
following the conditioning stimulus (Epoch Number 2) compared to the 100ms pre-stimulus 
period (Epoch Number 1) with a reduction in spike activity following the test stimulus (Epoch 
Number 3) . 
B. The spike activity following the test stimulus increased resulting in an increase in the TIC 
ratio following WINSS,212-2 (1 .2mg/kg, Lp) admin!stration . 
C. Late excitatory cells exhibited increased firing in the mid inter-stimuli period in the peri-
stimulus histogram and increased activity in the SOOms period following the conditioning 
stimulus (EpQch 2) compared to the SOOms pre-stimuli period (Epoch 1). There was a reduction 
in the spike activity following the test stimulus (Epoch 3). 
I 
D. There was no change in the peak activity following the conditioning stimulus or the test 
stimulus resulting in no change in the TIC ratio following WINSS,212-2 (1 .2mg/kg, i.p) 
administration. 
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Fig. 7.12 Effects of WIN55,212-2 on the single unit activity in the mPFC of a 
gating rat; representative peri-stimulus histograms (left panels; 10ms bin, ± 500ms 
peri-stimuli period) and the epoch counts (right panels; 10ms bin, peri-stimuli period ± 
100ms for early excitatory cells and ± 500ms for late excitatory cells; y axis = counts 
per bin) of the (A & 8) early excitatory and (C & D) late excitatory cells , basal 
activity compared to the activity 45min following WIN55,212-2 (WIN). 
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A. Increased unit activity was observed in the early excitatory cells during the 100ms period 
following the conditioning stimulus (Epoch Number 2) compared to the 100ms before the onset 
of the conditioning stimulus (Epoch Number 1) with a reduction in peak response following the 
test stimulus (Epoch Number 3). 
B. The peak activity following the test stimulus increased resulting in an increase in the TIC ratio 
following WINSS,212-2 (1 .2mg/kg , i.p) administration. 
C. Late excitatory cells exhibited peak activity in the mid inter-stimuli period in the peri-stimulus 
histogram and increased activity in the SOOms period following the conditioning stimulus (Epoch 
2) compared to the SOOms pre-stimuli period (Epoch 1). There was a reduction in the peak 
activity following the test stimulus (Epoch 3) . 
D. The spike activity of the late excitatory cells increased following the test stimulus resulting in 
an increase in the TIC ratio following WINSS,212-2 (1 .2mg/kg, i. p) administration. 
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7.3.4.4 Effects of SR141716A on the WIN55,212-2 induced changes in the 
single-unit activity of the gating rats 
Effects of SR141716A on the early excitatory cells 
Auditory responsive early excitatory cells (n = 15) in the CA3 (n = 6), DG (n = 5) 
and mPFC (n = 4) were examined for the effects of the CB1 receptor 
antagonist, SR141716A on the WIN55,212-2 induced changes in the unit 
activity (Table 7.2). 
Administration of SR141716A had no significant effect on the activity following 
the conditioning stimulus (P>0.05), test stimulus (P>0.05) or the TIC ratios 
(P>0.05) of the early excitatory cells in the CA3 and DG. In the mPFC, 
SR141716A had no effect on the activity following the conditioning stimulus 
(P>0.05) but significantly decreased the activity following the test stimulus 
(P<0.01) and the TIC ratio (Basal TIC = 58 ± 4%; SR TIC = 38 ± 1%; P<0.05) 
compared to pre-drug values. WIN55,212-2 failed to increase activity following 
the test stimulus (P>0.05) or the TIC ratios of the early excitatory cells in the 
CA3 (Basal TIC = 46 ± 16%; WIN TIC = 50 ± 15%; P>0.05), DG (Basal TIC = 
59 ± 6%; WIN TIC = 52 ± 5%; P>0.05) or mPFC (Basal TIC = 58 ± 4%; WIN TIC 
= 50 ± 5%; P>0.05) in the gating rats pre-treated with SR141716A. 
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Effects of SR141716A on the late excitatory cells 
Thirty eight auditory responsive late excitatory cells (CA3, n = 14; OG, n = 13; 
mPFC, n = 11) were examined for the effects of SR141716A on the WIN55,212-
2 induced changes in the unit activity (Table 7.2). 
The late excitatory cells in the CA3 and OG demonstrated no change in the 
activity following the conditioning stimulus (CA3, P>O.05; OG, P>O.05) but a 
significant decrease in the activity following the test stimulUS (CA3, P<O.01; OG, 
P<O.001) resulting in a significant decrease in the TIC ratio (CA3, TIC basal = 
55 ± 3%, TIC SR = 32± 9%, P<O.001; OG, TIC basal = 56 ± 3%, SR TIC ratio = 
27 ± 7%, P<O.001) following SR141716A. The late excitatory cells in the mPFC 
exhibited a significant increase in the activity following the conditioning stimulus 
(P<O.001) and the test stimulus (P<O.001) resulting in a significant increase in 
the TIC ratios (TIC basal = 49 ± 5%, TIC SR = 78 ± 9%, P<O.01) following 
SR141716A. WIN55,212-2 increased the activity following the conditioning 
stimulus in the CA3 (P<O.01) and OG (P<O.05), but had no effect on the unit 
activity following the test stimulus (P>O.05) or the TIC ratios in the CA3 (basal 
TIC = 55 ± 3%; WIN TIC = 57 ± 5%; P>O.05) or OG (basal TIC = 56 ± 5%; WIN 
TIC = 55 ± 4%; P>O.05) with pre-treatment of SR141716A. In the mPFC, 
WIN55,212-2 increased the unit activity following the conditioning stimulUS 
(P<O.001) and the test stimulus (P<O.01) resulting in a significant increase in 
the late unit TIC ratio (TIC basal = 49 ± 5%, TIC WIN = 79 ± 3%, P<O.01) in the 
rats pre-treated with SR141716A (Table 7.2). 
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Table 7.2 Summary table of the unit activities (spikes counts/epoch; epoch =100ms for 
early excitatory cells; SOOms for late excitatory cells) following conditioning stimulus 
(CACT) and test stimulus (TACT) with the T/C ratios, 4S min after WINSS,212-2 
(1.2mg/kg, i.p; WIN 4S) in the gating rats not treated with SR141716A and the gating rats 
pre-treated with SR141716A (1mg/kg, Lp; SR) compared to the basal values of the 
respective groups (8asal-1 and 8asal-2; * = P<O.OS, ** = P<O.01, *** = P<O.001). 
Region 8asal·1 WIN 45 8asal·2 SR WIN 45 
CA3 
Early excltatory (n. 6) 
cells (n • 14) 
CACT 172 ± 14 167 ± 74 122 ± 17 95 ± 16 110±41 
(spikes/epoch) 
TACT 147 ± 58* 74 ± 13 45 ± 12 48 ± 12 81±6 
( spikes/epoch) 
50 ± 15 57 ± 27 
TIC ratio (%) 41±5 75±11** 46 ± 16 
Late excltatory (n = 14) 
cells (n .6) 
CACT 216 ± 45 274 ± 54 209 ±43 308 ± 56 368 ± 65** 
TACT 126 ±25 177 ± 35 155 ± 36 114 ± 32 257 ± 56 
TIC ratio 51± 5 73 ±4* 55±3 32 ± 9*** 57 ±5 
ru! 
Early excitatory (n = 5) 
cells (n = 7) 
CACT 131 ± 10 140 ± 14 108 ± 15 96±6 81 ± 7* 
TACT 64 ± 15 142 ± 14* 66 ±5 59 ± 11 45±6 
TIC ratio 41 ± 10 106 ± 9*** 59 ± 5 57 ± 10 52 ± 5 
Late excltatory (n = 13) 
cells (n = 9) 
CACT 162 ± 31 195 ± 37 157 ± 28 193 ± 38 197 ± 34 
TACT 90 ± 19 108 ± 20 103 ± 18 35 ± 7*** 119 ± 27 
TIC ratio 53 ±2 57 ± 3 56 ± 5 27 ± 7*** 
55 ±4 
mPFC 
Early excitatory (n = 4) 
cells (n = 9) 
CACT 89 ± 11 86 ± 15 144 ± 25 123 ± 12 107 ± 24 
TACT 51±4 93 ± 12* 82 ± 8 47 ± 5** 50 ±6* 
TIC ratio 54 ± 2 141 ± 17*** 58±4 38 ± 1* 50 ± 5 
Late excitatory (n = 11) 
cells (n = 17) 
CACT '465 ± 96 401 ± 47 288 ± 58 499 ± 66*** 538 ± 54*** 
TACT 196 ± 52 227 ± 56 109 ± 51 275 ± 44* 348 ± 42** 
TIC ratio 50± 3 66 ± 4** 49± 5 78 ± 9** 
79 ± 3** 
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7.4 Discussion 
The current study demonstrated two different single-unit response types (early 
excitatory and late excitatory) in response to the conditioning stimulus with a 
significant reduction in the activity following the test stimulus in the CA3, DG 
and mPFC of the gating rats under isoflurane anaesthesia. Non-gating rats 
demonstrated higher test response activity measured as spike countsl epoch 
and higher TIC ratios of both early excitatory and late excitatory units compared 
to the gating rats. Administration of PCP or WIN55,212-2 increased the TIC 
ratios of one or both cell types in the CA3, DG and mPFC in the gating rats. 
Pre-administration of clozapine prevented the unit activity changes induced by 
PCP while SR141716A prevented the unit activity changes induced by 
WIN55,212-2. 
The auditory-evoked unit responses recorded from the CA3 region of the 
current study agree with some of the findings of previous studies which have 
detected prominent single unit responses to auditory conditioning-test paradigm 
in the CA3. In parallel to previous reports, the present study recorded a high 
percentage of auditory-responsive cells in the CA3 under anaesthesia (52%; 
Bickford et al., 1990; Miller and Freedman, 1993, 1995) and contrasts the 
finding of Moxon et al (1999) who reported only 15% percent of auditory-
responsive cells in the CA3 of freely moving rats. It is possible that anaesthesia 
improves the responsiveness to auditory stimuli by controlling other sensory 
inputs and preventing animal movements both of which can influence auditory 
responses in the brain. 
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The previous studies have detected early excitatory cells in the CA3 similar to 
those observed in the current study both under anaesthesia (Bickford-wimer et 
al., 1990; Miller et al., 1992; Miller and Freedman., 1995) and in freely moving 
rats (Moxon., et al., 1999). However, the current early excitatory peak occurred 
later (33ms) than the latencies reported in the previous studies (Bickford-Wimer 
et al., 1990, peak latency = 27 ms; Miller and Freedman, 1995, peak latency = 
28 ms; Moxon et al., 1999, peak latency = 20 ms) an effect, which could 
possibly be attributable to isoflurane anaesthesia, a drug that delays sensory-
evoked neuronal responses in the rat brain (Detsch et al., 2002). Similar to the 
finding of the other studies, the present study shows that the early excitatory 
peak occurred before the N2/N40 LFP peak in the CA3 (Bickford-Wimer et al., 
1990; Miller et al., 1992; Miller and Freeman., 1995; Moxon et al.,1999) 
suggesting the possibility that neuronal firing could be responsible for the 
subsequent evoked potential generation. However, we have found that the P1 
LFP latency corresponds to the peak unit activity of the early excitatory cells, 
suggesting that early unit excitation may be responsible for an early LFP activity 
which may be important to prime the N2 response and gating in the auditory 
conditioning-test paradigm. The unit TIC ratios were similar to the N2 LFP TIC 
ratio indicating that the early excitatory activity was correlated with N2 response 
gating. 
Miller and Freedman (1995) identified the early excitatory cells in the CA3 as 
pyramidal cells and also detected late excitatory cells similar to those observed 
in the current study, which were classified as interneurons, in the CA3 of both 
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the gating and the non-gating rats. This putative interneuron activity 
demonstrated multiple peaks during the inter-stimuli period and also 
demonstrated an inverse relationship with the putative pyramidal cells indicating 
inhibition of pyramidal cell activity by the interneurons in the gating rats (Miller 
and Freedman, 1995). The late excitatory cells in the current study also 
exhibited increased activity during the inter-stimuli period when the activity of 
the early excitatory cells were diminished suggesting the possibility of inhibitory 
control on early excitatory cells by the late excitatory cells in the gating rats. In 
contrast, the present study failed to detect correlated activity between pyramidal 
and interneurons within the first 100ms following the condition stimulus reported 
by Miller and Freedman (1995). Miller and Freedman suggested that the 
conditioning stimulus activates both pyramidal cells and interneurons 
simultaneously and continuous activation of the interneurons, especially during 
the 250ms inter-stimuli period, mediates a reduction of the test response of the 
pyramidal cells. According to the current findings, it appears that early excitatory 
cells are jnitially activated by the conditioning stimulus which activates the firing 
of the late excitatory cells which in turn inhibit the activity of the early excitatory 
cells to mediate gating of the test response. These recurrent inhibitory and 
excitatory relationships are consistent with intrinsic mechanisms between 
pyramidal cells and the interneurons in the CA3 of the hippocampus (see 1.2). 
However, auditory gating in the CA3 can not be solely attributable to the 
intrinsic recurrent inhibitory mechanisms, since the input from the areas such as 
the medial septum (Miller and Freedman, 1993), the brain stem (Bickford et 
al., 1993) and dentate gyrus (Moxon et al., 2003) have been shown to modulate 
the single-unit gating in the CA3. 
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The early excitatory and late excitatory unit responses in the dentate gyrus were 
similar to those recorded from the CA3, and the peak activity occurred earlier 
compared to the peaks of the CA3, suggesting that DG neurons are activated 
by the auditory stimuli prior to the activation of CA3 neurons. This observation 
also agrees with the latency measurements seen in the LFPs (see 3.3.1) 
indicating that DG functions as the preceding step to the CA3 in the multi step 
process of sensory gating and may also serve as a thoroughfare of gating 
information from cortical areas to CA3. 
The current study observed a similar percentage of auditory-responsive cells 
(78%) to the percentage reported by Mears et al (2006; 75%) in the mPFC in 
the freely moving rats suggesting that the anaesthetic effects may not have 
greatly influenced the auditory responsiveness in the mPFC. The early 
excitatory activity recorded from the mPFC in the current study is also 
comparable to the excitatory short duration units recorded from the mPFC by 
Mears et al (2003). Moreover, the peak latency of the early excitatory cells of 
the current study (30 ± 1 ms) is similar the peak latency they have observed (28 
± 6 ms) in the excitatory short duration cells. Mears and colleagues also 
observed gating of the peak activity similar to the gating of the early excitatory 
cells recorded in this study. However, they reported significantly higher LFP TIC 
ratios compared to the unit TIC ratios of the excitatory cells in the mPFC and 
suggested that these two levels of neuronal information (Le. LFPs and unit 
activity) might r ~ p r e s e n t t distinct sources or influences (Mears et al., 2006). We 
have not observed a significant difference between the TIC ratios of LFPs and 
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excitatory units possibly because we have selected the N2 wave for LFP 
analysis, while the Mears group selected the P60 wave which is of slightly 
prolonged latency compared to the N2 wave. We have not observed the 
excitatory long duration cells or the inhibitory cells reported by Mears et al 
(2003), but observed late excitatory cells with two prominent peaks in the inter-
stimuli period. The peaks appeared to coincide with the LFPs of longer latency 
(Le. P2, N3). It is possible that behavioural status or anaesthesia could alter the 
response patterns of auditory responsive neurons giving rise to the differences 
observed between the two studies. Nevertheless, Cromwell and his colleagues 
observed similar single-unit response types to the auditory conditioning-test 
paradigm in the mPFC (Mears et al. ,2006) , amygdala (Cromwell et aI., 2005), 
striatum (Anstrom et aI., 2007) and the midbrain (Cromwell et al., 2007) in freely 
moving rats and the current study observed similar response types in the CA3, 
DG and mPFC under isoflurane anesthesia indicating that single-unit gating 
responses are constant and pervasive across the areas mediating the auditory 
gating m ~ c h a n i s m m irrespective of the effects of anaesthesia. 
The non-gating rats demonstrated significant increases in the test response unit 
activity resulting in significantly higher TIC ratios compared to the gating rats in 
the CA3, DG and mPFC. These findings are similar to the results obtained with 
LFP responses (see chapter 3 and 4) confirming the possibility of neuronal 
dysfunctions mediating the gating process in the non-gating rat population. 
Miller and Freedman (1995) reported a lower percentage of auditory responsive 
cells in the CA3 region of the non-gating rats compared to the gating rats. We 
have observed a markedly lower percentage of auditory responsive cells in the 
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mPFC (53%) but not in the CA3 (45%) or DG (70%) in the non-gating rats 
compared to the gating rats. Non-gating rats also showed marked increase in 
the pre-stimulus firing rate of the interneurons in the CA3 (Miller and 
Freedman., 1995) which is similar to that observed with early excitatory cells in 
the CA3 and late excitatory cells in the DG and mPFC. Miller and Freedman 
(1995) failed to observe auditory responsive pyramidal cells in the CA3, but 
reported lower firing rate in pyramidal cells during the pre-stimulus period in the 
CA 1 region of the hippocampus in the non-gating rats. 
We have observed similar response patterns in the early excitatory cells with 
increased early peak activities following both conditioning and test stimuli in the 
CA3, DG and mPFC, to the pyramidal cells recorded from the CA 1 region of the 
non-gating rats by Miller and Freedman (1995). Late excitatory cells in the CA3, 
DG and mPFC also demonstrated a comparable response pattern to the 
interneurons in the CA3 with delayed peak activities in the inter-stimuli period 
compared to the gating rats suggesting a selective loss or alteration in late 
excitatory linterneuron response patterns in the non-gating rats (Miller and 
Freedman., 1995). Based on the findings of the current study and the study by 
Miller and Freedman (1995), it is possible to conclude that the activity of the late 
excitatory cells during the inter-stimuli period is crucial for normal gating and 
this activity is altered in the non-gating rats in the CA3, DG and mPFC. 
Supporting the finding of Miller et al (1992), which demonstrated disruption of 
pyramidal cell gating following local administration of phencyclidine, the current 
study demonstrated increased TIC ratios of the early excitatory and late 
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excitatory cells in the CA3, DG and mPFC following intra-peritoneal 
administration of PCP. These findings are similar to the changes in auditory-
evoked LFP responses recorded from the CA3, DG and mPFC in the gating rats 
following PCP (see chapter 5). The response patterns of late excitatory cells 
during the inter-stimuli period also changed with increased spike activity just 
before and after the test stimuli following PCP in all three regions (Fig. 7.7, Fig. 
7.8, Fig. 7.9), which support our view that the inter-stimuli activity of the late 
excitatory cells is a key factor in gating mechanisms at cellular level. As 
discussed in chapter 5, NMDA antagonists can reduce recurrent inhibition in 
neuronal networks, presumably by blocking the NMDA receptor dependent 
excitatory drive on the inhibitory interneurons which reduces the GABAergic 
inhibition on pyramidal cell activity causing hyper-excitation of the neuronal 
circuits (Jodo et al., 2005). The change in response pattern of the late excitatory 
cells with increased activity following the test stimulus in both cell types after 
PCP administration, indicate the disruptive effects of the NMDA antagonist on 
the intrinsic inhibitory pathways in the CA3, DG and mPFC which also explains 
the disruption of LFP gating following PCP observed in chapter 5. Systemic 
administration of NMDA antagonists have also been shown to disturb several 
other neurochemical systems including a profound dysregulation of the 
mesocorticolimbic dopamine system resulting in a severe impairment of the 
dynamic physiological response range of the neurons (Svensson, 2000). NMDA 
antagonists such as PCP has been shown to disrupt hippocampal function at 
the cellular level either following local application or following systemic 
administration (Jodo et al., 2005 ). However, mPFC neurons are not affected by 
local application of NMDA antagonists, but demonstrate tonic long lasting 
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hyper-activation following local application to the hippocampus, suggesting a 
hippocampal regulation of the mPFC neuronal activity (Jodo et al., 2005). The 
effects of PCP on auditory gating at cellular level in the CA3, DG and mPFC 
could therefore involve dysregulation of multiple neurotransmitter systems and 
hyper-activation or inhibition of reciprocal connections between the regions 
involved in the process. 
Clozapine, the atypical anti-psychotic drug which antagonises the 
noradrenergic, dopaminergic and serotoninergic transmission (see 1.5.1), 
prevented the PCP induced changes in the single-unit gating correlating with 
the changes observed with the LFP activity in chapter 5, emphasising its ability 
to act on PCP targets. Furthermore, clozapine decreased the single unit 
responses to the conditioning and test stimuli especially of the late excitatory 
cell types in the CA3, DG and mPFC suggesting the possibility that clozapine 
decreases the cell sensitivity to auditory stimUli probably by hyperpolarising 
some auditory responsive cells which in turn could increase the threshold of the 
PCP targets. 
The cannabinoid agonist, WIN55,212-2, disrupted single-unit gating in the CA3, 
DG and mPFC with changes comparable to the LFP changes recorded in the 
regions and also similar to the changes in the unit activities observed with PCP. 
The effect ofWIN55,212-2 were prevented by the CB1 antagonist, SR141716A, 
suggesting that the WIN55,212-2 induced changes in the single-unit activities 
were mediated via the CB 1 receptors. As discussed in chapter 6 the CB 1 
receptors are highly localized in the inhibitory neurons in the PFC and 
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hippocampus (Wilson and Nicoll, 2002) and activation of these receptors 
causes a reduction in release of the inhibitory neurotransmitter GABA (DSI; 
Wilson and Nicoll, 2002). Lack of GABAergic inhibition results in hyperactivity of 
the corticolimbic neurons, increases distractibility and disrupt sensory gating 
(Freedman, 2008). However, the effects of WIN55,212-2 were not as robust as 
the effects of PCP on the gating at single-unit level and did not affect gating of 
the late excitatory cells in the DG. It is possible that the effect of WIN55,212-2 
on sensory gating could be dose-dependent and administration of higher doses 
might have produced more disruptive effects on the two cell types. 
Nevertheless, the dose of WIN55,212-2 used (1.2mg/kg, i.p) exhibited profound 
effects on gating at LFP level which highlights the distinct pharmacological 
effects by the CB1 agonists on these two types of neuronal recordings. 
SR141716A decreased the TIC ratios of the late excitatory cells in the CA3 and 
DG (Table 7.2) producing an enhancement or improved gating in the areas. 
Apart from the effect on the GABAergic neurons CB 1 receptor activation has 
been shown to activate firing of the mesoprefrontocortical dopamine neurons 
and release dopamine in the pre-frontal cortex (Pistis et al., 2001). When 
administered alone SR141716A has been shown to inhibit a percentage of 
these dopaminergic neurons thus decreasing the excitability of the areas (Pistis 
et al., 2001). Increased GABAergic inhibition and lack of dopaminergic drive 
could explain the enhanced gating observed following SR141716A. However, 
SR141716A on its own had no effect on the LFP gating in any of the areas. 
Based on the definition of LFP activity as the vector sum of all the synaptic 
responses in the vicinity of the recording electrodes, it could be argued that 
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SR141716A may not have a total effect on the neural responses to the 
conditioning-test paradigm. However, similar to the finding with WIN55,212-2 it 
is also possible that CB1 antagonists have differential effects on LFP and 
single-unit activity. 
Studying the gating properties of neurons in the CA3, DG and mPFC in the 
Lister hooded rats under isoflurane anesthesia extended the results obtained 
from LFP recordings, to infer the cellular mechanisms underlying the auditory 
gating process. The results of the pharmacological effects on the neurons in the 
CA3, DG and mPFC broadened the understanding of the effects of the NMDA 
antagonist, PCP, and the cannabinoid agonist, WIN55,212-2 on the sensory 
gating process at the single-unit level and also opened doors for future 
electrophysiological and pharmacological research on sensory gating and 
schizophrenia. 
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8. General Discussion 
The previous chapters of the thesis discussed the findings of the current study 
in relation to the presence or absence of auditory gating in the CA3, DG and 
mPFC and the effects of pharmacological manipulations on the gating 
processes in the three areas. The general discussion of this thesis focuses on 
three important aspects of the auditory gating process, expanded and improved 
through findings of the current study; (1) the putative pathway for auditory 
gating in the CNS, (2) the putative neuronal mechanisms of auditory gating and 
(3) modelling schizophrenia using auditory gating deficits. 
8.1 Auditory gating pathway in the eNS 
In the current study, gating of the auditory responses was observed in the CA3, 
DG and the mPFC. Based on the latency differences and also the findings from 
other studies (Grunwald et aI., 2003; Kurthen et aI., 2007) it is possible to 
suggest that the mPFC region participates in the gating process prior to the 
hippocampus and that the CA3 region is the ultimate mediator of the process 
(see chapter 4). This is more evident with the CA3 region demonstrating lower 
TIC ratios compared to the mPFC (see chapter 4). The DG is quite likely the 
thoroughfare of gating information from the mPFC to the CA3. As mentioned in 
chapter 1, auditory gating has been detected in several other brain areas 
including the brain stem reticular formation (Bickford et aI., 1990, 1993; Moxon 
et al., 1999; Anstrom et al., 2007), medial septum (Miller and Freedman, 1993; 
Moxon et al., 1999), reticular thalamus (Krause et al., 2003), amygdala 
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(Cromwell et al., 2005) and striatum (Cromwell et al., 2007). Thus it is obvious 
that the gating mechanism is more widespread than the leminiscal pathway 
suggested by Moxon et al (1999; see Fig. 1.3). Recent human studies also 
suggest the existence of a pathway mediating the auditory gating process 
distinct from the well established auditory pathway which runs from the cochlea 
to the auditory cortex (Leavitt et al., 2007). Combining the finding of the current 
study with those of the previous studies a more complex auditory gating 
pathway propagating information to the CA3 is proposed. The figure 8.1 
highlights the putative stages of auditory gating process subserved by the 
mPFC, DG and CA3. As discussed in chapter 4, the projection of gating 
information to the mPFC is likely to be from the brain stem reticular areas which 
receive auditory inputs from the cochlear nucleus. Brain stem reticular region 
has been suggested to project gating information to the amygdala (Cromwell et 
al., 2005) and striatum (Cromwell et al., 2007). Krause et al (2003) suggested 
that the auditory gating information to the reticular thalamus arrives via the 
cholinergic afferents from the pons. Miller and Freedman (1993) reported that 
the medial septul neurons acquire auditory gating information from the brain 
stem reticular nucleus and proposed that the gating process originates from the 
brain stem. Thus brain stem has adequate evidence to be pronounced as the 
main distributor of the auditory gating information to the cortical and subcortical 
areas postulated in the gating pathway (Fig. 8.1). The CA3 of hippocampus 
receives the auditory gating information via the medial septum, enterohinal 
cortex and the dentate gyrus. The auditory gating process thus culminates in 
the CA3 and in turn assists the CA3 to modulate information processing in the 
PFC and the subcortical areas via its reciprocal connections. Two other areas 
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worth exploring in relation to the auditory gating are the nucleus accumbens 
and the ventral tegmental area which are important structures in the 
dopaminergic pathways in the CNS and influences the mPFC and hippocampal 
responses in crucial cognitive processes such as memory and learning (Goto 
and Grace, 2008). Yang et al (2006) suggested the presence of auditory gating 
in the ventral tegmental area and the neucleus accumbens in their multiple site 
recording study. However, neither characterization of the responses nor any 
relationship between areas was reported in the study as the focus was to 
demonstrate the effects of pharmacological manipulations (Yang et al., 2006). 
The results of the current study strengthen the findings of the previous studies 
and provide further evidence to a potential complex neural circuitry that 
regulates early attentive sensory processing reflected by the gating of the mid-
latency auditory responses. However, though the present findings favour the 
possibility, it is too early to argue that auditory gating is sharpened or improved 
by the subsequent components of the postulated circuits without recording from 
more areas in the circuitry simultaneously. Moxon et al (1999) found that the 
brain stem had the lowest TIC ratio compared to the medial septum and the 
CA3 and doubted that the gating process improved in the subsequent stages in 
the non-Ieminiscal pathway. Future work can build on the current findings in the 
search for the neural circuitry behind auditory gating and would be beneficial to 
perform simUltaneous multiple site recordings including the CA3 and brainstem 
to assist comparing and correlating regional responses. 
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Fig. 8.1 Putative neural circuitry of auditory gating information flow to the CA3 
of hippocampus from the brain stem. Brain stem receives auditory inputs via the 
cochlear nerve and subserves as the distributor of gating information to the cortical and 
subcortical structures. The CA3 region functions as the culminating point of auditory 
gating process. 
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8.2 Neural mechanisms of auditory gating 
Unravelling the exact neuronal mechanisms involved in sensory gating will 
advance the research on mechanisms behind cognitive brain functions and 
improve the diagnostic and therapeutic approaches to schizophrenia. Studies 
on auditory gating postulate that the decrement of the test response amplitude 
is mediated via the inhibitory mechanisms activated by the conditioning stimulus 
(Adler et aI., 1982). 
In the previous chapters the importance of the reciprocal connections between 
the GABAergic inhibitory interneurons and the glutamertigic excitatory 
pyramidal cells in mediating the auditory gating process was highlighted. 
According to the current findings we proposed that the early excitatory cells 
activate the late excitatory cells in the CA3, DG and mPFC following the 
conditioning stimulus and the late excitatory cells attenuated the test response 
of the early excitatory cells. Thus analysis of both the LFP activity and the 
single-unit activity in response to the auditory conditioning-test paradigm 
demonstrated the importance of inhibitory drive on the excitatory responses 
during the inter-stimuli period to suppress the test response amplitude. 
The current study emphasizes the importance of the integrity of glutamatergic 
and GABAergic neurotransmission for auditory gating by demonstrating the 
disruption of gating by NMDA antagonist, PCP and CB1 agonist, WIN55, 212-2 
(Fig. 8.2). Depending on the duration of the gating mechanism auditory gating is 
postulated to be mediated by long-acting GABAB mechanisms (Hershman et aI., 
1995; Moxon et al., 2003). Experimental evidence for this view was provided by 
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Hershman et al (1995) who demonstrated that the GABAs antagonists disrupt 
auditory gating in the rat CA3. Disruption of gating by the cannabinoid agonists 
has been postulated to be mediated via the suppression of pre-synaptic GABAs 
activity (Zachariou et al., 2008). Since the experimental evidences are not 
sufficient enough to pinpoint to GABAs receptor activity as the neurochemical 
mechanism of gating in the neural pathway proposed in Fig. 8.1, it is an 
interesting avenue for future experiments on neurophysiology of auditory gating 
and its' deficits in neuropsychiatric diseases. 
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Figure 8.2 Schematic representations of reciprocal connections between pyramidal 
cells (P) and interneurons (I) within a neural substrate mediating gating accompanied 
with the postulated extrinsic inputs i.e. GABAergic, glutamatergic and nicotinic, and the 
effects of pep and WIN55,212-2 (- = inhibition; + = excitation). 
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The multiplicity of the pharmacological actions of PCP and the reversal of its 
effects by clozapine indicated the involvement of the dopaminergic, 
serotonergic, noradrenergic and cholinergic mechanisms in mediating the 
auditory gating process (see chapter 5 and 7). 
The nicotinic cholinergic input to the neural substrates mediating auditory 
gating, though not discussed in detail in the thesis, is considered an important 
mechanism for normal gating (Fig. 8.2). Separation of medial septal cholinergic 
inputs has been shown to disrupt auditory gating in the CA3 which was 
corrected by nicotinic agonists (Miller and Freedman, 1993). The nicotinic 
receptor agonists have been shown to improve gating in schizophrenic patients 
(Martin et al., 2004) as well as the animal models (Stevens et al., 1998). It has 
also been suggested that clozapine improves auditory gating deficits by 
stimulating alpha-7 nicotinic receptors in the brain (Simosky et al., 2003). Adler 
et al (1998) in their review on sensory gating, nicotinic receptors and 
schizophrenia, proposed that in the paired stimulus paradigm, the first auditory 
stimulus activates the pyramidal cells in the CA3 through the perforant path 
input from the entorhinal cortex and the granule cell input from the dentate 
gyrus. They suggested that the nicotinic cholinergic input from the medial 
septum is also activated following the conditioning stimulus so that there is a 
burst of activity in the pyramidal cells as their entire network excites itself (Adler 
et al., 1998). The excitatory postsynaptic potentials associated with this massive 
excitation were suggested to give rise to the P50 wave observed on the scalp 
surface of humans and the N2 wave in the rat CA3 (Adler et al., 1998). The 
inhibitory neurons, especially those that likely activate GABAB receptors, were 
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also posited to be activated by the first stimulus (Adler et al., 1998). These 
neurons with high concentration of alpha7-nicotinic receptors were suggested to 
form channels that admit large amounts of calcium into the cells, which sustain 
a long-lasting excitation (Adler et al., 1998). The simultaneous activation of the 
NMDA receptors, which have a similar ability to admit calcium, was also 
suggested to join in to produce a long-lasting excitation of inhibitory neurons in 
the hippocampus. Adler et al (1998) proposed GABAs receptor activation 
inhibits release of glutamate from the granule cell mossy fibre synapses and 
from the recurrent pyramidal cell synapses but not the perforant path input. 
Thus, the second stimulus can engender only a modest excitation of the 
pyramidal cells and not the burst of recurrent excitation elicited by the first 
stimulus thereby diminishing the P50/N2 response to the second stimulus (Adler 
et al., 1998). So it is worth exploring experimentally whether the simultaneous 
nicotinic inputs on the excitatory glutamatergic neurons and the GABAs 
interneurons can mediate auditory gating in the neural substrates suggested in 
Fig.8.1 and participate in the neural mechanisms as postulated in Fig.8.2. 
The present findings demonstrated that the exogenous CB 1 agonists disrupt 
gating. However, the role of the endocannabnoid system in the auditory gating 
process is still unclear. Though the CB1 antagonist, SR141716A alone had no 
effect on the auditory-evoked LFP responses, it improved gating of the early 
excitatory and late excitatory cells in the CA3 and DG and had the opposite 
effects in the mPFC. Related to the current findings it could be argued that the 
inhibition of a tonically active endocannabnoid system in the brain may not 
produce effects on the cumulative neuronal responses related to gating 
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represented by LFPs but can have differential effects on the underlying specific 
neural responses. Both WIN55,212-2 and SR141716A had been shown to 
exhibit affinity towards a 'non-CB1, non-CB2' (some times referred to as CB3) 
cannabinoid receptor type suggested to be found in the CNS (Wilson and Nicoll, 
2002) and further studies on these effects may explain some of the 
contradictory effects observed in the different neuronal responses. 
The analysis of the single-unit activity in the current study focussed mainly to 
examine the stimuli-locked activities in response to auditory stimuli in the gating 
and the non-gating rats and to correlate the changes with the LFP activity and 
also to examine the effects of pharmacological manipulations on the unit activity 
of the gating rats in the CA3, DG and mPFC. Attempts were not made to 
examine the basic properties (Le. wave form analysis, basal firing rate, burst 
activity) of neurons to identify the cell types (e.g. pyramidal cells or 
interneurons). If not for the time constraints, these analyses would have 
provided. more information regarding the observations made in the current 
study. However, further analysiS of the current data with respect to the 
identification of the cell types and also assessing neuronal correlations between 
regions during the gating process and following pharmacological manipulations 
would enhance the understanding of the neuronal mechanisms responsible for 
auditory gating. 
Future studies examining the neuronal mechanisms could advance the current 
finding by examining the role played by the serotonergic agents in the gating 
process and also by examining whether GABAB agonists could prevent or 
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reverse the gating deficits induced by pep or WIN55,212-2, which will not only 
confirm the role played by GABAs receptors in the process but could suggest a 
therapeutic target for gating deficits observed in neuropsychiatric diseases. 
8.3 Modelling auditory gating deficits in schizophrenia 
There are several potential difficulties in modeling schizophrenia in animals, 
including the caveat of reproducing an essentially cognitive disorder in less 
cognitively developed animals. Accordingly, current animal models of 
schizophrenia are not intended to serve as the complete animal equivalent of 
the human disorder, but are often designed to test causative and mechanistic 
hypotheses (Marcotte et al., 2001). 
As mentioned in chapter 3, comparison of our findings with previous rat studies 
on auditory gating requires the consideration of the methodological differences. 
Previous. studies have used either Sprague-Dawley or Wistar rats who were 
either freely moving or under injectable anaesthetics (Bickford et aI., 1990; 
Moxon et al., 1999; Krause et al., 2003). We have used Lister-hooded rats 
under isoflurane anaesthesia. Lister hooded rats have been shown to be more 
sensitive to pre-pulse inhibition paradigm especially with pharmacological 
manipulations (Varty & Higgins, 1994; Kalnichev and Pemberton, 2005) and it 
was postulated that they would be more sensitive to the auditory-conditioning 
test paradigm compared to other rat strains. Isoflurane is an easily maintainable 
gaseous anesthetic which minimises the fluctuation of the level of anaesthesia. 
The advantage of using anaesthetised rats is the ability to control sensory 
inputs and movements, both of which can influence auditory responses in 
225 
polysensory areas (Miller & Freeciman, 1995). Adopting a change in the 
methodology was expected to produce an animal model of auditory gating with 
a better predictive validity and an easier approach to invasive recording. 
As reviewed by de Bruin et al (2003), one of the main problems in comparing rat 
studies on sensory gating aiming to model human deficits, is the lack of 
standardized methodology as opposed to human recordings, resulting in 
different studies describing different components of rat AERs as the PSO 
equivalent. Some studies propose an early vertex component (P13) as the rat 
equivalent of PSO (Miyazato et aI., 1995; 1996; 1999) while others suggest the 
vertex N40 (Boutros et al., 1997; Boutros and Kwan, 1998) or NSO/N2 (Adler et 
al., 1986; De Bruin et al., 2001) as the PSO equivalent. Studies recording AERs 
from CA3 region of the hippocampus proposed N3S (De Bruin et al., 1999; 
2001) or N40 (Bickford et al., 1990; 1993; Miller et al., 1992) wave as the rat 
homologues of PSO. Drug-induced changes observed with both vertex N40/NSO 
components and hippocampal N3S/N40 components which are comparable to 
PSO changes are strong arguments in favour of these negative waves, since 
such changes have not been reported with P13 (de Bruin et al., 2003). The 
different methods adopted by different groups in identification of N40 could lead 
to misidentification of early negative components N2S1 N20/N1 as N40, giving 
rise to differences in latency, amplitude and gating values. 
Human studies have attempted to correct the error of identifying P30 as PSO by 
having a higher latency value for the lower limit of the latency range (e.g. 40 
ms) and identifying PSO as the second positive wave in the AER complex 
(Nagamoto et aI., 1999; Boutros et aI., 1999; 2004). Identification of AER 
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according to the polarity and order of occurrence has been adopted by some 
rodent studies (Van Luijtelaar et al., 2001). However, this method of 
identification of AER requires the elicitation of wave form complexes in rats 
comparable to human AER complexes which is not commonly reported in 
hippocampal CA3 recordings. Adler et al (1986) reported positive and negative 
waveform complexes within 100ms from the onset of the conditioning stimulus, 
which are similar to the AERs recorded in the present study. However, the 
same study reported morphological differences (e.g. absence of N1) observed 
in Sprague-Dawley rats obtained from different breeding sources which 
suggests the possibility of environmental factors affecting the morphology of rat 
AERs. 
The waveforms recorded after 100 ms in the present study (P2, N3) have not 
been reported from rat hippocampus so far. However, as described in chapter 1 
human studies have consistently shown scalp recorded waveforms of similar 
latencies which are representative of higher cognitive stages of information 
processing (Cadenhead et al., 2000; Soutros et al., 2004). Thus, the P2 and N3 
recorded from this study could be homologues to human N 1 00 and P200 
recordings, respectively. Post-100 ms waveforms demonstrated apparent gating 
in response to the test stimulus which is also in accordance with the findings of 
human studies (Soutros et al., 2004). Here we have focused on the N2 mid 
latency wave which is occurring in a latency range comparable to P50 and also 
has the same order of occurrence as the P50 in the AER wave form complexes. 
Based on the findings of the current study, it is quite likely that strain differences 
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also affect the AER morphology and gating with Lister-hooded rats 
demonstrating AER complexes and gating which are more equivalent to human 
AERs compared to the other rat strains. 
8.3.1 The non-gating rats as a model of auditory gating deficits 
in schizophrenia 
The non-gating rats exhibited some changes such as shorter response 
latencies and the negative correlation between the conditioning amplitude and 
the TIC ratio similar to those reported in schizophrenic patients (Adler et al., 
1982). Related to the findings of the present study, we suggested that the non-
gating rats could be harbouring neurodevelopmental or neurochemical 
abnormalities comparable to some of the deficits observed in schizophrenia 
(see chapter 3 & 4). It could also be suggested that this rat group could be 
sharing ~ o m e e genetic mutations similar to the rat genotypes (WAG/Rij) or mice 
genotypes (DBAl2) with gating difficulties and would be a cheaper source for 
future experiments. However, there are obvious limitations in relation to the 
usage of this rat group for future research. One is that the non-gating rats can 
not be separately identified from the gating rats prior to electrophysiological 
experiments. Furthermore, the TIC ratios of the non-gating rats were resistant 
to PCP and WIN55,212-2 treatment and did not improve with clozapine 
treatment (see chapter 5 and 6) , thus shedding doubts whether the gating 
deficits in this rat group represent gating deficits in schizophrenia. However, the 
single-unit analysis of the non-gating rats revealed alternation in the response 
patterns of the inhibitory inputs on the excitatory responses which might 
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represent the deficits in the GABAergic inhibitory processes in schizophrenia. 
Thus non-gating rats may have a place in future studies on sensory gating 
deficits in schizophrenia despite the considerable limitations. 
8.3.2 Single dose pep treatment to model auditory gating 
deficits in schizophrenia 
Reviewing the studies on pep, Morris et al (2005) suggested that "pep can be 
used in rodents to produce a pattern of metabolic, neurochemical and 
behavioural changes that reproduces almost exactly those seen in patients with 
schizophrenia". Some researchers prefer sub-acute and chronic administration 
of pep to acute/ single administration as the chronic pep has been shown to 
produce long-lasting cognitive and structural deficits resembling those seen in 
schizophrenia and is considered more representative of the deficits than those 
created following single administration. However, Jentsch and Roth (1999) 
reported that both acute and chronic administration of pep produce similar 
behavioural and cognitive deficits in both human and animals apart from the 
differences in the duration of the effects and some associated structural 
changes. Though the deficits are short-term and reversible, the acute 
administration of pep holds an important place in modelling cognitive and 
behavioural abnormalities of schizophrenia in animal models (Jentsch and Roth, 
1999). 
In the current study we used single dose pep under isoflurane anesthesia to 
model auditory gating deficits in Lister-hooded rats. The anaesthetic properties 
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of isoflurane are mediated mainly via the G A B ~ ~ agonist effects. In adult 
humans GABAA activation has been shown to enhance the voltage-dependent 
Mg2+ block of NMDA channels and decrease the Ca2+ influx through NMDA 
channels thus decreasing glutamatergic neural transmission (Xiang et aI., 
1996). The GABAergic enhancement would be expected to improve auditory 
gating and the glutamate inhibition may be expected to disrupt gating. However, 
the robust gating of auditory responses under isoflurane anaesthesia suggested 
that the hypoglutamatergic effect of isoflurane did not disrupt gating. 
Furthermore, observation of consistently non-gating animals, which have been 
reported in previous studies of freely moving animals, suggest the G A B ~ ~
enhancement had no effect on any deficits in the inhibitory mechanism of this 
rat group. This again brings out the possibility that GABAB activation is the 
inhibitory process behind the neural mechanism of gating. Based on the current 
findings it is possible to argue that isoflurane neither had an effect on the gating 
properties of the Lister hooded rats nor altered the effects of PCP on their 
gating parameters. 
Previous studies examining the dose-response of PCP and clozapine were 
used to identify the minimum effective dose of the drugs when given 
intraperitoneally (Miller et al., 1992; Joy et al., 2004). The decision was made 
only to do studies with higher or lower doses if the dose selected failed to have 
an effect on gating or if there were side effects affecting the results. This 
approach was taken to minimise the number of animals used for the study. 
However, further studies on the dose response relationship of PCP and the 
effects of clozapine on PCP-induced effects would significantly enhance the 
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findings of the current study towards developing an animal model of gating 
deficits. 
As discussed in chapter 5 and 7, the acute administration of PCP disrupted 
auditory gating in the CA3, DG and mPFC and the PCP induced disruption was 
prevented by clozapine, resembling the gating deficits observed in the 
schizophrenic patients. According to Geyer and Markou (1994) a valid animal 
model of schizophrenia should exhibit some symptomatic isomorphism with the 
disease, presents a robust and a reproducible measure that can be objectively 
quantified and yield predictive insight to novel treatment strategies. Findings of 
the current study indicate that auditory gating deficits following a single systemic 
administration of PCP to Lister hooded rats under isoflurane anaesthesia 
possess the qualities of a valid animal model of gating deficits observed in 
schizophrenia. This study could be considered as an open door for the future 
studies to examine the effects of chronic PCP in anesthetised and freely moving 
rats to improve and produce an animal model with a high predictive validity to 
advance research on gating abnormalities and treatment of schizophrenia. 
8.3.2 Single dose WIN55,212-2 treatment to model auditory 
gating deficits in schizophrenia 
As discussed in chapter 1 and 6 previous research has provided evidence to 
link cannabis and schizophrenia. The findings of the present study added more 
evidence to the proposed link. The effect of single dose WIN55,212-2 on 
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auditory gating was similar to those observed following acute PCP 
administration suggesting the possibility of using auditory gating deficits 
following WIN55,212-2 to pharmacologically model information processing 
deficits observed in schizophrenic patients. It would be interesting to find out 
whether clozapine could prevent or reverse the gating deficits induced by 
WIN55,212-2; if the deficits are prevented the findings would improve the 
predictive validity of the acute WIN55,212-2 model and if not prevented it could 
be argued that the WIN55,212-2 induced deficits may represent the cognitive 
deficits that are resistant to clozapine treatment. Clozapine has been shown to 
alter the CB 1 receptor activity in rats and attenuated the maximal stimulation of 
CB1 receptors in the PFC by L\9-THC (Wiley et al., 2008). Clozapine also 
decreases binding of the CB1 receptor agonist, C55,940 in the nucleus 
accumbens (Sundram et al., 2005). Above findings indicate that some of the 
'atypical' effects of clozapine could be mediated via the CB1 receptors and 
future research would improve the understanding of the neurochemical 
properties of clozapine and its relationship with the endocannabnoid system. 
Interestingly a recent study showed that the chronic intermittent PCP treatment 
altered CB 1 receptor functions and elevated endocannabinoid levels in the rat 
PFC suggesting that PCP induced deficits could be related to the imbalance of 
the endocannabnoid system (Vigano et al., 2008). Furthermore, Tzavara et al 
(2003) demonstrated that SR141716A reverses the PCP induced 
hyperlocomotion in mice and also has procholinergic properties and mild 
stimulatory effects on serotonin and noradrenaline, suggesting it as a unique 
candidate for treating cognitive disorders. The above studies implicate a link 
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between the effects observed with PCP and WIN55,212-2 in the current study 
suggesting auditory gating deficits observed with them could indicate a link 
between the NMDA hypofunction and endocannabnoid dysregulation. 
8.4 Conclusion 
The current study is the first to show that CB1 receptor agonist, WIN55,212-2 
disrupts auditory gating in the CA3, DG and mPFC by affecting the inhibitory 
mechanisms attenuating the test response, thus providing evidence to a 
potential role played by the endocannabnoid system in the neuronal 
mechanisms behind auditory gating. The present study is also the first to 
demonstrate that clozapine reverses the auditory gating deficits induced by 
PCP, which apart from the clinical implications discussed in 8.3.2, highlights the 
complexity of the neurophysiology of auditory gating. The current study 
expanded the studies linking NMDA hypofunction and cannabis with auditory 
gating deficits in schizophrenia and suggested pharmacological models using 
PCP and WIN55,212-2 for further studies on these deficits. Furthermore the 
current findings with SR141716A also suggest the endocannabnoid system as a 
possible therapeutic target for schizophrenia. 
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